The Goodyear Tire & Rubber Company (GT) 10-K 9 Feb 21 2020 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2020	Jan. 31, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Document Fiscal Period Focus	FY
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Period End Date	Dec. 31, 2020
Current Fiscal Year End Date	--12-31
Document Annual Report	true
Document Transition Report	false
Entity File Number	1-1927
Entity Registrant Name	THE GOODYEAR TIRE & RUBBER COMPANY
Entity Central Index Key	0000042582
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	34-0253240
Entity Address, Address Line One	200 Innovation Way
Entity Address, City or Town	Akron
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44316-0001
City Area Code	330
Local Phone Number	796-2121
Title of 12(b) Security	Common Stock, Without Par Value
Trading Symbol	GT
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2.1
Entity Common Stock Outstanding		233,220,098
Documents Incorporated by Reference	Portions of the Company’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 12, 2021 are incorporated by reference in Part III.

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net Sales	$ 12,321	$ 14,745	$ 15,475
Cost of Goods Sold	10,337	11,602	11,961
Selling, Administrative and General Expense	2,192	2,323	2,312
Goodwill and Other Asset Impairments	330	0	0
Rationalizations	159	205	44
Interest Expense	324	340	321
Other (Income) Expense	119	98	(174)
Income (Loss) before Income Taxes	(1,140)	177	1,011
United States and Foreign Tax Expense	110	474	303
Net Income (Loss)	(1,250)	(297)	708
Less: Minority Shareholders’ Net Income	4	14	15
Goodyear Net Income (Loss)	$ (1,254)	$ (311)	$ 693
Goodyear Net Income (Loss) — Per Share of Common Stock
Basic (in dollars per share)	$ (5.35)	$ (1.33)	$ 2.92
Weighted Average Shares Outstanding (in shares)	234	233	237
Diluted (in dollars per share)	$ (5.35)	$ (1.33)	$ 2.89
Weighted Average Shares Outstanding (in shares)	234	233	239

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net Income (Loss)	$ (1,250)	$ (297)	$ 708
Other Comprehensive Income (Loss):
Foreign currency translation, net of tax of $4 in 2020 ($4 in 2019, ($10) in 2018)	(134)	5	(264)
Defined benefit plans:
Amortization of prior service cost and unrecognized gains and losses included in total benefit cost, net of tax of $35 in 2020 ($33 in 2019, $34 in 2018)	109	104	105
(Increase)/decrease in net actuarial losses, net of tax of ($10) in 2020 (($42) in 2019, $1 in 2018)	(3)	(169)	16
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures, net of tax of $7 in 2020 ($2 in 2019, $5 in 2018)	22	4	20
Prior service credit (cost) from plan amendments, net of tax of ($1) in 2020 ($1 in 2019, ($3) in 2018)	(2)	1	(12)
Deferred derivative gains (losses), net of tax of $0 in 2020 ($0 in 2019, $3 in 2018)	15	10	9
Reclassification adjustment for amounts recognized in income, net of tax of $0 in 2020 ($0 in 2019, $0 in 2018)	(13)	(14)	7
Other Comprehensive Income (Loss)	(6)	(59)	(119)
Comprehensive Income (Loss)	(1,256)	(356)	589
Less: Comprehensive Income (Loss) Attributable to Minority Shareholders	(3)	15	(4)
Goodyear Comprehensive Income (Loss)	$ (1,253)	$ (371)	$ 593

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement Of Income And Comprehensive Income [Abstract]
Tax on foreign currency translation	$ 4	$ 4	$ (10)
Defined benefit plans:
Tax on amortization of prior service cost and unrecognized gains and losses included in total benefit cost	35	33	34
Tax on (increase)/decrease in net actuarial losses	(10)	(42)	1
Tax on immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures	7	2	5
Tax on prior service (credit) cost from plan amendments	(1)	1	(3)
Tax effect of deferred derivative gains (losses)	0	0	3
Tax effect of reclassification adjustment for amounts recognized in income	$ 0	$ 0	$ 0

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and Cash Equivalents	$ 1,539	$ 908
Accounts Receivable, net	1,691	1,941
Inventories	2,153	2,851
Prepaid Expenses and Other Current Assets	237	234
Total Current Assets	5,620	5,934
Goodwill (Note 11)	408	565
Intangible Assets (Note 11)	135	137
Deferred Income Taxes	1,467	1,527
Other Assets (Note 12)	952	959
Operating Lease Right-of-Use Assets	851	855
Property, Plant and Equipment	7,073	7,208
Total Assets	16,506	17,185
Current Liabilities:
Accounts Payable — Trade	2,945	2,908
Compensation and Benefits	540	536
Other Current Liabilities	865	734
Notes Payable and Overdrafts	406	348
Operating Lease Liabilities due Within One Year	198	199
Long Term Debt and Finance Leases due Within One Year	152	562
Total Current Liabilities	5,106	5,287
Operating Lease Liabilities	684	668
Long Term Debt and Finance Leases	5,432	4,753
Compensation and Benefits	1,470	1,334
Deferred Income Taxes	84	90
Other Long Term Liabilities	471	508
Total Liabilities	13,247	12,640
Commitments and Contingent Liabilities	0	0
Common Stock, no par value:
Authorized, 450 million shares, Outstanding shares — 233 million (233 million in 2019)	233	233
Capital Surplus	2,171	2,141
Retained Earnings	4,809	6,113
Accumulated Other Comprehensive Loss	(4,135)	(4,136)
Goodyear Shareholders’ Equity	3,078	4,351
Minority Shareholders’ Equity — Nonredeemable	181	194
Total Shareholders’ Equity	3,259	4,545
Total Liabilities and Shareholders’ Equity	$ 16,506	$ 17,185

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Common Stock, par value (in dollars per share)	$ 0	$ 0
Common Stock, shares authorized (in shares)	450,000,000	450,000,000
Common Stock, shares outstanding (in shares)	233,000,000	233,000,000

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Capital Surplus	Retained Earnings	Retained EarningsCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Goodyear Shareholders' Equity	Goodyear Shareholders' EquityCumulative Effect, Period of Adoption, Adjustment	Minority Shareholders' Equity - Non-Redeemable
Beginning balance at Dec. 31, 2017	$ 4,850	$ (1)	$ 240	$ 2,295	$ 6,044	$ (1)	$ (3,976)	$ 4,603	$ (1)	$ 247
Common stock beginning balance (in shares) at Dec. 31, 2017			240,154,602
Comprehensive income (loss):
Net Income (Loss)	708				693			693		15
Foreign currency translation, net of tax of $4 in 2020 ($4 in 2019, ($10) in 2018)	(264)						(245)	(245)		(19)
Amortization of prior service cost and unrecognized gains and losses included in total benefit cost, net of tax of $35 in 2020 ($33 in 2019, $34 in 2018)	105						105	105
(Increase)/decrease in net actuarial losses, net of tax of ($10) in 2020 (($42) in 2019, $1 in 2018)	16						16	16
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures, net of tax of $7 in 2020 ($2 in 2019, $5 in 2018)	20						20	20
Prior service credit (cost) from plan amendments, net of tax of ($1) in 2020 ($1 in 2019, ($3) in 2018)	(12)						(12)	(12)
Deferred derivative gains (losses), net of tax of $0 in 2020 ($0 in 2019, $3 in 2018)	9						9	9
Reclassification adjustment for amounts recognized in income, net of tax of $0 in 2020 ($0 in 2019, $0 in 2018)	7						7	7
Other Comprehensive Income (Loss)	(119)							(100)		(19)
Comprehensive Income (Loss)	$ 589							593		(4)
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201409Member
Stock-based compensation plans	$ 19			19				19
Repurchase of common stock	(220)		$ (9)	(211)				(220)
Repurchase of common stock (in shares)			(8,936,302)
Dividends declared	(147)				(139)			(139)		(8)
Common stock issued from treasury	4		$ 1	3				4
Common stock issued from treasury (in shares)			952,743
Purchase of minority shares	(24)			5				5		(29)
Ending balance at Dec. 31, 2018	5,070	(23)	$ 232	2,111	6,597	(23)	(4,076)	4,864	(23)	206
Common stock ending balance (in shares) at Dec. 31, 2018			232,171,043
Comprehensive income (loss):
Net Income (Loss)	(297)				(311)			(311)		14
Foreign currency translation, net of tax of $4 in 2020 ($4 in 2019, ($10) in 2018)	5						4	4		1
Amortization of prior service cost and unrecognized gains and losses included in total benefit cost, net of tax of $35 in 2020 ($33 in 2019, $34 in 2018)	104						104	104
(Increase)/decrease in net actuarial losses, net of tax of ($10) in 2020 (($42) in 2019, $1 in 2018)	(169)						(169)	(169)
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures, net of tax of $7 in 2020 ($2 in 2019, $5 in 2018)	4						4	4
Prior service credit (cost) from plan amendments, net of tax of ($1) in 2020 ($1 in 2019, ($3) in 2018)	1						1	1
Deferred derivative gains (losses), net of tax of $0 in 2020 ($0 in 2019, $3 in 2018)	10						10	10
Reclassification adjustment for amounts recognized in income, net of tax of $0 in 2020 ($0 in 2019, $0 in 2018)	(14)						(14)	(14)
Other Comprehensive Income (Loss)	(59)							(60)		1
Comprehensive Income (Loss)	$ (356)							(371)		15
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201602Member
Stock-based compensation plans	$ 29			29				29
Repurchase of common stock (in shares)			0
Dividends declared	(155)				(150)			(150)		(5)
Common stock issued from treasury	1		$ 1					1
Common stock issued from treasury (in shares)			479,275
Purchase of minority shares	(21)			1				1		(22)
Ending balance at Dec. 31, 2019	$ 4,545	$ (12)	$ 233	2,141	6,113	$ (12)	(4,136)	4,351	$ (12)	194
Common stock ending balance (in shares) at Dec. 31, 2019	233,000,000		232,650,318
Comprehensive income (loss):
Net Income (Loss)	$ (1,250)				(1,254)			(1,254)		4
Foreign currency translation, net of tax of $4 in 2020 ($4 in 2019, ($10) in 2018)	(134)						(128)	(128)		(6)
Amortization of prior service cost and unrecognized gains and losses included in total benefit cost, net of tax of $35 in 2020 ($33 in 2019, $34 in 2018)	109						109	109
(Increase)/decrease in net actuarial losses, net of tax of ($10) in 2020 (($42) in 2019, $1 in 2018)	(3)						(2)	(2)		(1)
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures, net of tax of $7 in 2020 ($2 in 2019, $5 in 2018)	22						22	22
Prior service credit (cost) from plan amendments, net of tax of ($1) in 2020 ($1 in 2019, ($3) in 2018)	(2)						(2)	(2)
Deferred derivative gains (losses), net of tax of $0 in 2020 ($0 in 2019, $3 in 2018)	15						15	15
Reclassification adjustment for amounts recognized in income, net of tax of $0 in 2020 ($0 in 2019, $0 in 2018)	(13)						(13)	(13)
Other Comprehensive Income (Loss)	(6)							1		(7)
Comprehensive Income (Loss)	$ (1,256)							(1,253)		(3)
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Stock-based compensation plans	$ 32			32				32
Repurchase of common stock (in shares)			0
Dividends declared	(48)				(38)			(38)		(10)
Common stock issued from treasury	(2)			(2)				(2)
Common stock issued from treasury (in shares)			569,780
Ending balance at Dec. 31, 2020	$ 3,259		$ 233	$ 2,171	$ 4,809		$ (4,135)	$ 3,078		$ 181
Common stock ending balance (in shares) at Dec. 31, 2020	233,000,000		233,220,098

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement Of Stockholders Equity [Abstract]
Common treasury shares (in shares)	45,243,329	45,813,109	46,292,384	38,308,825
Tax on foreign currency translation	$ 4	$ 4	$ (10)
Tax on amortization of prior service cost and unrecognized gains and losses included in total benefit cost	35	33	34
Tax on (increase)/decrease in net actuarial losses	(10)	(42)	1
Tax on immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures	7	2	5
Prior service (cost) credit from plan amendments, tax	(1)	1	(3)
Tax effect of deferred derivative gains (losses)	0	0	3
Tax effect of reclassification adjustment for amounts recognized in income	$ 0	$ 0	$ 0
Cash dividends declared per common share (in dollars per share)	$ 0.16	$ 0.64	$ 0.58

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash Flows from Operating Activities:
Net Income (Loss)	$ (1,250)	$ (297)	$ 708
Adjustments to Reconcile Net Income (Loss) to Cash Flows from Operating Activities:
Depreciation and Amortization	859	795	778
Amortization and Write-Off of Debt Issuance Costs	11	15	15
Goodwill and Other Asset Impairments	330	0	0
Provision for Deferred Income Taxes	23	323	131
Net Pension Curtailments and Settlements (Note 17)	18	6	22
Rationalizations	159	205	44
Rationalization Payments	(186)	(59)	(174)
Net (Gains) Losses on Asset Sales (Note 5)	2	(16)	(1)
Gain on TireHub transaction, net of transaction costs (Note 5)	0	0	(272)
Operating Lease Expense	286	292	0
Operating Lease Payments	(268)	(267)	0
Pension Contributions and Direct Payments	(56)	(79)	(74)
Changes in Operating Assets and Liabilities, Net of Asset Acquisitions and Dispositions:
Accounts Receivable	132	71	(172)
Inventories	713	6	(171)
Accounts Payable — Trade	26	5	223
Compensation and Benefits	95	184	(26)
Other Current Liabilities	26	(50)	(181)
Other Assets and Liabilities	195	73	66
Total Cash Flows from Operating Activities	1,115	1,207	916
Cash Flows from Investing Activities:
Capital Expenditures	(647)	(770)	(811)
Asset Dispositions	0	12	2
Short Term Securities Acquired	(96)	(113)	(68)
Short Term Securities Redeemed	96	106	68
Notes Receivable	(13)	(7)	(55)
Other Transactions	(7)	(28)	(3)
Total Cash Flows from Investing Activities	(667)	(800)	(867)
Cash Flows from Financing Activities:
Short Term Debt and Overdrafts Incurred	1,651	1,880	1,944
Short Term Debt and Overdrafts Paid	(1,593)	(1,933)	(1,795)
Long Term Debt Incurred	6,251	5,942	6,455
Long Term Debt Paid	(6,059)	(6,008)	(6,469)
Common Stock Issued	0	1	4
Common Stock Repurchased (Note 20)	0	0	(220)
Common Stock Dividends Paid (Note 20)	(37)	(148)	(138)
Transactions with Minority Interests in Subsidiaries	(10)	(26)	(31)
Debt Related Costs and Other Transactions	0	(15)	7
Total Cash Flows from Financing Activities	203	(307)	(243)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	(1)	1	(43)
Net Change in Cash, Cash Equivalents and Restricted Cash	650	101	(237)
Cash, Cash Equivalents and Restricted Cash at Beginning of the Period	974	873	1,110
Cash, Cash Equivalents and Restricted Cash at End of the Period	$ 1,624	$ 974	$ 873

Accounting Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Accounting Policies	Note 1. Accounting Policies A summary of the significant accounting policies used in the preparation of the accompanying consolidated financial statements follows: Basis of Presentation We maintain a robust business continuity plan to adequately respond to situations such as the COVID-19 pandemic, including a framework for remote work arrangements, in order to effectively maintain operations, including financial reporting systems, internal control over financial reporting and disclosure controls and procedures. Effective January 1, 2020, we early adopted, as permitted, SEC amendments to the financial disclosure requirements for registered debt securities with subsidiary guarantees. The amendments replace the condensed consolidating financial information with summarized financial information of the issuers and guarantors, require expanded qualitative disclosures with respect to information about guarantors, the terms and conditions of guarantees and the factors that may affect payment, and permit these disclosures to be provided outside the footnotes to the parent company’s audited annual and interim consolidated financial statements. We have elected to provide this information in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Recently Adopted Accounting Standards Effective January 1, 2020, we adopted an accounting standards update with new guidance on accounting for credit losses on financial instruments. The new guidance includes an impairment model for estimating credit losses that is based on expected losses, rather than incurred losses. As a result of using the modified retrospective adoption approach, $12 million was recorded as a cumulative effect adjustment to decrease Retained Earnings, with Accounts Receivable decreasing by $15 million and Deferred Income Taxes increasing by $3 million. The following table presents the balance of allowances for credit losses, which represents our allowance for doubtful accounts associated with accounts receivable, and the changes during the year ended December 31, 2020: (In millions) Americas Europe, Middle East & Africa Asia Pacific Total Balance at January 1, 2020 $ 38 $ 78 $ 10 $ 126 Current period provision 10 15 5 30 Write-offs charged against the allowance (4 ) (7 ) — (11 ) Translation (2 ) 6 1 5 Balance at December 31, 2020 $ 42 $ 92 $ 16 $ 150 Effective January 1, 2020, we adopted an accounting standards update with new guidance requiring a customer in a cloud computing arrangement that is a service contract to follow existing internal-use software guidance to determine which implementation costs to capitalize as an asset. The adoption of this standards update did not impact our consolidated financial statements. Effective April 1, 2020, we early adopted, as permitted, an accounting standards update with new guidance that changes the accounting for certain income tax transactions. The adoption of this standards update did not have a material impact on our consolidated financial statements. Recently Issued Accounting Standards In January 2020, the Financial Accounting Standards Board issued an accounting standards update which eliminates differences in practice among fair value accounting for investments in equity securities, equity method investments and certain derivative instruments. The new standard is expected to increase comparability of the accounting for these items. Principles of Consolidation The consolidated financial statements include the accounts of all legal entities in which we hold a controlling financial interest. A controlling financial interest generally arises from our ownership of a majority of the voting shares of our subsidiaries. We would also hold a controlling financial interest in variable interest entities if we are considered to be the primary beneficiary. Investments in companies in which we do not own a majority interest and we have the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. Investments in other companies are carried at cost. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and related notes to the consolidated financial statements. Actual results could differ from those estimates. On an ongoing basis, management reviews its estimates, including those related to: • general and product liabilities and other litigation, • workers’ compensation, • goodwill, intangibles and other long-lived assets, • deferred tax asset valuation allowances and uncertain income tax positions, • pension and other postretirement benefits, and • various other operating allowances and accruals, based on currently available information. Changes in facts and circumstances may alter such estimates and affect results of operations and financial position in future periods. Revenue Recognition and Accounts Receivable Valuation Sales are recognized when obligations under the terms of a contract are satisfied and control is transferred. This generally occurs with shipment or delivery, depending on the terms of the underlying contract, or when services have been rendered. Sales are measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The amount of consideration we receive and sales we recognize can vary due to changes in sales incentives, rebates, rights of return or other items we offer our customers, for which we estimate the expected amounts based on an analysis of historical experience, or as the most likely amount in a range of possible outcomes. Payment terms with customers vary by region and customer, but are generally 30-90 days or at the point of sale for our consumer retail locations. Net sales exclude sales, value added and other taxes. Costs to obtain contracts are generally expensed as incurred due to the short term nature of individual contracts. Incidental items that are immaterial in the context of the contract are recognized as expense as incurred. We have elected to recognize the costs incurred for transportation of products to customers as a component of cost of goods sold ("CGS"). Appropriate provisions are made for uncollectible accounts based on historical loss experience, portfolio duration, economic conditions and credit risk, considering both expected future losses as well as current incurred losses. The adequacy of the allowances are assessed quarterly. Research and Development Costs Research and development costs include, among other things, materials, equipment, compensation and contract services. These costs are expensed as incurred and included as a component of CGS. Research and development expenditures were $390 Warranty Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. Tire replacement under most of the warranties we offer is on a prorated basis. Warranty reserves are based on past claims experience, sales history and other considerations. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities. Environmental Cleanup Matters We expense environmental costs related to existing conditions resulting from past or current operations and from which no current or future benefit is discernible. Expenditures that extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. We determine our liability on a site by site basis and record a liability at the time when it is probable and can be reasonably estimated. Our estimated liability is reduced to reflect the anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are legally responsible and financially capable of paying their respective shares of the relevant costs. Our estimated liability is not discounted or reduced for possible recoveries from insurance carriers. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities. Legal Costs We record a liability for estimated legal and defense costs related to pending general and product liability claims, environmental matters and workers’ compensation claims. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities. Advertising Costs Costs incurred for producing and communicating advertising are generally expensed when incurred as a component of selling, administrative and general expense ("SAG"). Costs incurred under our cooperative advertising programs with dealers and franchisees are generally recorded as reductions of sales as related revenues are recognized. Advertising costs, including costs for our cooperative advertising programs with dealers and franchisees, were $304 million, $353 million and $345 million in 2020, 2019 and 2018, respectively. Rationalizations We record costs for rationalization actions implemented to reduce excess and high-cost manufacturing capacity and operating and administrative costs. Associate-related costs include severance, supplemental unemployment compensation and benefits, medical benefits, pension curtailments, postretirement benefits, and other termination benefits. For ongoing benefit arrangements, a liability is recognized when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. For one-time benefit arrangements, a liability is incurred and must be accrued at the date the plan is communicated to employees, unless they will be retained beyond a minimum retention period. In this case, the liability is calculated at the date the plan is communicated to employees and is accrued ratably over the future service period. For voluntary benefit arrangements, a liability is not estimable and is not recognized until eligible associates apply for the benefit and we accept the applications. Other costs generally include non-cancelable lease, contract termination and relocation costs. A liability for these costs is recognized in the period in which the liability is incurred. Rationalization charges related to accelerated depreciation and asset impairments are recorded in CGS or SAG. Refer to Note to the Consolidated Financial Statements No. 3, Costs Associated with Rationalization Programs. Income Taxes Income taxes are recognized during the year in which transactions enter into the determination of financial statement income, with deferred taxes being provided for temporary differences between carrying values of assets and liabilities for financial reporting purposes and such carrying values as measured under applicable tax laws. The effect on deferred tax assets or liabilities of a change in the tax law or tax rate is recognized in the period the change is enacted. Valuation allowances are recorded to reduce net deferred tax assets to the amount that is more likely than not to be realized. The calculation of our tax liabilities also involves considering uncertainties in the application of complex tax regulations. We recognize liabilities for uncertain income tax positions based on our estimate of whether it is more likely than not that additional taxes will be required and we report related interest and penalties as income taxes. To the extent that we incur expense under the global intangible low-taxed income provisions we will treat it as a component of income tax expense in the period incurred. Refer to Note to the Consolidated Financial Statements No. 6, Income Taxes. Cash and Cash Equivalents / Consolidated Statements of Cash Flows Cash and cash equivalents consist of cash on hand and marketable securities with original maturities of three months or less. Substantially all of our cash and short-term investment securities are held with investment grade rated counterparties. At December 31, 2020, our cash investments with any single counterparty did not exceed approximately $345 million. Cash flows associated with derivative financial instruments designated as hedges of identifiable transactions or events are classified in the same category as the cash flows from the related hedged items. Cash flows associated with derivative financial instruments not designated as hedges are classified as operating activities. Bank overdrafts, if any, are recorded within Notes Payable and Overdrafts. Cash flows associated with bank overdrafts are classified as financing activities. Customer prepayments for products and government grants received that predominately relate to operations are reported as operating activities. Government grants received that are predominately related to capital expenditures are reported as investing activities. The Consolidated Statements of Cash Flows are presented net of finance leases of $3 million, $36 million and $6 million originating in the years ended December 31, 2020, 2019 and 2018, respectively, and accrued capital expenditures financed with extended terms of $15 million in 2020. Cash flows from investing activities in 2020 exclude $224 million of accrued capital expenditures remaining unpaid at December 31, 2020, and include payment for $243 million of capital expenditures that were accrued and unpaid at December 31, 2019. Cash flows from investing activities in 2019 exclude $243 million of accrued capital expenditures remaining unpaid at December 31, 2019, and include payment for $266 million of capital expenditures that were accrued and unpaid at December 31, 2018. Cash flows from investing activities in 2018 exclude $266 million of accrued capital expenditures remaining unpaid at December 31, 2018, and include payment for $265 million of capital expenditures that were accrued and unpaid at December 31, 2017. Restricted Cash The following table provides a reconciliation of Cash, Cash Equivalents and Restricted Cash as reported within the Consolidated Statements of Cash Flows: December 31, (In millions) 2020 2019 2018 Cash and Cash Equivalents $ 1,539 $ 908 $ 801 Restricted Cash 85 66 72 Total Cash, Cash Equivalents and Restricted Cash $ 1,624 $ 974 $ 873 Restricted Cash, which is included in Prepaid Expenses and Other Current Assets in the Consolidated Balance Sheets, primarily represents amounts required to be set aside in connection with accounts receivable factoring programs. The restrictions lapse when cash from factored accounts receivable is remitted to the purchaser of those receivables. Restricted Net Assets In certain countries where we operate, transfers of funds into or out of such countries by way of dividends, loans or advances are generally or periodically subject to various governmental regulations. In addition, certain of our credit agreements and other debt instruments limit the ability of foreign subsidiaries to make cash distributions. At December 31, 2020, approximately $680 million of net assets were subject to such regulations or limitations. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or the average cost method. Costs include direct material, direct labor and applicable manufacturing and engineering overhead. We allocate fixed manufacturing overheads based on normal production capacity and recognize abnormal manufacturing costs as period costs. We determine a provision for excess and obsolete inventory based on management’s review of inventories on hand compared to estimated future usage and sales. Refer to Note to the Consolidated Financial Statements No. 10, Inventories. Goodwill and Other Intangible Assets Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and intangible assets with indefinite useful lives are not amortized but are assessed for impairment annually with the option to perform a qualitative assessment to determine whether further impairment testing is necessary or to perform a quantitative assessment by comparing the fair value of the reporting unit or indefinite-lived intangible to its carrying amount. Under the qualitative assessment, an entity is not required to calculate the fair value unless the entity determines that it is more likely than not that the fair value is less than the carrying amount. If under the quantitative assessment the fair value is less than the carrying amount, then an impairment loss will be recorded for the difference between the carrying value and the fair value . We perform a quantitative assessment at least once every five years. In addition to annual testing, impairment testing is conducted when events occur or circumstances change that would more likely than not reduce the fair value of the asset below its carrying amount. Goodwill and intangible assets with indefinite useful lives would be written down to fair value if considered impaired. Intangible assets with finite useful lives are amortized to their estimated residual values over such finite lives, and reviewed for impairment whenever events or circumstances warrant such a review. Refer to Note to the Consolidated Financial Statements No. 11, Goodwill and Intangible Assets. Investments Investments in marketable securities are stated at fair value. Fair value is determined using quoted market prices at the end of the reporting period and, when appropriate, exchange rates at that date. Unrealized gains and losses on marketable equity securities are recorded in earnings. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recorded in Accumulated Other Comprehensive Income (Loss) (“AOCL”), net of tax. Our investment in TireHub, LLC (“TireHub”), a distribution joint venture in the U.S., is accounted for under the equity method. We regularly review our investments to determine whether a decline in fair value below their recorded amount is other than temporary. If the decline in fair value is judged to be other than temporary, the investment is written down to fair value and the amount of the write-down is included in the Consolidated Statements of Operations. Refer to Notes to the Consolidated Financial Statements No. 12, Other Assets and Investments, No. 16, Fair Value Measurements, and No. 21, Reclassifications out of Accumulated Other Comprehensive Loss. Property, Plant and Equipment Property, plant and equipment are stated at cost. Depreciation is computed using the straight-line method. Additions and improvements that substantially extend the useful life of property, plant and equipment, and interest costs incurred during the construction period of major projects are capitalized. Government grants to us that are predominately related to capital expenditures are recorded as reductions of the cost of the associated assets. Repair and maintenance costs are expensed as incurred. Property, plant and equipment are depreciated to their estimated residual values over their estimated useful lives, and reviewed for impairment whenever events or circumstances warrant such a review. Depreciation expense for property, plant and equipment was $857 million, $793 million and $776 million in 2020, 2019 and 2018, respectively. Refer to Notes to the Consolidated Financial Statements No. 4, Interest Expense, and No. 13, Property, Plant and Equipment. Leases Effective January 1, 2019, we adopted, using the modified retrospective adoption approach, an accounting standards update with new guidance relating to leases. Our adoption of this standards update resulted in adjustments that increased Total Assets by $873 million, increased Long Term Debt and Finance Leases by $14 million, and decreased Goodyear Shareholders’ Equity and Total Shareholders’ Equity by $23 million. Periods prior to 2019 have not been restated for the adoption of this standards update. We determine if an arrangement is or contains a lease at inception. We enter into leases primarily for our distribution facilities, manufacturing equipment, administrative offices, retail stores, vehicles and data processing equipment under varying terms and conditions. Our leases have remaining lease terms of less than 1 year to approximately 50 years. Most of our leases include options to extend the lease, with renewal terms ranging from 1 to 50 years or more, and some include options to terminate the lease within 1 year. If it is reasonably certain that an option to extend or terminate a lease will be exercised, that option is considered in the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and we recognize short-term lease expense for these leases on a straight-line basis over the lease term. Certain of our lease agreements include variable lease payments, generally based on consumer price indices. Variable lease payments that are assigned to an index are determined based on the initial index at commencement, and the variability based on changes in the index is accounted for as it changes. The variable portion of payments is not included in the initial measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. We have lease agreements with lease and non-lease components, which are accounted for separately. Operating leases are included in Operating Lease Right-of-Use (“ROU”) Assets, Operating Lease Liabilities due Within One Year and Operating Lease Liabilities on our Consolidated Balance Sheets. Finance leases are included in Property, Plant and Equipment, Long Term Debt and Finance Leases due Within One Year, and Long Term Debt and Finance Leases on our Consolidated Balance Sheets. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Generally, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments, unless there is a rate stated in the lease agreement. Operating lease expense is recognized on a straight-line basis over the lease term. Refer to Note to the Consolidated Financial Statements No. 14, Leases. Foreign Currency Translation The functional currency for most subsidiaries outside the United States is the local currency. Financial statements of these subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. The U.S. dollar is used as the functional currency in countries with a history of high inflation and in countries that predominantly sell into the U.S. dollar export market. For all operations, gains or losses from remeasuring foreign currency transactions into the functional currency are included in Other (Income) Expense. Translation adjustments are recorded in AOCL. Income taxes are generally not provided for foreign currency translation adjustments. Derivative Financial Instruments and Hedging Activities To qualify for hedge accounting, hedging instruments must be designated as hedges and meet defined correlation and effectiveness criteria. These criteria require that the anticipated cash flows and/or changes in fair value of the hedging instrument substantially offset those of the position being hedged. Derivative contracts are reported at fair value on the Consolidated Balance Sheets as Accounts Receivable, Other Assets, Other Current Liabilities or Other Long Term Liabilities. Deferred gains and losses on contracts designated as cash flow hedges are recorded net of tax in AOCL. Interest Rate Contracts — Gains and losses on contracts designated as cash flow hedges are initially deferred and recorded in AOCL. Amounts are transferred from AOCL and recognized in income as Interest Expense in the same period that the hedged item is recognized in income. Gains and losses on contracts designated as fair value hedges are recognized in income in the current period as Interest Expense. Gains and losses on contracts with no hedging designation are recorded in the current period in Other (Income) Expense. Foreign Currency Contracts — Gains and losses on contracts designated as cash flow hedges are initially deferred and recorded in AOCL. Amounts are transferred from AOCL and recognized in income in the same period and on the same line that the hedged item is recognized in income. Gains and losses on contracts designated as fair value hedges, excluding premiums and discounts, are recorded in Other (Income) Expense in the current period. Gains and losses on contracts with no hedging designation are also recorded in Other (Income) Expense in the current period. We do not include premiums or discounts on forward currency contracts in our assessment of hedge effectiveness. Premiums and discounts on contracts designated as hedges are recorded in AOCL. The amounts are recognized in the Statement of Operations on a straight-line basis over the life of the contract on the same line that the hedged item is recognized in the Statement of Operations. Net Investment Hedging — Nonderivative instruments denominated in foreign currencies are used from time to time to hedge net investments in foreign subsidiaries. Gains and losses on these instruments are deferred and recorded in AOCL as Foreign Currency Translation Adjustments. These gains and losses are only recognized in income upon the complete or partial sale of the related investment or the complete liquidation of the investment. Termination of Contracts — Gains and losses (including deferred gains and losses in AOCL) are recognized in Other (Income) Expense when contracts are terminated concurrently with the termination of the hedged position. To the extent that such position remains outstanding, gains and losses are amortized to Interest Expense or to Other (Income) Expense over the remaining life of that position. Gains and losses on contracts that we temporarily continue to hold after the early termination of a hedged position, or that otherwise no longer qualify for hedge accounting, are recognized in Other (Income) Expense. Refer to Note to the Consolidated Financial Statements No. 15, Financing Arrangements and Derivative Financial Instruments. Stock-Based Compensation We measure compensation cost arising from the grant of stock-based awards to employees at fair value and recognize such cost in income over the period during which the service is provided, usually the vesting period. We recognize compensation expense using the straight-line approach. Stock-based awards to employees include grants of performance share units, restricted stock units and stock options. We measure the fair value of grants of performance share units and restricted stock units based primarily on the closing market price of a share of our common stock on the date of the grant, modified as appropriate to take into account the features of such grants. We estimate the fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate compensation expense are determined as follows: • Expected term represents the period of time that options granted are expected to be outstanding based on our historical experience of option exercises; • Expected volatility is measured using the weighted average of historical daily changes in the market price of our common stock over the expected term of the award and implied volatility calculated for our exchange traded options with an expiration date greater than one year; • Risk-free interest rate is equivalent to the implied yield on zero-coupon U.S. Treasury bonds with a remaining maturity equal to the expected term of the awards; and • Forfeitures are based substantially on the history of cancellations of similar awards granted in prior years. Refer to Note to the Consolidated Financial Statements No. 18, Stock Compensation Plans. Earnings Per Share of Common Stock Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share primarily reflects the dilutive impact of outstanding stock options and other stock based awards. All earnings per share amounts in these notes to the consolidated financial statements are diluted, unless otherwise noted. Refer to Note to the Consolidated Financial Statements No. 7, Earnings Per Share. Fair Value Measurements Valuation Hierarchy Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date. • Level 1 — Valuation is based upon quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 — Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3 — Valuation is based upon other unobservable inputs that are significant to the fair value measurement. The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement. Valuation methodologies used for assets and liabilities measured at fair value are as follows: Investments Where quoted prices are available in an active market, investments are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid government bonds, certain mortgage products and exchange-traded equities. If quoted market prices are not available, fair values are estimated using quoted prices of securities with similar characteristics or inputs other than quoted prices that are observable for the security, and would be classified within Level 2 of the valuation hierarchy. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities would be classified within Level 3 of the valuation hierarchy. Derivative Financial Instruments Exchange-traded derivative financial instruments that are valued using quoted prices would be classified within Level 1 of the valuation hierarchy. Derivative financial instruments valued using internally-developed models that use as their basis readily observable market parameters are classified within Level 2 of the valuation hierarchy. Derivative financial instruments that are valued based upon models with significant unobservable market parameters, and that are normally traded less actively, would be classified within Level 3 of the valuation hierarchy. Refer to Notes to the Consolidated Financial Statements No. 15, Financing Arrangements and Derivative Financial Instruments, and No. 16, Fair Value Measurements. Reclassifications and Adjustments Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation.

Net Sales

Net Sales	12 Months Ended
	Dec. 31, 2020
Revenue From Contract With Customer [Abstract]
Net Sales	Note 2. Net Sales The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2020: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales (1) $ 5,138 $ 3,611 $ 1,590 $ 10,339 Other tire and related sales 549 309 98 956 Retail services and service related sales 538 95 55 688 Chemical sales 317 — — 317 Other 14 5 2 21 Net Sales by reportable segment $ 6,556 $ 4,020 $ 1,745 $ 12,321 (1) Americas tire unit sales for 2020 include a gain of $34 million for a one-time legal settlement. The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2019: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales $ 6,300 $ 4,300 $ 1,924 $ 12,524 Other tire and related sales 659 363 117 1,139 Retail services and service related sales 535 39 70 644 Chemical sales 403 — — 403 Other 25 6 4 35 Net Sales by reportable segment $ 7,922 $ 4,708 $ 2,115 $ 14,745 The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2018: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales $ 6,381 $ 4,670 $ 2,009 $ 13,060 Other tire and related sales 656 379 127 1,162 Retail services and service related sales 564 34 77 675 Chemical sales 554 — — 554 Other 13 7 4 24 Net Sales by reportable segment $ 8,168 $ 5,090 $ 2,217 $ 15,475 Tire unit sales consist of consumer, commercial, farm and off-the-road tire sales, including the sale of new Company-branded tires through Company-owned retail channels. Other tire and related sales consist of aviation, race and motorcycle tire sales, retread sales and other tire related sales. Sales of tires in this category are not included in reported tire unit information. Retail services and service related sales consist of automotive services performed for customers through our Company-owned retail channels, and includes service related products. Chemical sales relate to the sale of synthetic rubber and other chemicals to third parties, and exclude intercompany sales. Other sales include items such as franchise fees and ancillary tire parts. When we receive consideration from a customer prior to transferring goods or services under the terms of a sales contract, we record deferred revenue, which represents a contract liability. Deferred revenue included in Other Current Liabilities in the Consolidated Balance Sheets totaled $23 million at December 31, 2020 and 2019. Deferred revenue included in Other Long Term Liabilities in the Consolidated Balance Sheets totaled $27 million and $31 million at December 31, 2020 and 2019, respectively. We recognize deferred revenue after we have transferred control of the goods or services to the customer and all revenue recognition criteria are met. The following table presents the balances of deferred revenue related to contracts with customers, and changes during the years ended December 31: (In millions) 2020 2019 Balance at January 1 $ 54 $ 78 Revenue deferred during period 169 155 Revenue recognized during period (173 ) (179 ) Impact of foreign currency translation — — Balance at December 31 $ 50 $ 54

Costs Associated with Rationali

Costs Associated with Rationalization Programs	12 Months Ended
	Dec. 31, 2020
Restructuring And Related Activities [Abstract]
Costs Associated with Rationalization Programs	Note 3. Costs Associated with Rationalization Programs In order to maintain our global competitiveness, we have implemented rationalization actions over the past several years to reduce high-cost and excess manufacturing capacity and operating and administrative costs. The following table presents the roll-forward of the liability balance between periods: (In millions) Associate- Related Costs Other Costs Total Balance at December 31, 2017 $ 210 $ 3 $ 213 2018 charges (1) 47 17 64 Incurred, net of foreign currency translation of $(3) million and $0 million, respectively (158 ) (19 ) (177 ) Reversed to the Statement of Operations (19 ) — (19 ) Balance at December 31, 2018 $ 80 $ 1 $ 81 2019 charges (1) 185 19 204 Incurred, net of foreign currency translation of $(2) million and $0 million, respectively (41 ) (20 ) (61 ) Reversed to the Statement of Operations (4 ) — (4 ) Balance at December 31, 2019 $ 220 $ — $ 220 2020 charges (1) 129 27 156 Incurred, net of foreign currency translation of $12 million and $0 million, respectively (147 ) (27 ) (174 ) Reversed to the Statement of Operations (2 ) — (2 ) Balance at December 31, 2020 $ 200 $ — $ 200 (1) Charges of $156 million, $204 million and $64 million in 2020, 2019 and 2018, respectively, exclude $5 million, $5 million and $(1) million, respectively, of benefit plan curtailments and settlements recorded in Rationalizations in the Statements of Operations. On April 17, 2020, we reached a tentative bargaining agreement, which was ratified on May 1, 2020, and subsequently permanently closed our Gadsden, Alabama tire manufacturing facility (“Gadsden”) as part of our continuing strategy to strengthen the competitiveness of our manufacturing footprint by curtailing production of tires for declining, less profitable segments of the tire market. The plan will result in approximately 470 job reductions. We have $32 million accrued related to this plan at December 31, 2020, which is expected to be substantially paid through 2021. During the first quarter of 2019, we approved a plan to modernize two of our tire manufacturing facilities in Germany. We have $89 million accrued related to this plan at December 31, 2020, which is expected to be substantially paid through 2022. The remainder of the accrual balance at December 31, 2020 is expected to be substantially utilized in the next 12 months and includes $35 million related to the closed Amiens, France tire manufacturing facility, $11 million related to global plans to reduce SAG headcount, $9 million related to plans to reduce manufacturing headcount and improve operating efficiency in EMEA, and $7 million related to a plan primarily to offer voluntary buy-outs to certain associates at Gadsden. The following table shows net rationalization charges included in Income (Loss) before Income Taxes: (In millions) 2020 2019 2018 Current Year Plans Associate severance and other related costs $ 77 $ 183 $ 40 Benefit plan curtailment and special termination benefits 9 5 — Other exit and non-cancelable lease costs 16 11 — Current Year Plans - Net Charges $ 102 $ 199 $ 40 Prior Year Plans Associate severance and other related costs $ 50 $ (2 ) $ (11 ) Benefit plan curtailment and special termination benefits (4 ) — (1 ) Other exit and non-cancelable lease costs 11 8 16 Prior Year Plans - Net Charges $ 57 $ 6 $ 4 Total Net Charges $ 159 $ 205 $ 44 Asset write-off and accelerated depreciation charges $ 105 $ 15 $ 4 Substantially all of the new charges in 2020 related to future cash outflows. Net current year plan charges for the year ended December 31, 2020 primarily related to the permanent closure of Gadsden. Prior year plan charges recognized in the year ended December 31, 2020 include $30 million related to additional termination benefits for associates at the closed Amiens, France manufacturing facility. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities. In addition, prior year plan charges for the year ended December 31, 2020 include $19 million related to the plan to modernize two of our manufacturing facilities in Germany, $5 million related to a plan primarily to offer voluntary buy-outs to certain associates at Gadsden, a curtailment credit of $4 million for a postretirement benefit plan related to the exit of employees under an approved rationalization plan, and $3 million related to the closure of our tire manufacturing facility in Philippsburg, Germany. Prior year plan charges for the year ended December 31, 2020 also include reversals of $2 million for actions no longer needed for their originally intended purposes. Ongoing rationalization plans had approximately $990 million in charges through 2020 and approximately $80 million is expected to be incurred in future periods. Approximately 800 associates will be released under new plans initiated in 2020, of which approximately 600 were released through December 31, 2020, primarily related to the permanent closure of Gadsden. In 2020, approximately 1,200 associates were released under plans initiated in prior years. Approximately 450 associates remain to be released under all ongoing rationalization plans. Rationalization activities initiated in 2019 include current year charges of $105 million related to the plan to modernize two of our manufacturing facilities in Germany, $76 million related to the Gadsden voluntary buy-out plan, and $18 million related to separate plans to reduce manufacturing headcount and improve operating efficiency in Americas and EMEA. Prior year plan charges recognized in the year ended December 31, 2019 include $10 million primarily related to EMEA manufacturing plans. Prior year plan charges for the year ended December 31, 2019 also include reversals of $4 million for actions no longer needed for their originally intended purposes. Rationalization activities initiated in 2018 include current year charges of $28 million related to a global plan to reduce SAG headcount and $13 million related to plans to reduce manufacturing headcount and improve operating efficiency in EMEA. Current year plan charges for the year ended December 31, 2018 also include reversals of $1 million for actions no longer needed for their originally intended purposes. Prior year plan charges recognized in the year ended December 31, 2018 include charges of $15 million related to the closure of our tire manufacturing facility in Philippsburg, Germany, $3 million related to a plan to reduce manufacturing headcount in EMEA, and $3 million related to a global plan to reduce SAG headcount. Prior year plan charges for the year ended December 31, 2018 also include reversals of $18 million for actions no longer needed for their originally intended purposes. Asset write-off and accelerated depreciation charges in 2020 and 2019 primarily related to Gadsden. Asset write-off and accelerated depreciation charges in 2018 primarily related to the closure of our tire manufacturing facility in Philippsburg, Germany. Asset write-off and accelerated depreciation charges for all periods were recorded in CGS.

Interest Expense

Interest Expense	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Interest Expense	Note 4. Interest Expense Interest expense includes interest and the amortization of deferred financing fees and debt discounts, less amounts capitalized, as follows: (In millions) 2020 2019 2018 Interest expense before capitalization $ 339 $ 351 $ 335 Capitalized interest (15 ) (11 ) (14 ) $ 324 $ 340 $ 321 Cash payments for interest, net of amounts capitalized, were $315 million, $324 million and $331 million in 2020, 2019 and 2018, respectively.

Other (Income) Expense

Other (Income) Expense	12 Months Ended
	Dec. 31, 2020
Other Income And Expenses [Abstract]
Other (Income) Expense	Note 5. Other (Income) Expense (In millions) 2020 2019 2018 Gain on TireHub transaction, net of transaction costs $ — $ — $ (272 ) Non-service related pension and other postretirement benefits costs 110 118 121 Interest income on indirect tax settlements in Brazil — (8 ) (38 ) Financing fees and financial instruments expense 26 34 36 Net foreign currency exchange (gains) losses (9 ) (22 ) (16 ) General and product liability expense - discontinued products 10 11 9 Royalty income (19 ) (19 ) (20 ) Net (gains) losses on asset sales 2 (16 ) (1 ) Interest income (14 ) (18 ) (16 ) Miscellaneous (income) expense 13 18 23 $ 119 $ 98 $ (174 ) Gain on TireHub transaction represented the difference between the initial fair value of the equity interest received and the net book value of the assets and liabilities contributed in connection with the formation of TireHub in 2018, net of transaction costs. For the year ended December 31, 2018, we recognized a gain of $286 million and incurred transaction costs of $14 million. Non-service related pension and other postretirement benefits cost consists primarily of the interest cost, expected return on plan assets and amortization components of net periodic cost, as well as curtailments and settlements which are not related to rationalization plans. Non-service related pension and other postretirement benefits cost included net pension settlement and curtailment charges of $18 million, $6 million and $21 million in 2020, 2019 and 2018, respectively. For further information, refer to Note to the Consolidated Financial Statements No. 17, Pension, Other Postretirement Benefits and Savings Plans. We previously filed claims with the Brazilian tax authorities challenging the legality of the calculation of certain indirect taxes for the years 2001 through 2018. During 2018, we received favorable rulings related to these claims. As a result of the rulings, we recorded a gain of $53 million in CGS and related interest income of $38 million in Other (Income) Expense for the year ended December 31, 2018. During 2019, there were additional favorable rulings related to these claims. As a result, we recorded an additional gain of $11 million in CGS and related interest income of $8 million in Other (Income) Expense. Miscellaneous expense for the year ended December 31, 2019 includes expenses of $25 million incurred by the Company as a direct result of flooding at our Beaumont, Texas chemical facility during the third quarter of 2019. Miscellaneous expense in 2018 includes $12 million related to expenses incurred by the Company as a direct result of hurricanes Harvey and Irma during 2017. Other (Income) Expense also includes financing fees and financial instruments expense which consists of commitment fees and charges incurred in connection with financing transactions; net foreign currency exchange (gains) and losses; general and product liability expense - discontinued products, which consists of charges for claims against us related primarily to asbestos personal injury claims, net of probable insurance recoveries; royalty income which is derived primarily from licensing arrangements; net (gains) and losses on asset sales, and interest income.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 6. Income Taxes The components of Income (Loss) before Income Taxes follow: (In millions) 2020 2019 2018 U.S. $ (993 ) $ (39 ) $ 439 Foreign (147 ) 216 572 $ (1,140 ) $ 177 $ 1,011 A reconciliation of income taxes at the U.S. statutory rate to United States and Foreign Tax Expense follows: (In millions) 2020 2019 2018 U.S. federal income tax expense (benefit) at the statutory rate of 21% $ (239 ) $ 37 $ 212 Net establishment (release) of U.S. valuation allowances 310 (98 ) 25 Net foreign losses (income) with no tax due to valuation allowances 37 48 7 Goodwill impairment 34 — — Deferred tax impact of enacted tax rate and law changes (18 ) 3 — State income taxes, net of U.S. federal benefit (17 ) (1 ) (1 ) U.S. charges (benefits) related to foreign tax credits, R&D and foreign derived intangible deduction (9 ) (17 ) 20 Adjustment for foreign income taxed at different rates 7 16 30 Net establishment of uncertain tax positions 6 7 18 Federal and state tax on accelerated royalty income transaction — 334 — Net establishment (release) of foreign valuation allowances — 140 (5 ) Other (1 ) 5 (3 ) United States and Foreign Tax Expense $ 110 $ 474 $ 303 The components of United States and Foreign Tax Expense by taxing jurisdiction, follow: (In millions) 2020 2019 2018 Current: Federal $ (5 ) $ — $ (15 ) Foreign 95 134 188 State (3 ) 17 (1 ) 87 151 172 Deferred: Federal 63 133 120 Foreign (31 ) 153 6 State (9 ) 37 5 23 323 131 United States and Foreign Tax Expense $ 110 $ 474 $ 303 Income tax expense in 2020 was $110 million on a loss before income taxes of $1,140 million. In 2020, income tax expense was unfavorably impacted by net discrete adjustments totaling $305 million, including the establishment of a $295 million valuation allowance on certain deferred tax assets for foreign tax credits during the first quarter of 2020 as discussed below. Discrete adjustments also reflect a net charge of $10 million, including a $15 million charge related to a U.S. valuation allowance for state loss carryforwards, a $13 million benefit to adjust our deferred tax assets in England for a third quarter enacted change in the tax rate, and various other net charges totaling $8 million. In 2019, income tax expense of $474 million was unfavorably impacted by net discrete adjustments totaling $386 million. Discrete adjustments were due to non-cash charges of $334 million related to an acceleration of royalty income in the U.S. from the sale of certain European royalty payments to Luxembourg and $150 million related to an increase in our valuation allowance on tax losses in Luxembourg, which were partially offset by a non-cash tax benefit of $98 million related to a reduction of our U.S. valuation allowance for foreign tax credits. In 2018, income tax expense of $303 million was unfavorably impacted by net discrete adjustments of $65 million. Discrete adjustments were primarily due to charges totaling $135 million related to deferred tax assets for foreign tax credits, including the establishment of a valuation allowance on foreign tax credits of $98 million, partially offset by a tax benefit of $88 million related to a worthless stock deduction created by permanently ceasing operations of our Venezuelan subsidiary during the fourth quarter of 2018. Income tax expense in 2018 also included net charges of $18 million for various other discrete tax adjustments, including those related to finalizing our accounting for certain provisional items related to the Tax Cuts and Jobs Act. We consider both positive and negative evidence when measuring the need for a valuation allowance. The weight given to the evidence is commensurate with the extent to which it may be objectively verified. Current and cumulative financial reporting results are a source of objectively verifiable evidence. We give operating results during the most recent three-year period a significant weight in our analysis. We typically only consider forecasts of future profitability when positive cumulative operating results exist in the most recent three-year period. We perform scheduling exercises to determine if sufficient taxable income of the appropriate character exists in the periods required in order to realize our deferred tax assets with limited lives (such as tax loss carryforwards and tax credits) prior to their expiration. We consider tax planning strategies available to accelerate taxable amounts if required to utilize expiring deferred tax assets. A valuation allowance is not required to the extent that, in our judgment, positive evidence exists with a magnitude and duration sufficient to result in a conclusion that it is more likely than not that our deferred tax assets will be realized. At December 31, 2020, we had approximately $1.2 billion of U.S. federal, state and local deferred tax assets, net of valuation allowances totaling $368 million primarily for foreign tax credits with limited lives. Approximately $900 million of these U.S. net deferred tax assets have unlimited lives and approximately $300 million have limited lives and expire between 2025 and 2040. At December 31, 2019, we had approximately $1.2 billion of U.S. federal, state and local deferred tax assets, net of valuation allowances totaling $13 million. In the U.S., we have a cumulative loss for the three-year period ending December 31, 2020. However, as the three-year cumulative loss in the U.S. is driven by the business disruption created by the COVID-19 pandemic, in assessing our ability to utilize our deferred tax assets, we also considered objectively verifiable information including recent favorable recovery trends in the tire industry and our tire volume as well as the return to profitability of our U.S. business by the end of the fourth quarter and its expected continued improvement. While the COVID-19 related disruptions to our business are ultimately expected to be temporary, there is still considerable uncertainty around the extent and duration of these disruptions , as well as what additional actions federal, state or local governments may take to contain the pandemic. As such, an additional valuation allowance may be required against all, or a portion of, our U.S. net deferred tax assets in a future period. At December 31, 2020 and 2019, our U.S. deferred tax assets included $133 million and $403 million of foreign tax credits with limited lives, net of valuation allowances of $328 million and $3 million, respectively, generated primarily from the receipt of foreign dividends. During the first quarter of 2020, we established a valuation allowance of $295 million against all of these foreign tax credits with expiration dates through 2024 and a portion of those expiring in 2025. In addition, during the fourth quarter of 2020, we increased our valuation allowance by $30 million with a corresponding increase to our deferred tax assets to reflect the impact of a decrease in foreign tax credits utilized on our 2019 income tax return. Due to the sudden and sharp decline in industry demand and the temporary suspension of production at our U.S. manufacturing facilities as a result of the COVID-19 pandemic, we have a significant U.S. tax loss for 2020. As loss carryforwards must be utilized prior to foreign tax credits in offsetting future income for tax purposes, we concluded that it is not more likely than not that we will be able to utilize these foreign tax credits prior to their expiration. Our earnings and forecasts of future profitability, taking into consideration recent trends, along with three significant sources of foreign income provide us sufficient positive evidence that we will be able to utilize our remaining foreign tax credits that expire between 2025 and 2030. Our sources of foreign income are (1) 100% of our domestic profitability can be re-characterized as foreign source income under current U.S. tax law to the extent domestic losses have offset foreign source income in prior years, (2) annual net foreign source income, exclusive of dividends, primarily from royalties, and (3) tax planning strategies, including capitalizing research and development costs, accelerating income on cross border transactions, including sales of inventory or raw materials to our subsidiaries, and reducing U.S. interest expense by, for example, reducing intercompany loans through repatriating current year earnings of foreign subsidiaries, all of which would increase our domestic profitability. We consider our current forecasts of future profitability in assessing our ability to realize our deferred tax assets, including our foreign tax credits. As noted above, these forecasts include the impact of recent trends, including various macroeconomic factors such as the impact of the COVID-19 pandemic, on our profitability, as well as the impact of tax planning strategies. Macroeconomic factors, including the impact of the COVID-19 pandemic, possess a high degree of volatility and can significantly impact our profitability. As such, there is a risk that future earnings will not be sufficient to fully utilize our U.S. net deferred tax assets, including our remaining foreign tax credits. However, we believe our forecasts of future profitability along with the three significant sources of foreign income described above provide us sufficient positive, objectively verifiable evidence to conclude that it is more likely than not that, at December 31, 2020, our U.S. net deferred tax assets, including our foreign tax credits, net of valuation allowances, will be fully utilized. At December 31, 2020 and 2019, we had approximately $1.3 billion and $1.2 billion of foreign deferred tax assets, respectively, and valuation allowances of $1.1 billion and $1.0 billion, respectively. Our losses in various foreign taxing jurisdictions in recent periods represented sufficient negative evidence to require us to maintain a full valuation allowance against certain of these net foreign deferred tax assets. Most notably, in Luxembourg, we maintain a valuation allowance of $978 million on all of our net deferred tax assets. Each reporting period, we assess available positive and negative evidence and estimate if sufficient future taxable income will be generated to utilize these existing deferred tax assets. We do not believe that sufficient positive evidence required to release valuation allowances having a significant impact on our financial position or results of operations will exist within the next twelve months. Temporary differences and carryforwards giving rise to deferred tax assets and liabilities at December 31 follow: (In millions) 2020 2019 Tax loss carryforwards and credits $ 1,570 $ 1,159 Prepaid royalty income 629 576 Capitalized research and development expenditures 421 416 Accrued expenses deductible as paid 255 347 Postretirement benefits and pensions 209 221 Lease liabilities 76 75 Rationalizations and other provisions 34 38 Vacation and sick pay 21 23 Other 133 106 3,348 2,961 Valuation allowance (1,469 ) (982 ) Total deferred tax assets 1,879 1,979 Property basis differences (420 ) (467 ) Right-of-use assets (75 ) (74 ) Tax on undistributed earnings of subsidiaries (1 ) (1 ) Total net deferred tax assets $ 1,383 $ 1,437 At December 31, 2020, we had $704 million of tax assets for net operating loss, capital loss and tax credit carryforwards related to certain foreign subsidiaries. These carryforwards are primarily from countries with unlimited carryforward periods, but include $69 million of tax credit carryforwards in various European countries that are subject to expiration from 2021 to 2030. A valuation allowance totaling $1,101 million has been recorded against these and other deferred tax assets where recovery of the asset or carryforward is uncertain. In addition, we had $767 million of federal and $99 million of state tax assets for net operating loss and tax credit carryforwards. The federal carryforwards include $461 million of foreign tax credits that are subject to expiration from 2022 to 2030 and $92 million of tax assets related to research and development credits and other federal credits that are subject to expiration from 2030 to 2040. The state carryforwards include $87 million that are subject to expiration from 2021 to 2040. A valuation allowance of $368 million has been recorded against federal and state deferred tax assets where recovery is uncertain. At December 31, 2020, we had unrecognized tax benefits of $85 million that if recognized, would have a favorable impact on our tax expense of $58 million. We had accrued interest of $2 million as of December 31, 2020. If not favorably settled, $9 (In millions) 2020 2019 2018 Balance at January 1 $ 82 $ 71 $ 52 Increases related to prior year tax positions 26 24 9 Decreases related to prior year tax positions (1 ) — (1 ) Settlements (15 ) (11 ) (2 ) Foreign currency impact (7 ) (2 ) (5 ) Increases related to current year tax positions — — 21 Lapse of statute of limitations — — (3 ) Balance at December 31 $ 85 $ 82 $ 71 We are open to examination in the U.S. for 2020 and in Germany from 2018 onward. Generally, for our remaining tax jurisdictions, years from 2015 onward are still open to examination. We have undistributed earnings and profits of our foreign subsidiaries totaling approximately $2.3 billion at December 31, 2020. We have concluded that no provision for tax in the U.S. is required because substantially all of the remaining undistributed earnings and profits have been or will be reinvested in property, plant and equipment and working capital outside of the U.S . A foreign withholding tax charge of approximately $ 85 million (net of foreign tax credits) would be required if these earnings and profits were to be distributed to the U.S. On March 27, 2020, the President signed the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), a substantial tax and spending package intended to provide economic stimulus to address the impact of the COVID-19 pandemic. The CARES Act allows corporations with net operating losses generated in 2018, 2019 and 2020 to elect to carryback those losses for a period of five years and relaxes the limitation for business interest deductions for 2019 and 2020. These provisions did not have a material impact on our operating results. We did, however, benefit from a CARES Act provision that accelerates the ability of corporations to claim a refund of alternative minimum tax credit carryforwards. Under this provision, we received a refund of $5 million during the third quarter of 2020 that would otherwise have been received in two equal annual installments in 2021 and 2022. Net cash payments for income taxes were $45 million, $142 million and $178 million in 2020, 2019 and 2018, respectively.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Note 7. Earnings Per Share Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share are calculated to reflect the potential dilution that could occur if securities or other contracts were exercised or converted into common stock. Basic and diluted earnings per common share are calculated as follows: (In millions, except per share amounts) 2020 2019 2018 Earnings (loss) per share — basic: Goodyear net income (loss) $ (1,254 ) $ (311 ) $ 693 Weighted average shares outstanding 234 233 237 Earnings (loss) per common share — basic $ (5.35 ) $ (1.33 ) $ 2.92 Earnings (loss) per share — diluted: Goodyear net income (loss) $ (1,254 ) $ (311 ) $ 693 Weighted average shares outstanding 234 233 237 Dilutive effect of stock options and other dilutive securities — — 2 Weighted average shares outstanding — diluted 234 233 239 Earnings (loss) per common share — diluted $ (5.35 ) $ (1.33 ) $ 2.89 Weighted average shares outstanding — diluted for 2020 excludes approximately 9 million equivalent shares related to options with exercise prices greater than the average market price of our common shares (i.e., “underwater” options). There were approximately 2 million equivalent shares related to underwater options for both 2019 and 2018. Additionally, weighted average shares outstanding — diluted for 2019 excludes the dilutive effect of approximately 3 million equivalent shares related primarily to options with exercise prices less than the average market price of our common shares (i.e., "in-the-money" options), as their inclusion would have been anti-dilutive due to the Goodyear net loss. There were no in-the-money options for 2020.

Business Segments

Business Segments	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Business Segments	Note 8. Business Segments Segment information reflects our strategic business units (“SBUs”), which are organized to meet customer requirements and global competition. For the year ended December 31, 2020, we operated our business through three operating segments representing our regional tire businesses: Americas; Europe, Middle East and Africa; and Asia Pacific. Segment information is reported on the basis used for reporting to our Chief Executive Officer. Each of the three regional business segments is involved in the development, manufacture, distribution and sale of tires. Certain of the business segments also provide related products and services, which include retreads and automotive and commercial truck maintenance and repair services. Each segment also exports tires to other segments. Americas manufactures and sells tires for automobiles, trucks, buses, earthmoving, mining and industrial equipment, aircraft, and for various other applications throughout North, Central and South America. Americas also provides related products and services including retreaded tires, tread rubber, and automotive and commercial truck maintenance and repair services, as well as sells chemical and natural rubber products to our other business segments and to unaffiliated customers. EMEA manufactures and sells tires for automobiles, trucks, buses, aircraft, motorcycles, and earthmoving, mining and industrial equipment throughout Europe, the Middle East and Africa. EMEA also sells retreaded aviation tires, retreading and related services for commercial truck and earthmoving, mining and industrial equipment, and automotive maintenance and repair services. Asia Pacific manufactures and sells tires for automobiles, trucks, aircraft, farm, and earthmoving, mining and industrial equipment throughout the Asia Pacific region. Asia Pacific also provides related products and services including retreaded truck and aviation tires, tread rubber, and automotive maintenance and repair services. The following table presents segment sales and operating income (loss), and the reconciliation of segment operating income (loss) to Income (Loss) before Income Taxes: (In millions) 2020 2019 2018 Sales Americas $ 6,556 $ 7,922 $ 8,168 Europe, Middle East and Africa 4,020 4,708 5,090 Asia Pacific 1,745 2,115 2,217 Net Sales $ 12,321 $ 14,745 $ 15,475 Segment Operating Income (Loss) Americas $ 9 $ 550 $ 654 Europe, Middle East and Africa (72 ) 202 363 Asia Pacific 49 193 257 Total Segment Operating Income (Loss) $ (14 ) $ 945 $ 1,274 Less: Goodwill and Other Asset Impairments (Notes 11 and 12) 330 — — Rationalizations (Note 3) 159 205 44 Interest expense (Note 4) 324 340 321 Other (income) expense (Note 5) 119 98 (174 ) Asset write-offs and accelerated depreciation (Note 3) 105 15 4 Corporate incentive compensation plans 44 50 13 Retained expenses of divested operations 8 10 9 Other (1) 37 50 46 Income (Loss) before Income Taxes $ (1,140 ) $ 177 $ 1,011 ( 1 ) Primarily represents unallocated corporate costs and the elimination of $17 million, $17 million and $18 million for the years ended December 31, 2020, 2019 and 2018, respectively, of royalty income attributable to the strategic business units. The following table presents segment assets at December 31: (In millions) 2020 2019 Assets Americas $ 6,666 $ 7,606 Europe, Middle East and Africa 4,825 4,724 Asia Pacific 2,725 2,711 Total Segment Assets 14,216 15,041 Corporate (1) 2,290 2,144 $ 16,506 $ 17,185 (1) Corporate includes substantially all of our U.S. net deferred tax assets. Results of operations are measured based on net sales to unaffiliated customers and segment operating income. Each segment exports tires to other segments. The financial results of each segment exclude sales of tires exported to other segments, but include operating income derived from such transactions. Segment operating income is computed as follows: Net sales less CGS (excluding asset write-offs and accelerated depreciation charges) and SAG (including certain allocated corporate administrative expenses). Segment operating income also includes certain royalties and equity in earnings of most affiliates. Segment operating income does not include net rationalization charges, asset sales, and certain other items. The following table presents geographic information. Net sales by country were determined based on the location of the selling subsidiary. Long-lived assets consisted of property, plant and equipment. Besides Germany, management did not consider the net sales of any other individual countries outside the United States to be significant to the consolidated financial statements. For long-lived assets, only China and Germany were considered to be significant. (In millions) 2020 2019 2018 Net Sales United States $ 5,424 $ 6,489 $ 6,692 Germany (1) 705 979 1,691 Other international 6,192 7,277 7,092 $ 12,321 $ 14,745 $ 15,475 Long-Lived Assets United States $ 2,517 $ 2,681 China 742 722 Germany 729 653 Other international 3,085 3,152 $ 7,073 $ 7,208 (1) The decrease in net sales from 2018 primarily related to a business reorganization that centralized our OE sales for EMEA in Luxembourg. At December 31, 2020, significant concentrations of cash and cash equivalents held by our international subsidiaries included the following amounts: • $387 million or 25% in Asia Pacific, primarily China and Japan ($337 million or 37% at December 31, 2019), • $387 million or 25% in EMEA, primarily Belgium ($214 million or 24% at December 31, 2019), and • $384 million or 25% in Americas, primarily Brazil, Canada and Chile ($190 million or 21% at December 31, 2019). Goodwill and other asset impairments, as described in Notes to the Consolidated Financial Statements No. 11, Goodwill and Intangible Assets, and No. 12, Other Assets and Investments; rationalizations, as described in Note to the Consolidated Financial Statements No. 3, Costs Associated with Rationalization Programs; net (gains) losses on asset sales, as described in Note to the Consolidated Financial Statements No. 5, Other (Income) Expense, and asset write-offs and accelerated depreciation were not charged (credited) to the SBUs for performance evaluation purposes but were attributable to the SBUs as follows: (In millions) 2020 2019 2018 Goodwill and Other Asset Impairments Americas $ 148 $ — $ — Europe, Middle East and Africa 182 — — Total Segment Goodwill and Other Asset Impairments $ 330 $ — $ — (In millions) 2020 2019 2018 Rationalizations Americas $ 94 $ 90 $ 3 Europe, Middle East and Africa 59 115 36 Asia Pacific 4 — 3 Total Segment Rationalizations $ 157 $ 205 $ 42 Corporate 2 — 2 $ 159 $ 205 $ 44 (In millions) 2020 2019 2018 Net (Gains) Losses on Asset Sales Americas (1) $ — $ — $ (275 ) Europe, Middle East and Africa 2 (16 ) 2 Total Segment Asset Sales $ 2 $ (16 ) $ (273 ) (1) Americas Net (Gains) Losses on Asset Sales for the year ended December 31, 2018 includes the gain of $272 million related to the TireHub transaction, net of transaction costs. (In millions) 2020 2019 2018 Asset Write-Offs and Accelerated Depreciation Americas $ 103 $ 13 $ — Europe, Middle East and Africa 2 2 4 Total Segment Asset Write-Offs and Accelerated Depreciation $ 105 $ 15 $ 4 The following tables present segment capital expenditures and depreciation and amortization: (In millions) 2020 2019 2018 Capital Expenditures Americas $ 302 $ 369 $ 406 Europe, Middle East and Africa 235 227 180 Asia Pacific 91 141 188 Total Segment Capital Expenditures $ 628 $ 737 $ 774 Corporate 19 33 37 $ 647 $ 770 $ 811 (In millions) 2020 2019 2018 Depreciation and Amortization Americas $ 490 $ 430 $ 414 Europe, Middle East and Africa 201 197 201 Asia Pacific 133 133 131 Total Segment Depreciation and Amortization $ 824 $ 760 $ 746 Corporate 35 35 32 $ 859 $ 795 $ 778 The following table presents segment equity in the net income (loss) of investees accounted for by the equity method: (In millions) 2020 2019 2018 Equity in (Income) Loss Americas $ 31 $ 32 $ 11 Europe, Middle East and Africa — — (1 ) Total Segment Equity in (Income) Loss $ 31 $ 32 $ 10

Accounts Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Accounts Receivable	Note 9. Accounts Receivable (In millions) 2020 2019 Accounts receivable $ 1,841 $ 2,052 Allowance for doubtful accounts (150 ) (111 ) $ 1,691 $ 1,941

Inventories

Inventories	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Note 10. Inventories (In millions) 2020 2019 Raw materials $ 517 $ 530 Work in process 143 143 Finished goods 1,493 2,178 $ 2,153 $ 2,851

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Note 11. Goodwill and Intangible Assets The following table presents the net carrying amount of goodwill allocated by segment, and changes during 2020 (In millions) Balance at December 31, 2019 Acquisitions Divestitures Impairment Translation Balance at December 31, 2020 Americas $ 91 $ — $ — $ — $ — $ 91 Europe, Middle East and Africa 411 10 — (182 ) 11 250 Asia Pacific 63 — — — 4 67 $ 565 $ 10 $ — $ (182 ) $ 15 $ 408 The following table presents the net carrying amount of goodwill allocated by segment, and changes during 2019: (In millions) Balance at December 31, 2018 Acquisitions Divestitures Impairment Translation Balance at December 31, 2019 Americas $ 91 $ — $ — $ — $ — $ 91 Europe, Middle East and Africa 415 2 — — (6 ) 411 Asia Pacific 63 1 — — (1 ) 63 $ 569 $ 3 $ — $ — $ (7 ) $ 565 The following table presents information about intangible assets: 2020 2019 (In millions) Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Intangible assets with indefinite lives $ 125 $ (6 ) $ 119 $ 124 $ (6 ) $ 118 Trademarks and patents 23 (19 ) 4 24 (19 ) 5 Other intangible assets 25 (13 ) 12 25 (11 ) 14 $ 173 $ (38 ) $ 135 $ 173 $ (36 ) $ 137 (1) Includes impact of foreign currency translation. Intangible assets are primarily comprised of the rights to use the Dunlop brand name and related trademarks and certain other brand names and trademarks. Amortization expense for intangible assets totaled $2 million in 2020, 2019 and 2018. We estimate that annual amortization expense related to intangible assets will be $2 million in 2021, and $1 million in 2022 through 2025. The weighted average remaining amortization period is approximately 20 years. As a result of the COVID-19 pandemic and the resulting decline in the macroeconomic environment, as well as a significant decrease in our market capitalization, we performed an interim impairment analysis as of March 31, 2020 utilizing a discounted cash flow model. Based on the results of this interim analysis, we recorded a non-cash impairment charge of $182 million related to our EMEA reporting unit in the first quarter of 2020. The most critical assumptions used in the calculation of the estimated fair value of our reporting units were the timing of the recovery in sales from the COVID-19 pandemic, the projected long-term operating margin and the discount rate. Since the date of our 2019 annual quantitative goodwill impairment assessment, the overall discount rate increased, reflecting an increase in the risk premium components of the rate partially offset by a decrease in the risk-free interest rate component, as a result of the macroeconomic environment. Also, we gave consideration to the expected near-term negative cash flow impact of the COVID-19 pandemic and subsequent recovery, based on our forecasts at that time, as well as a decrease in our market capitalization. Since the first quarter of 2020, our forecasts as well as our market capitalization have both improved and we have concluded that there were no additional triggering events during the remaining nine months of 2020. Likewise, our 2020 annual impairment analysis as of October 31, 2020 indicated no impairment of goodwill or intangible assets with indefinite lives. Our annual impairment analyses for 2019 and 2018 also indicated no impairment of goodwill or intangible assets with indefinite lives. Our quantitative goodwill analysis as of October 31, 2020 concluded that the fair values substantially exceeded the carrying amounts for each reporting unit tested. There were no events or circumstances that indicated the quantitative impairment tests should be re-performed for goodwill or for intangible assets with indefinite lives for any reporting unit at December 31, 2020. Nonetheless, if we make future adverse revisions to our significant assumptions, including as a result of business performance or market conditions, or if our market capitalization declines and if such decline becomes indicative that the fair value of our reporting units has declined below their carrying values, we may need to record a material, non-cash impairment charge in a future period.

Other Assets and Investments

Other Assets and Investments	12 Months Ended
	Dec. 31, 2020
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Other Assets and Investments	Note 12. Other Assets and Investments Dividends received from our consolidated subsidiaries were $155 million, $43 million and $608 million in 2020, 2019 and 2018, respectively. Dividends received in 2020 were primarily from Singapore, Peru and Brazil and paid to the United States. Dividends received in 2019 were primarily from Singapore and Brazil and paid to the United States. Dividends received in 2018 were primarily from Singapore and Japan and paid to the United States. Dividends received from our affiliates accounted for using the equity method were $5 million, $4 million and $5 million in 2020, 2019 and 2018, respectively. Investment in TireHub The carrying value of our investment in TireHub was $77 million and $262 million at December 31, 2020 and 2019, respectively, and was included in Other Assets on our Consolidated Balance Sheets. In addition, we have an outstanding loan receivable from TireHub of $14 million as of December 31, 2020, which is also included in Other Assets on our Consolidated Balance Sheets. Our investment in TireHub is accounted for under the equity method of accounting and, as such, includes our 50% share of the net losses of TireHub, which totaled $36 million, $33 million and $15 million in 2020, 2019 and 2018, respectively. We regularly review our investment in TireHub for potential impairment and will recognize an impairment charge if the estimated fair value of our investment declines below its recorded amount and such decline is determined to be other-than temporary. The most critical assumptions used in our discounted cash flow model for estimating the fair value of our investment are forecasted tire volume for TireHub, including the extent and duration of, as well as the timing of the recovery from, the ongoing impacts of the COVID-19 pandemic, and the discount rate. Our TireHub joint venture was initially formed during the second quarter of 2018 and, as previously disclosed, its net losses included higher than expected start-up expenses and additional costs incurred to build out TireHub’s distribution footprint for future growth. These additional costs as well as TireHub’s net losses were expected to be temporary and moderate in 2020. However, higher than expected net losses for TireHub continued into 2020, driven by the severe impacts of the COVID-19 pandemic. Accordingly, we evaluated our investment and concluded that there had been an other-than-temporary decline in the fair value of our investment during the second quarter of 2020. As such, we conducted an impairment assessment and estimated the fair value of our investment utilizing updated forecasts of TireHub’s volume, revised expectations as to the extent and duration of, as well as the timing of the recovery from, the COVID-19 pandemic, and an updated discount rate reflective of current market conditions at that time. As a result, during the second quarter of 2020, we recognized a non-cash impairment charge of $ 148 million. During the second half of 2020, we concluded that there was no additional other-than-temporary decline in the fair value of our investment in TireHub. Nonetheless, there remains a high degree of uncertainty as to the extent and duration of, as well as timing of the recovery from, the COVID-19 pandemic. If we make future adverse revisions to these or our other significant assumptions, including as a result of business performance or market conditions, we may need to record an additional material, non-cash impairment charge in a future period. Other Assets Other Assets at December 31, 2020 included a $30 million trade receivable from a customer that was refinanced into a collateral-backed note receivable in the second quarter of 2020.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Property, Plant and Equipment	Note 13. Property, Plant and Equipment 2020 2019 (In millions) Owned Finance Leases Total Owned Finance Leases Total Property, plant and equipment, at cost: Land $ 436 $ 1 $ 437 $ 425 $ 1 $ 426 Buildings 2,467 232 2,699 2,431 227 2,658 Machinery and equipment 13,893 29 13,922 13,624 30 13,654 Construction in progress 737 — 737 681 1 682 17,533 262 17,795 17,161 259 17,420 Accumulated depreciation (10,931 ) (60 ) (10,991 ) (10,438 ) (50 ) (10,488 ) 6,602 202 6,804 6,723 209 6,932 Spare parts 269 — 269 276 — 276 $ 6,871 $ 202 $ 7,073 $ 6,999 $ 209 $ 7,208 The range of useful lives of property used in arriving at the annual amount of depreciation is as follows: buildings and improvements, 3 to 45 years 3 to 40 years

Leases

Leases	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Leases	Note 14. Leases The components of lease expense included in Income (Loss) before Income Taxes for the years ended December 31, 2020 and 2019 are as follows: (In millions) 2020 2019 Operating Lease Expense $ 286 $ 292 Finance Lease Expense: Amortization of ROU assets 11 11 Interest on lease liabilities 21 21 Short Term Lease Expense 6 6 Variable Lease Expense 3 7 Sublease Income (11 ) (15 ) Total Lease Expense $ 316 $ 322 Net rental expense for the year ended December 31, 2018 is comprised of the following: (In millions) 2018 Gross rental expense $ 333 Sublease rental income (16 ) $ 317 Supplemental cash flow information related to leases for the years ended December 31, 2020 and 2019 is as follows: (In millions) 2020 2019 Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating Cash Flows for Operating Leases $ 268 $ 267 Operating Cash Flows for Finance Leases 21 21 Financing Cash Flows for Finance Leases 7 7 ROU Assets Obtained in Exchange for Lease Obligations Operating Leases 202 197 Finance Leases 3 34 Supplemental balance sheet information related to leases as of December 31, 2020 and 2019 is as follows: (In millions, except lease term and discount rate) 2020 2019 Operating Leases Operating Lease ROU Assets $ 851 $ 855 Operating Lease Liabilities due Within One Year $ 198 $ 199 Operating Lease Liabilities 684 668 Total Operating Lease Liabilities $ 882 $ 867 Finance Leases Property, Plant and Equipment, at cost $ 262 $ 259 Accumulated Depreciation (60 ) (50 ) Property, Plant and Equipment, net $ 202 $ 209 Long Term Debt and Finance Leases due Within One Year $ 18 $ 6 Long Term Debt and Finance Leases 232 243 Total Finance Lease Liabilities $ 250 $ 249 Weighted Average Remaining Lease Term (years) Operating Leases 7.3 7.2 Finance Leases 30.9 31.6 Weighted Average Discount Rate Operating Leases 6.85% 6.69% Finance Leases 8.48% 8.46% Future maturities of our lease liabilities, excluding subleases, as of December 31, 2020 are as follows: (In millions) Operating Leases Finance Leases 2021 $ 245 $ 38 2022 186 23 2023 146 21 2024 110 21 2025 88 22 Thereafter 376 671 Total Lease Payments 1,151 796 Less: Imputed Interest 269 546 Total $ 882 $ 250 As of December 31, 2020, we have additional operating and finance leases that have not yet commenced for which the present value of lease payments over the respective lease terms totals $23 million. Accordingly, these leases are not recorded on the Consolidated Balance Sheets at December 31, 2020. These leases will commence in 2021 and 2022 with lease terms of 7 years
Leases	Note 14. Leases The components of lease expense included in Income (Loss) before Income Taxes for the years ended December 31, 2020 and 2019 are as follows: (In millions) 2020 2019 Operating Lease Expense $ 286 $ 292 Finance Lease Expense: Amortization of ROU assets 11 11 Interest on lease liabilities 21 21 Short Term Lease Expense 6 6 Variable Lease Expense 3 7 Sublease Income (11 ) (15 ) Total Lease Expense $ 316 $ 322 Net rental expense for the year ended December 31, 2018 is comprised of the following: (In millions) 2018 Gross rental expense $ 333 Sublease rental income (16 ) $ 317 Supplemental cash flow information related to leases for the years ended December 31, 2020 and 2019 is as follows: (In millions) 2020 2019 Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating Cash Flows for Operating Leases $ 268 $ 267 Operating Cash Flows for Finance Leases 21 21 Financing Cash Flows for Finance Leases 7 7 ROU Assets Obtained in Exchange for Lease Obligations Operating Leases 202 197 Finance Leases 3 34 Supplemental balance sheet information related to leases as of December 31, 2020 and 2019 is as follows: (In millions, except lease term and discount rate) 2020 2019 Operating Leases Operating Lease ROU Assets $ 851 $ 855 Operating Lease Liabilities due Within One Year $ 198 $ 199 Operating Lease Liabilities 684 668 Total Operating Lease Liabilities $ 882 $ 867 Finance Leases Property, Plant and Equipment, at cost $ 262 $ 259 Accumulated Depreciation (60 ) (50 ) Property, Plant and Equipment, net $ 202 $ 209 Long Term Debt and Finance Leases due Within One Year $ 18 $ 6 Long Term Debt and Finance Leases 232 243 Total Finance Lease Liabilities $ 250 $ 249 Weighted Average Remaining Lease Term (years) Operating Leases 7.3 7.2 Finance Leases 30.9 31.6 Weighted Average Discount Rate Operating Leases 6.85% 6.69% Finance Leases 8.48% 8.46% Future maturities of our lease liabilities, excluding subleases, as of December 31, 2020 are as follows: (In millions) Operating Leases Finance Leases 2021 $ 245 $ 38 2022 186 23 2023 146 21 2024 110 21 2025 88 22 Thereafter 376 671 Total Lease Payments 1,151 796 Less: Imputed Interest 269 546 Total $ 882 $ 250 As of December 31, 2020, we have additional operating and finance leases that have not yet commenced for which the present value of lease payments over the respective lease terms totals $23 million. Accordingly, these leases are not recorded on the Consolidated Balance Sheets at December 31, 2020. These leases will commence in 2021 and 2022 with lease terms of 7 years

Financing Arrangements and Deri

Financing Arrangements and Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2020
Financing Arrangements And Derivative Financial Instruments [Abstract]
Financing Arrangements and Derivative Financial Instruments	Note 15. Financing Arrangements and Derivative Financial Instruments At December 31, 2020, we had total credit arrangements of $9,707 million, of which $3,881 million were unused. At that date, 24% of our debt was at variable interest rates averaging 2.79%. Notes Payable and Overdrafts, Long Term Debt and Finance Leases due Within One Year and Short Term Financing Arrangements At December 31, 2020, we had short term committed and uncommitted credit arrangements totaling $1,075 million, of which $639 million were unused. These arrangements are available primarily to certain of our foreign subsidiaries through various banks at quoted market interest rates. The following table presents amounts due within one year: December 31, December 31, (In millions) 2020 2019 Chinese credit facilities $ 163 $ 118 Other domestic and foreign debt 243 230 Notes Payable and Overdrafts $ 406 $ 348 Weighted average interest rate 4.52 % 4.92 % Chinese credit facilities $ 13 $ 95 8.75% due 2020 — 280 Other domestic and foreign debt (including finance leases) 139 187 Long Term Debt and Finance Leases due Within One Year $ 152 $ 562 Weighted average interest rate 3.87 % 6.58 % Total obligations due within one year $ 558 $ 910 Long Term Debt and Finance Leases and Financing Arrangements At December 31, 2020, we had long term credit arrangements totaling $8,632 million, of which $3,242 million were unused. The following table presents long term debt and finance leases, net of unamortized discounts, and interest rates: December 31, 2020 December 31, 2019 (In millions) Amount Interest Rate Amount Interest Rate Notes: 8.75% due 2020 $ — $ 280 5.125% due 2023 1,000 1,000 3.75% Euro Notes due 2023 307 281 9.5% due 2025 803 — 5% due 2026 900 900 4.875% due 2027 700 700 7% due 2028 150 150 Credit Facilities: First lien revolving credit facility due 2025 — — — — Second lien term loan facility due 2025 400 2.15 % 400 3.97 % European revolving credit facility due 2024 — — — — Pan-European accounts receivable facility 291 1.18 % 327 0.98 % Mexican credit facilities 152 1.87 % 200 3.44 % Chinese credit facilities 212 4.49 % 195 4.87 % Other foreign and domestic debt (1) 451 3.22 % 661 4.02 % 5,366 5,094 Unamortized deferred financing fees (32 ) (28 ) 5,334 5,066 Finance lease obligations (2) 250 249 5,584 5,315 Less portion due within one year (152 ) (562 ) $ 5,432 $ 4,753 (1) Interest rates are weighted average interest rates related to various foreign credit facilities with customary terms and conditions. (2) Includes non-cash financing additions of $3 million during the twelve month period ended December 31, 2020. NOTES $282 million 8.75% Senior Notes due 2020 On August 17, 2020, we repaid in full our $282 million 8.75% senior notes at maturity. $1.0 billion 5.125% Senior Notes due 2023 At December 31, 2020, $1.0 billion aggregate principal amount of 5.125% senior notes due 2023 were outstanding. These notes were sold at 100% of the principal amount and will mature on November 15, 2023. These notes are unsecured senior obligations and are guaranteed by our U.S. and Canadian subsidiaries that also guarantee our obligations under our U.S. senior secured credit facilities described below. We have the option to redeem these notes, in whole or in part, at any time at a redemption price of 100%, plus accrued and unpaid interest to the redemption date. The terms of the indenture for these notes, among other things, limit the ability of the Company and certain of its subsidiaries, including Goodyear Europe B.V. ("GEBV"), to (i) incur additional debt or issue redeemable preferred stock, (ii) pay dividends, repurchase shares or make certain other restricted payments or investments, (iii) incur liens, (iv) sell assets, (v) incur restrictions on the ability of our subsidiaries to pay dividends or to make other payments to us, (vi) enter into affiliate transactions, (vii) engage in sale and leaseback transactions, and (viii) consolidate, merge, sell or otherwise dispose of all or substantially all of our assets. These covenants are subject to significant exceptions and qualifications. For example, if these notes are assigned an investment grade rating from at least two of Moody's , Standard and Poor's and Fitch and no default has occurred and is continuing, certain covenants will be suspended and we may elect to suspend the subsidiary guarantees. The indenture has customary defaults, including a cross-default to material indebtedness of Goodyear and our subsidiaries. €250 million 3.75% Senior Notes due 2023 of GEBV At December 31, 2020, €250 million aggregate principal amount of GEBV’s 3.75% senior notes due 2023 were outstanding. These notes were sold at 100% of the principal amount and will mature on December 15, 2023. These notes are unsecured senior obligations of GEBV and are guaranteed, on an unsecured senior basis, by the Company and our U.S. and Canadian subsidiaries that also guarantee our obligations under our U.S. senior secured credit facilities described below. We have the option to redeem these notes, in whole or in part, at any time at a redemption price of 100%, plus accrued and unpaid interest to the redemption date. The indenture for these notes includes covenants that are substantially similar to those contained in the indenture governing our 5.125% senior notes due 2023, described above. $800 million 9.5% Senior Notes due 2025 On May 18, 2020, we issued $600 million in aggregate principal amount of 9.5% senior notes due 2025. These notes were sold at 100% of the principal amount We have the option to redeem these notes, in whole or in part, at any time on or after May 31, 2022 at a redemption price of 104.75%, 102.375% and 100% during the 12-month periods commencing on May 31, 2022, 2023 and 2024 and thereafter, respectively, plus accrued and unpaid interest to the redemption date. Prior to May 31, 2022, we may redeem these notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium and accrued and unpaid interest to the redemption date. In addition, prior to May 31, 2022, we may redeem up to 35% of the original aggregate principal amount of these notes from the net cash proceeds of certain equity offerings at a redemption price equal to 109.5% of the principal amount plus accrued and unpaid interest to the redemption date. The indenture for these notes includes covenants that are substantially similar to those contained in the indenture governing our 5.125% senior notes due 2023, described above. $900 million 5% Senior Notes due 2026 At December 31, 2020, $900 million aggregate principal amount of 5% senior notes due 2026 were outstanding. These notes were sold at 100% of the principal amount and will mature on May 31, 2026. These notes are unsecured senior obligations and are guaranteed by our U.S. and Canadian subsidiaries that also guarantee our obligations under our U.S. senior secured credit facilities described below. We have the option to redeem these notes, in whole or in part, at any time on or after May 31, 2021 at a redemption price of 102.5%, 101.667%, 100.833% and 100% during the 12-month periods commencing on May 31, 2021, 2022, 2023 and 2024 and thereafter, respectively, plus accrued and unpaid interest to the redemption date. Prior to May 31, 2021, we may redeem these notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium and accrued and unpaid interest to the redemption date. The indenture for these notes includes covenants that are substantially similar to those contained in the indenture governing our 5.125% senior notes due 2023, described above. $700 million 4.875% Senior Notes due 2027 At December 31, 2020, $700 million aggregate principal amount of 4.875% senior notes due 2027 were outstanding. These notes were sold at 100% of the principal amount and will mature on March 15, 2027. These notes are unsecured senior obligations and are guaranteed by our U.S. and Canadian subsidiaries that also guarantee our obligations under our U.S. senior secured credit facilities described below. We have the option to redeem these notes, in whole or in part, at any time prior to their maturity. If we elect to redeem the notes prior to December 15, 2026, we will pay a redemption price equal to the greater of 100% of the principal amount of the notes redeemed or the sum of the present values of the remaining scheduled payments on the notes redeemed, discounted using a defined treasury rate plus 50 basis points, plus in either case accrued and unpaid interest to the redemption date. If we elect to redeem the notes on or after December 15, 2026, we will pay a redemption price equal to 100% of the principal amount of the notes redeemed plus accrued and unpaid interest to the redemption date. The terms of the indenture for these notes, among other things, limit our ability and the ability of certain of our subsidiaries to (i) incur certain liens, (ii) engage in sale and leaseback transactions, and (iii) consolidate, merge, sell or otherwise dispose of all or substantially all of our assets. These covenants are subject to significant exceptions and qualifications. $150 million 7% Senior Notes due 2028 At December 31, 2020, $150 million aggregate principal amount of 7% notes due 2028 were outstanding. These notes are unsecured senior obligations and will mature on March 15, 2028. We have the option to redeem these notes, in whole or in part, at any time at a redemption price equal to the greater of 100% of the principal amount thereof or the sum of the present values of the remaining scheduled payments thereon, discounted using a defined treasury rate plus 15 basis points, plus in either case accrued and unpaid interest to the redemption date. The terms of the indenture for these notes, among other things, limit our ability and the ability of certain of our subsidiaries to (i) incur secured debt, (ii) engage in sale and leaseback transactions, and (iii) consolidate, merge, sell or otherwise dispose of all or substantially all of our assets. These covenants are subject to significant exceptions and qualifications. CREDIT FACILITIES $2.0 billion Amended and Restated First Lien Revolving Credit Facility due 2025 On April 9, 2020, we amended and restated our $2.0 billion first lien revolving credit facility. Changes to the facility include extending the maturity to April 9, 2025 and increasing the borrowing base for the facility by increasing the amount attributable to the value of our principal trademarks by $100 million and adding the value of eligible machinery and equipment. The interest rate for loans under the facility increased by 50 basis points to LIBOR plus 175 basis points, based on our current liquidity as described below, and undrawn amounts under the facility will be subject to an annual commitment fee of 25 basis points. Our amended and restated first lien revolving credit facility is available in the form of loans or letters of credit. Up to $800 million in letters of credit and $50 million of swingline loans are available for issuance under the facility. Subject to the consent of the lenders whose commitments are to be increased, we may request that the facility be increased by up to $250 million Our obligations under the facility are guaranteed by most of our wholly-owned U.S. and Canadian subsidiaries. Our obligations under the facility and our subsidiaries' obligations under the related guarantees are secured by first priority security interests in collateral that includes, subject to certain exceptions: • U.S. and Canadian accounts receivable and inventory; • certain of our U.S. manufacturing facilities; • equity interests in our U.S. subsidiaries and up to 65% of the voting equity interests in most of our directly owned foreign subsidiaries; and • substantially all other tangible and intangible assets, including equipment, contract rights and intellectual property. Availability under the facility is subject to a borrowing base, which is based on (i) eligible accounts receivable and inventory of The Goodyear Tire & Rubber Company and certain of its U.S. and Canadian subsidiaries, after adjusting for customary factors that are subject to modification from time to time by the administrative agent or the majority lenders at their discretion (not to be exercised unreasonably), (ii) the value of our principal trademarks in an amount not to exceed $400 million, (iii) the value of eligible machinery and equipment, and (iv) certain cash in an amount not to exceed $200 million. of credit under the facility exceeds the borrowing base, we are required to prepay borrowings and/or cash collateralize letters of credit sufficient to eliminate the excess. As of December 31, 20 20 , our borrowing base, and therefore our availability, under this facility was $ 454 million below the facility's stated amount of $ 2.0 billion. The facility, which matures on April 9, 2025, contains covenants that, among other things, limit our ability and the ability of certain of our subsidiaries to (i) incur additional debt or issue redeemable preferred stock, (ii) pay dividends, repurchase shares or make certain other restricted payments or investments, (iii) incur liens, (iv) sell assets, (v) incur restrictions on the ability of our subsidiaries to pay dividends or to make other payments to us, (vi) enter into affiliate transactions, (vii) engage in sale and leaseback transactions, and (viii) consolidate, merge, sell or otherwise dispose of all or substantially all of our assets. These covenants are subject to significant exceptions and qualifications. In addition, in the event that the availability under the facility plus the aggregate amount of our Available Cash is less than $200 million 2.0 The facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in our business or financial condition since December 31, 2019. The facility also has customary defaults, including a cross-default to material indebtedness of Goodyear and our subsidiaries. If Available Cash (as defined in the facility) plus the availability under the facility is greater than $750 million, amounts drawn under the facility will bear interest, at our option, at (i) 175 basis points over LIBOR or (ii) 75 basis points over an alternative base rate (the higher of (a) the prime rate, (b) the federal funds effective rate or the overnight bank funding rate plus 50 basis points or (c) LIBOR plus 100 basis points). If Available Cash plus the availability under the facility is equal to or less than $750 million, then amounts drawn under the facility will bear interest, at our option, at (i) 200 basis points over LIBOR or (ii) 100 basis points over an alternative base rate. At December 31, 2020, we had no borrowings and $11 million of letters of credit issued under the revolving credit facility. At December 31, 2019, we had no borrowings and $37 million of letters of credit issued under the revolving credit facility. Amended and Restated Second Lien Term Loan Facility due 2025 Our amended and restated second lien term loan facility matures on March 7, 2025. The term loan bears interest, at our option, at (i) 200 basis points over LIBOR or (ii) 100 basis points over an alternative base rate (the higher of (a) the prime rate, (b) the federal funds effective rate or the overnight bank funding rate plus 50 basis points or (c) LIBOR plus 100 basis points). In addition, if the Total Leverage Ratio is equal to or less than 1.25 to 1.00, we have the option to further reduce the spreads described above by 25 basis points. "Total Leverage Ratio" has the meaning given it in the facility. Our obligations under our second lien term loan facility are guaranteed by most of our wholly-owned U.S. and Canadian subsidiaries and are secured by second priority security interests in the same collateral securing the $2.0 billion first lien revolving credit facility. The facility contains covenants, representations, warranties and defaults similar to those in the $2.0 billion first lien revolving credit facility. In addition, if our Pro Forma Senior Secured Leverage Ratio (the ratio of Consolidated Net Secured Indebtedness to EBITDA) for any period of four consecutive fiscal quarters is greater than 3.0 to 1.0, before we may use cash proceeds from certain asset sales to repay any junior lien, senior unsecured or subordinated indebtedness, we must first offer to use such cash proceeds to prepay borrowings under the second lien term loan facility. "Pro Forma Senior Secured Leverage Ratio," "Consolidated Net Secured Indebtedness" and "EBITDA" have the meanings given them in the facility. At December 31, 2020 and 2019, the amounts outstanding under this facility were $400 million. €800 million Amended and Restated Senior Secured European Revolving Credit Facility due 2024 Our amended and restated European revolving credit facility consists of (i) a €180 million German tranche that is available only to Goodyear Dunlop Tires Germany GmbH (“GDTG”) and (ii) a €620 million all-borrower tranche that is available to GEBV, GDTG and Goodyear Dunlop Tires Operations S.A. Up to €175 million of swingline loans and €75 million in letters of credit are available for issuance under the all-borrower tranche. Amounts drawn under this facility will bear interest at LIBOR plus 150 basis points for loans denominated in U.S. dollars or pounds sterling and EURIBOR plus 150 basis points for loans denominated in euros, and undrawn amounts under the facility are subject to an annual commitment fee of 25 basis points. GEBV and certain of its subsidiaries in the United Kingdom, Luxembourg, France and Germany provide guarantees to support the facility. GEBV’s obligations under the facility and the obligations of its subsidiaries under the related guarantees are secured by security interests in collateral that includes, subject to certain exceptions: • the capital stock of the principal subsidiaries of GEBV; and • a substantial portion of the tangible and intangible assets of GEBV and certain of its subsidiaries in the United Kingdom, Luxembourg, France and Germany, including real property, equipment, inventory, contract rights, intercompany receivables and cash accounts, but excluding accounts receivable and certain cash accounts in subsidiaries that are or may become parties to securitization or factoring transactions. The German guarantors secure the German tranche on a first-lien basis and the all-borrower tranche on a second-lien basis. GEBV and its other subsidiaries that provide guarantees secure the all-borrower tranche on a first-lien basis and generally do not provide collateral support for the German tranche. The Company and its U.S. and Canadian subsidiaries that guarantee our U.S. senior secured credit facilities described above also provide unsecured guarantees in support of the facility. The facility contains covenants similar to those in our first lien revolving credit facility, with additional limitations applicable to GEBV and its subsidiaries. In addition, under the facility, GEBV’s ratio of Consolidated Net GEBV Indebtedness to Consolidated GEBV EBITDA for a period of four consecutive fiscal quarters is not permitted to be greater than 3.0 to 1.0 at the end of any fiscal quarter. “Consolidated Net GEBV Indebtedness” and “Consolidated GEBV EBITDA” have the meanings given them in the facility. The facility has customary representations and warranties including, as a condition to borrowing, that all such representations and warranties are true and correct, in all material respects, on the date of the borrowing, including representations as to no material adverse change in our business or financial condition since December 31, 2018. The facility also has customary defaults, including a cross-default to material indebtedness of Goodyear and our subsidiaries. At December 31, 2020 and 2019, there were no borrowings and no letters of credit outstanding under the European revolving credit facility. Accounts Receivable Securitization Facilities (On-Balance Sheet) GEBV and certain other of our European subsidiaries are parties to a pan-European accounts receivable securitization facility that expires in 2023. The terms of the facility provide the flexibility to designate annually the maximum amount of funding available under the facility in an amount of not less than €30 million and not more than €450 million. For the period from October 18, 2018 through October 15, 2020, the designated maximum amount of the facility was €320 million. For the period from October 16, 2020 through October 18, 2021, the designated maximum amount of the facility was decreased to €280 million. The facility involves an ongoing daily sale of substantially all of the trade accounts receivable of certain GEBV subsidiaries. These subsidiaries retain servicing responsibilities. Utilization under this facility is based on eligible receivable balances. The funding commitments under the facility will expire upon the earliest to occur of: (a) September 26, 2023, (b) the non-renewal and expiration (without substitution) of all of the back-up liquidity commitments, (c) the early termination of the facility according to its terms (generally upon an Early Amortisation Event (as defined in the facility), which includes, among other things, events similar to the events of default under our senior secured credit facilities; certain tax law changes; or certain changes to law, regulation or accounting standards), or (d) our request for early termination of the facility. The facility’s current back-up liquidity commitments will expire on October 18, 2021. At December 31, 2020, the amounts available and utilized under this program totaled $291 million (€237 million). At December 31, 2019, the amounts available and utilized under this program totaled $327 million (€291 million). The program does not qualify for sale accounting, and accordingly, these amounts are included in Long Term Debt and Finance Leases. Accounts Receivable Factoring Facilities (Off-Balance Sheet) We have sold certain of our trade receivables under off-balance sheet programs. For these programs, we have concluded that there is generally no risk of loss to us from non-payment of the sold receivables. At December 31, 2020, the gross amount of receivables sold was $451 million, compared to $548 million at December 31, 2019. Other Foreign Credit Facilities A Mexican subsidiary and a U.S. subsidiary have a revolving credit facility in Mexico. At December 31, 2020, the amounts available and utilized under this facility were $200 million and $152 million, respectively. At December 31, 2019, the amounts available and utilized under this facility were $200 million. The facility ultimately matures in 2022, has covenants relating to the Mexican and U.S. subsidiary, and has customary representations and warranties and default provisions relating to the Mexican and U.S. subsidiary’s ability to perform its respective obligations under the facility. A Chinese subsidiary has several financing arrangements in China. At December 31, 2020 and 2019, the amounts available under these facilities were $981 million and $735 million, respectively. At December 31, 2020, the amount utilized under these facilities was $375 million, of which $163 million represented notes payable and $212 million represented long term debt. At December 31, 2020, $13 million of the long term debt was due within a year. At December 31, 2019, the amount utilized under these facilities was $313 million, of which $118 million represented notes payable and $195 million represented long term debt. At December 31, 2019, $95 million of the long term debt was due within a year. The facilities contain covenants relating to the Chinese subsidiary and have customary representations and warranties and defaults relating to the Chinese subsidiary’s ability to perform its obligations under the facilities. Certain of the facilities can only be used to finance the expansion of our manufacturing facility in China and, at December 31, 2020 and 2019, the unused amounts available under these facilities were $99 million and $106 million, respectively. Debt Maturities The annual aggregate maturities of our debt (excluding the impact of deferred financing fees and unamortized discounts) and finance leases for the five years subsequent to December 31, 2020 are presented below. Maturities of debt credit agreements have been reported on the basis that the commitments to lend under these agreements will be terminated effective at the end of their current terms. (In millions) 2021 2022 2023 2024 2025 U.S. $ 1 $ 151 $ 999 $ — $ 1,199 Foreign 555 324 699 88 19 $ 556 $ 475 $ 1,698 $ 88 $ 1,218 DERIVATIVE FINANCIAL INSTRUMENTS We utilize derivative financial instrument contracts and nonderivative instruments to manage interest rate, foreign exchange and commodity price risks. We have established a control environment that includes policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities. We do not hold or issue derivative financial instruments for trading purposes. Foreign Currency Contracts We enter into foreign currency contracts in order to manage the impact of changes in foreign exchange rates on our consolidated results of operations and future foreign currency-denominated cash flows. These contracts may be used to reduce exposure to currency movements affecting existing foreign currency-denominated assets, liabilities, firm commitments and forecasted transactions resulting primarily from trade purchases and sales, equipment acquisitions, intercompany loans and royalty agreements. Contracts hedging short term trade receivables and payables normally have no hedging designation. The following table presents the fair values for foreign currency hedge contracts that do not meet the criteria to be accounted for as cash flow hedging instruments: December 31, December 31, (In millions) 2020 2019 Fair Values — Current asset (liability): Accounts receivable $ 1 $ 1 Other current liabilities (27 ) (15 ) At December 31, 2020 and 2019, these outstanding foreign currency derivatives had notional amounts of $1,664 million and $1,707 million, respectively, and were primarily related to intercompany loans. Other (Income) Expense included net transaction losses on derivatives of $87 million in 2020 and net transaction gains on derivatives of $22 million in 2019. These amounts were substantially offset in Other (Income) Expense by the effect of changing exchange rates on the underlying currency exposures. The following table presents fair values for foreign currency hedge contracts that meet the criteria to be accounted for as cash flow hedging instruments: December 31, December 31, (In millions) 2020 2019 Fair Values — Current asset (liability): Accounts receivable $ — $ 9 Other current liabilities (7 ) (3 ) Fair Values — Long term asset (liability): Other assets $ — $ 1 Other long term liabilities — (1 ) At December 31, 2020 and 2019, these outstanding foreign currency derivatives had notional amounts of $50 million and $365 million, respectively, and primarily related to U.S. dollar denominated intercompany transactions. Based on our current forecasts, including the expected ongoing impacts of the COVID-19 pandemic, we believe that it is probable that the underlying hedge transactions will occur within an appropriate time frame in order to continue to qualify for cash flow hedge accounting treatment. We enter into master netting agreements with counterparties. The amounts eligible for offset under the master netting agreements are not material and we have elected a gross presentation of foreign currency contracts in the Consolidated Balance Sheets. The following table presents the classification of changes in fair values of foreign currency contracts that meet the criteria to be accounted for as cash flow hedging instruments (before tax and minority): Year Ended December 31, (In millions) 2020 2019 2018 Amount of gains (losses) deferred to AOCL (1) $ 15 $ 10 $ 9 Reclassification adjustment for amounts recognized in CGS (1) (13 ) (14 ) 7 (1) Excluded components deferred to AOCL and excluded components reclassified from AOCL to CGS for the twelve months ended December 31, 2020, 2019 and 2018 were not material. The estimated net amount of the deferred gains at December 31, 2020 The counterparties to our foreign currency contracts were considered by us to be substantial and creditworthy financial institutions that were recognized market makers at the time we entered into those contracts. We seek to control our credit exposure to these counterparties by diversifying across multiple counterparties, by setting counterparty credit limits based on long term credit ratings and other indicators of counterparty credit risk such as credit default swap spreads, and by monitoring the financial strength of these counterparties on a regular basis. We also enter into master netting agreements with counterparties when possible. By controlling and monitoring exposure to counterparties in this manner, we believe that we effectively manage the risk of loss due to nonperformance by a counterparty. However, the inability of a counterparty to fulfill its contractual obligations to us could have a material adverse effect on our liquidity, financial position or results of operations in the period in which it occurs.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 16. Fair Value Measurements The following table presents information about assets and liabilities recorded at fair value on the Consolidated Balance Sheet at December 31: Total Carrying Value in the Consolidated Balance Sheet Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (In millions) 2020 2019 2020 2019 2020 2019 2020 2019 Assets: Investments $ 11 $ 11 $ 11 $ 11 $ — $ — $ — $ — Foreign Exchange Contracts 1 11 — — 1 11 — — Total Assets at Fair Value $ 12 $ 22 $ 11 $ 11 $ 1 $ 11 $ — $ — Liabilities: Foreign Exchange Contracts $ 34 $ 19 $ — $ — $ 34 $ 19 $ — $ — Total Liabilities at Fair Value $ 34 $ 19 $ — $ — $ 34 $ 19 $ — $ — The following table presents supplemental fair value information about long term fixed rate and variable rate debt, excluding finance leases, at December 31: December 31, December 31, (In millions) 2020 2019 Fixed Rate Debt (1) Carrying amount — liability $ 4,094 $ 3,434 Fair value — liability 4,283 3,558 Variable Rate Debt (1) Carrying amount — liability $ 1,240 $ 1,632 Fair value — liability 1,197 1,632 (1) Excludes Notes Payable and Overdrafts of $406 million and $348 million at December 31, 2020 and 2019, respectively, of which $227 million and $143 million, respectively, are at fixed rates and $179 million and $205 million, respectively, are at variable rates. The carrying value of Notes Payable and Overdrafts approximates fair value due to the short term nature of the facilities. Long term debt with fair values of $4,391 million and $3,808 million at December 31, 2020 and 2019, respectively, were estimated using quoted Level 1 market prices. The carrying value of the remaining debt was based upon internal estimates of fair value derived from market prices for similar debt.

Pension, Other Postretirement B

Pension, Other Postretirement Benefits and Savings Plans	12 Months Ended
	Dec. 31, 2020
Compensation And Retirement Disclosure [Abstract]
Pension, Other Postretirement Benefits and Savings Plans	Note 17. Pension, Other Postretirement Benefits and Savings Plans We provide employees with defined benefit pension or defined contribution savings plans. Our hourly U.S. pension plans are frozen and provide benefits based on length of service. The principal salaried U.S. pension plans are frozen and provide benefits based on final five-year average earnings formulas. Salaried employees who made voluntary contributions to these plans receive higher benefits. We also provide certain U.S. employees and employees at certain non-U.S. subsidiaries with health care benefits or life insurance benefits upon retirement. Substantial portions of the health care benefits for U.S. salaried retirees are not insured and are funded from operations. During 2020, we recognized settlement charges of $28 million, primarily related to certain of our salaried U.S. pension plans, of which $24 million was recognized in Other (Income) Expense and $4 million in Rationalizations, related to the exit of employees under approved rationalization plans. The settlement charges resulted from total lump sum payments exceeding annual service and interest cost of the applicable plans. In addition, we recognized a curtailment credit of $6 million in Other (Income) Expense during 2020, related to a freeze of one of our non-U.S. defined benefit pension plans. During 2020, we also recognized a curtailment credit of $4 million related to one of our Other Postretirement Benefits plans and a termination benefits charge of $5 million related to our hourly U.S. pension plan in Rationalizations, related to the exit of employees under approved rationalization plans. During 2019, we recognized settlement charges of $6 million in Other (Income) Expense primarily related to certain of our U.S. pension plans. The settlement charges resulted from total lump sum payments exceeding annual service and interest cost of the applicable plans. During 2019, we also recognized curtailment and special termination benefit charges of $5 million in Rationalizations, primarily related to the acceptance of voluntary buy-outs at our tire manufacturing facility in Gadsden, Alabama. During 2018, we recognized settlement charges of $13 million in Other (Income) Expense for our frozen U.K. pension plan. These settlement charges related primarily to an offer of lump sum payments over a limited time during 2018 to non-retiree participants of the plan. Lump sum payments of $103 million, primarily related to this offer, were made from existing plan assets in 2018. As a result, total lump sum payments related to this plan exceeded annual interest cost for 2018. During 2018, we recognized settlement charges of $8 million in Other (Income) Expense related to certain of our U.S. pension plans. The settlement charges resulted from total lump sum payments exceeding annual service and interest cost of the applicable plans. We have increased the obligation for our U.K. pension plan by $16 million to recognize the estimated impact to our plan from court rulings in 2018 and later, involving a plan with similar features to ours that was sponsored by another company, that required equal guaranteed minimum pension benefits for males and females. The increases were recognized in AOCL as prior service cost from plan amendments. The actual impact to our U.K. pension plan is still subject to the finalization of plan amendments in response to the court rulings and potential future judicial decisions. During 2018, the Brazil pension regulator approved our plan to replace certain benefits in our Brazil retiree medical plan with an increase in benefits in our Brazil pension plan. The changes were effective in the fourth quarter of 2019 and resulted in an increase to our pension obligation of $16 million and a decrease in our other postretirement benefits obligation of $14 million at December 31, 2018. The increase to the pension obligation and decrease to the other postretirement benefits obligation were recognized in AOCL as prior service cost and prior service credit, respectively. Total benefits cost and amounts recognized in other comprehensive (income) loss follows: Pension Plans U.S. Non-U.S. Other Postretirement Benefits (In millions) 2020 2019 2018 2020 2019 2018 2020 2019 2018 Benefits cost (credit): Service cost $ 4 $ 3 $ 4 $ 30 $ 26 $ 28 $ 2 $ 2 $ 3 Interest cost 126 173 157 56 69 69 8 11 12 Expected return on plan assets (193 ) (223 ) (219 ) (54 ) (59 ) (70 ) — — — Amortization of prior service cost (credit) — — — 1 2 — (9 ) (9 ) (8 ) Amortization of net losses 109 112 112 38 29 29 4 3 4 Net periodic cost $ 46 $ 65 $ 54 $ 71 $ 67 $ 56 $ 5 $ 7 $ 11 Net curtailments/settlements /termination benefits 31 8 8 (4 ) 3 13 (4 ) — — Total benefits cost $ 77 $ 73 $ 62 $ 67 $ 70 $ 69 $ 1 $ 7 $ 11 Recognized in other comprehensive (income) loss before tax and minority: Prior service cost (credit) from plan amendments $ — $ — $ — $ 3 $ (2 ) $ 31 $ — $ — $ (16 ) Increase (decrease) in net actuarial losses 108 4 14 (100 ) 201 (18 ) 5 6 (14 ) Amortization of prior service (cost) credit in net periodic cost — — — (2 ) (2 ) — 9 9 8 Amortization of net losses in net periodic cost (109 ) (112 ) (112 ) (38 ) (29 ) (30 ) (4 ) (3 ) (5 ) Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures (26 ) (5 ) (11 ) (9 ) (3 ) (14 ) 6 2 — Total recognized in other comprehensive (income) loss before tax and minority (27 ) (113 ) (109 ) (146 ) 165 (31 ) 16 14 (27 ) Total recognized in total benefits cost and other comprehensive (income) loss before tax and minority $ 50 $ (40 ) $ (47 ) $ (79 ) $ 235 $ 38 $ 17 $ 21 $ (16 ) Service cost is recorded in CGS or SAG. Other components of net periodic cost are recorded in Other (Income) Expense. Net curtailments, settlements and termination benefits are recorded in Other (Income) Expense or Rationalizations if related to a rationalization plan. We use the fair value of pension assets in the calculation of pension expense for all plans. Total benefits cost for our other postretirement benefits was $1 million, $3 million and $4 million for our U.S. plans in 2020, 2019 and 2018, respectively, and $0 million, $4 million and $7 million for our non-U.S. plans in 2020, 2019 and 2018, respectively. The Medicare Prescription Drug Improvement and Modernization Act provides plan sponsors a federal subsidy for certain qualifying prescription drug benefits covered under the sponsor’s postretirement health care plans. Our other postretirement benefits cost is presented net of this subsidy, which is less than $1 million annually. The change in benefit obligation and plan assets for 2020 and 2019 and the amounts recognized in our Consolidated Balance Sheets at December 31, 2020 and 2019 are as follows: Pension Plans U.S. Non-U.S. Other Postretirement Benefits (In millions) 2020 2019 2020 2019 2020 2019 Change in benefit obligation: Beginning balance $ (5,009 ) $ (4,734 ) $ (3,195 ) $ (2,774 ) $ (241 ) $ (234 ) Newly adopted plans — — — (19 ) — — Service cost — benefits earned (4 ) (3 ) (30 ) (26 ) (2 ) (2 ) Interest cost (126 ) (173 ) (56 ) (69 ) (8 ) (11 ) Plan amendments — — (3 ) 2 — — Actuarial loss (520 ) (477 ) (123 ) (381 ) (4 ) (6 ) Participant contributions — — (3 ) (2 ) (8 ) (12 ) Curtailments/settlements/termination benefits 51 12 21 5 — (2 ) Foreign currency translation — — (133 ) (62 ) 4 (5 ) Benefit payments 373 366 140 131 23 31 Ending balance $ (5,235 ) $ (5,009 ) $ (3,382 ) $ (3,195 ) $ (236 ) $ (241 ) Change in plan assets: Beginning balance $ 4,780 $ 4,445 $ 2,740 $ 2,464 $ — $ 3 Newly adopted plans — — — 19 — — Actual return on plan assets 605 696 305 252 — — Company contributions to plan assets — — 20 39 — — Cash funding of direct participant payments 14 20 22 20 15 16 Participant contributions — — 3 2 8 12 Settlements (56 ) (15 ) (8 ) (5 ) — — Foreign currency translation — — 99 80 — — Benefit payments (373 ) (366 ) (140 ) (131 ) (23 ) (31 ) Ending balance $ 4,970 $ 4,780 $ 3,041 $ 2,740 $ — $ — Funded status at end of year $ (265 ) $ (229 ) $ (341 ) $ (455 ) $ (236 ) $ (241 ) Significant actuarial losses related to changes in benefit obligations for 2020 and 2019 primarily resulted from decreases in discount rates. Other postretirement benefits unfunded status was $106 million for our U.S. plans at December 31, 2020 and 2019, and $130 million and $135 million for our non-U.S. plans at December 31, 2020 and 2019, respectively. The funded status recognized in the Consolidated Balance Sheets consists of: Pension Plans Other Postretirement U.S. Non-U.S. Benefits (In millions) 2020 2019 2020 2019 2020 2019 Noncurrent assets $ — $ — $ 408 $ 237 $ — $ — Current liabilities (11 ) (16 ) (22 ) (20 ) (16 ) (16 ) Noncurrent liabilities (254 ) (213 ) (727 ) (672 ) (220 ) (225 ) Net amount recognized $ (265 ) $ (229 ) $ (341 ) $ (455 ) $ (236 ) $ (241 ) The amounts recognized in AOCL, net of tax, consist of: Pension Plans Other Postretirement U.S. Non-U.S. Benefits (In millions) 2020 2019 2020 2019 2020 2019 Prior service (credit) cost $ (3 ) $ (3 ) $ 25 $ 25 $ (7 ) $ (23 ) Net actuarial loss 2,353 2,380 636 782 30 30 Gross amount recognized 2,350 2,377 661 807 23 7 Deferred income taxes (43 ) (50 ) (104 ) (135 ) (29 ) (22 ) Minority shareholders’ equity — — (2 ) (1 ) — — Net amount recognized $ 2,307 $ 2,327 $ 555 $ 671 $ (6 ) $ (15 ) The following table presents significant weighted average assumptions used to determine benefit obligations at December 31: Pension Plans Other Postretirement Benefits 2020 2019 2020 2019 Discount rate: —U.S. 2.42 % 3.22 % 2.34 % 3.14 % —Non-U.S. 1.49 1.98 4.09 4.39 Rate of compensation increase: —U.S. N/A N/A N/A N/A —Non-U.S. 2.89 2.92 N/A N/A The following table presents significant weighted average assumptions used to determine benefits cost for the years ended December 31: Pension Plans Other Postretirement Benefits 2020 2019 2018 2020 2019 2018 Discount rate for determining interest cost: —U.S. 2.66 % 3.85 % 3.09 % 2.68 % 3.79 % 2.99 % —Non-U.S. 2.26 2.84 2.56 5.68 6.25 6.13 Expected long term return on plan assets: —U.S. 4.22 5.25 4.58 N/A N/A N/A —Non-U.S. 2.52 2.95 3.02 N/A N/A N/A Rate of compensation increase: —U.S. N/A N/A N/A N/A N/A N/A —Non-U.S. 2.92 2.91 2.91 N/A N/A N/A For 2020, a weighted average discount rate of 2.66% was used to determine interest cost for the U.S. pension plans. This rate was derived from spot rates along a yield curve developed from a portfolio of corporate bonds from issuers rated AA or higher by established rating agencies as of December 31, 2019, applied to our expected benefit payment cash flows. For our non-U.S. locations, a weighted average discount rate of 2.26% was used. This rate was developed based on the nature of the liabilities and local environments, using available bond indices, yield curves, projected cash flows, and long term inflation. For 2020, an assumed weighted average long term rate of return of 4.22% was used for the U.S. pension plans. In developing the long term rate of return, we evaluated input from our pension fund consultant on asset class return expectations, including determining the appropriate rate of return for our plans, which are primarily invested in fixed income securities. For our non-U.S. locations, an assumed weighted average long term rate of return of 2.52% was used. Input from local pension fund consultants concerning asset class return expectations and long term inflation form the basis of this assumption. The U.S. pension plan mortality assumption is based on our actual historical experience and expected future mortality improvements based on published actuarial tables. For our non-U.S. locations, mortality assumptions are based on published actuarial tables which include The following table presents estimated future benefit payments from the plans as of December 31, 2020. Benefit payments for other postretirement benefits are presented net of retiree contributions and Medicare Part D Subsidy Receipts: Pension Plans Other Postretirement (In millions) U.S. Non-U.S. Benefits 2021 $ 417 $ 136 $ 16 2022 390 129 16 2023 366 130 15 2024 352 137 15 2025 339 138 14 2026-2030 1,578 743 68 The following table presents selected information on our pension plans: U.S. Non-U.S. (In millions) 2020 2019 2020 2019 All plans: Accumulated benefit obligation $ 5,220 $ 4,994 $ 3,284 $ 3,097 Plans not fully-funded: Projected benefit obligation $ 5,235 $ 5,009 $ 933 $ 1,059 Accumulated benefit obligation 5,220 4,994 856 991 Fair value of plan assets 4,970 4,780 185 370 Certain non-U.S. subsidiaries maintain unfunded pension plans consistent with local practices and requirements. At December 31, 2020, these plans accounted for $264 million of our accumulated pension benefit obligation, $299 million of our projected pension benefit obligation, and $90 million of our AOCL adjustment. At December 31, 2019, these plans accounted for $247 million of our accumulated pension benefit obligation, $277 million of our projected pension benefit obligation, and $82 million of our AOCL adjustment. We expect to contribute $25 million to $50 million to our funded non-U.S. pension plans in 2021. Assumed health care cost trend rates at December 31 follow: 2020 2019 Health care cost trend rate assumed for the next year 6.0 % 6.3 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 5.0 5.0 Year that the rate reaches the ultimate trend rate 2025 2025 Our pension plan weighted average investment allocation at December 31, by asset category, follows: U.S. Non-U.S. 2020 2019 2020 2019 Cash and short term securities 3 % 2 % 2 % 1 % Equity securities 4 6 4 3 Debt securities 93 92 93 96 Alternatives — — 1 — Total 100 % 100 % 100 % 100 % Our pension investment policy recognizes the long term nature of pension liabilities, and is primarily designed to offset the future impact of discount rate movements on the funded status for our plans. All assets are managed externally according to target asset allocation guidelines we have established. Manager guidelines prohibit the use of any type of investment derivative without our prior approval. Portfolio risk is controlled by having managers comply with guidelines, establishing the maximum size of any single holding in their portfolios, and using managers with different investment styles. We periodically undertake asset and liability modeling studies to determine the appropriateness of the investments. The portfolio of our U.S. pension plan assets includes holdings of global high quality and high yield fixed income securities, short term interest bearing deposits, and private equities. The target asset allocation of our U.S. pension plans is 94% in duration-matched fixed income securities and 6% in private equity and private credit securities. Actual U.S. pension fund asset allocations are reviewed on a periodic basis and the pension funds are rebalanced to target ranges on an as needed basis. The portfolios of our non-U.S. pension plans include holdings of U.S. and non-U.S. equities, global high quality and high yield fixed income securities, insurance contracts, repurchase agreements, and short term interest bearing deposits. The weighted average target asset allocation of the non-U.S. pension funds is approximately 95% fixed income and 5% equities. The fair values of our pension plan assets at December 31, 2020 by asset category are as follows: U.S. Non-U.S (In millions) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Cash and Short Term Securities $ 122 $ 122 $ — $ — $ 46 $ 42 $ 4 $ — Equity Securities Common and Preferred Stock — — — — 24 24 — — Commingled Funds — — — — 19 19 — — Mutual Funds — — — — 6 6 — — Debt Securities Corporate Bonds 2,843 — 2,842 1 230 24 206 — Government Bonds 1,038 — 1,038 — 2,503 42 2,461 — Repurchase Agreements — — — — (650 ) — (650 ) — Asset Backed Securities 280 — 280 — 76 8 68 — Commingled Funds — — — — 20 20 — — Mutual Funds — — — — 19 9 10 — Alternatives Insurance Contracts 2 — — 2 28 — — 28 Other Investments 7 — 7 — 6 — 5 1 Total Investments in the Fair Value Hierarchy 4,292 $ 122 $ 4,167 $ 3 2,327 $ 194 $ 2,104 $ 29 Investments Measured at Net Asset Value, as Practical Expedient: Equity Securities Commingled Funds 23 62 Mutual Funds — 4 Partnership Interests 166 — Debt Securities Mutual Funds 148 81 Commingled Funds 295 665 Partnership Interests 102 — Short Term Securities Commingled Funds 22 3 Alternatives Commingled Funds — 6 Total Investments 5,048 3,148 Other (78 ) (107 ) Total Plan Assets $ 4,970 $ 3,041 The fair values of our pension plan assets at December 31, 2019 by asset category are as follows: U.S. Non-U.S. (In millions) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Cash and Short Term Securities $ 47 $ 47 $ — $ — $ 33 $ 29 $ 4 $ — Equity Securities Common and Preferred Stock — — — — 24 24 — — Commingled Funds — — — — 36 36 — — Mutual Funds — — — — 5 5 — — Debt Securities Corporate Bonds 2,577 — 2,576 1 190 10 180 — Government Bonds 1,120 — 1,120 — 2,271 60 2,211 — Repurchase Agreements — — — — (511 ) — (511 ) — Asset Backed Securities 283 — 282 1 74 5 69 — Mutual Funds — — — — 19 9 10 — Alternatives Insurance Contracts 2 — — 2 22 — — 22 Other Investments 2 — 2 — (4 ) — (5 ) 1 Total Investments in the Fair Value Hierarchy 4,031 $ 47 $ 3,980 $ 4 2,159 $ 178 $ 1,958 $ 23 Investments Measured at Net Asset Value, as Practical Expedient: Equity Securities Commingled Funds 9 69 Mutual Funds — 11 Partnership Interests 267 — Debt Securities Mutual Funds 141 7 Commingled Funds 310 604 Short Term Securities Commingled Funds 67 4 Alternatives Commingled Funds — 6 Total Investments 4,825 2,860 Other (45 ) (120 ) Total Plan Assets $ 4,780 $ 2,740 At December 31, 2020 and 2019, the Plans did not directly hold any of our common stock. The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement. Investments that are measured at Net Asset Value ("NAV") as a practical expedient to estimate fair value are not classified in the fair value hierarchy. Under the practical expedient approach, the NAV is based on the fair value of the underlying investments held by each fund less its liabilities. This practical expedient would not be used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to total plan assets. Valuation methodologies used for assets and liabilities measured at fair value are as follows: • Cash and Short Term Securities: Cash and cash equivalents consist of U.S. and foreign currencies. Foreign currencies are reported in U.S. dollars based on currency exchange rates readily available in active markets. Short term securities held in commingled funds are valued at the NAV of units held at year end, as determined by the investment manager. • Equity Securities: Common and preferred stock, which are held in non-U.S. companies, are valued at the closing price reported on the active market on which the individual securities are traded. Commingled funds are valued at the NAV of units held at year end, as determined by a pricing vendor or the fund family. Mutual funds are valued at the NAV of shares held at year end, as determined by the closing price reported on the active market on which the individual securities are traded, or a pricing vendor or the fund family if an active market is not available. Partnership interests in private equity securities are priced based on valuations using the partnership’s latest available financial statements and the plan's percent ownership, adjusted for any cash transactions which occurred between the date of those financial statements and our year end. • Debt Securities: Corporate and government bonds, including asset backed securities, are valued at the closing price reported on the active market on which the individual securities are traded, or based on institutional bid evaluations using proprietary models if an active market is not available. Repurchase agreements are valued at the contract price plus accrued interest. These secured borrowings are collateralized by government bonds held by the non-U.S. plans and have maturities less than one year. Commingled funds are valued at the NAV of units held at year end, as determined by a pricing vendor or the fund family. Mutual funds are valued at the NAV of shares held at year end, as determined by the closing price reported on the active market on which the individual securities are traded, or a pricing vendor or the fund family if an active market is not available. Partnership interests in private credit securities are priced based on valuations using the partnership’s latest available financial statements and the plan's percent ownership, adjusted for any cash transactions which occurred between the date of those financial statements and our year end. • Alternatives: Commingled funds are valued based on the NAV as determined by the fund manager using the most recent financial information available. Other investments primarily include derivative financial instruments, which are valued using independent pricing sources which utilize industry standard derivative valuation models. Directed insurance contracts are valued as reported by the issuer, based on discounted cash flows using weighted average discount rates of 1.7% and 2.3% at December 31, 2020 and 2019, respectively. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date. The following table sets forth a summary of changes in fair value of the non-U.S. pension plan insurance contracts classified as Level 3: (In millions) 2020 2019 Balance, beginning of year $ 22 $ 19 Unrealized gains relating to instruments still held at the reporting date 3 1 Purchases, sales, issuances and settlements (net) 1 2 Foreign currency translation 2 — Balance, end of year $ 28 $ 22 Savings Plans Substantially all employees in the U.S. and employees of certain non-U.S. locations are eligible to participate in a defined contribution savings plan. Expenses recognized for contributions to these plans were $100 million, $110 million and $111 million for 2020, 2019 and 2018, respectively.

Stock Compensation Plans

Stock Compensation Plans	12 Months Ended
	Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Compensation Plans	Note 18. Stock Compensation Plans Our stock compensation plans (collectively, the “Plans”) permit the grant of stock options, stock appreciation rights (“SARs”), performance share units, restricted stock, restricted stock units and other stock-based awards to employees and directors. Our current stock compensation plan, the 2017 Performance Plan, was adopted on April 10, 2017 and expires on April 9, 2027. A total of 18 million shares of our common stock may be issued in respect of grants made under the 2017 Performance Plan. Any shares of common stock that are subject to awards of stock options or SARs will be counted as one share for each share granted for purposes of the aggregate share limit and any shares of common stock that are subject to any other awards will be counted as 2 shares for each share granted for purposes of the aggregate share limit. In addition, shares of common stock that are subject to awards issued under the 2017 Performance Plan or certain prior stock compensation plans that expire according to their terms or are forfeited, terminated, canceled or surrendered or are settled, or can be paid, only in cash, or are surrendered in payment of taxes associated with such awards (other than stock options or SARs) will be available for issuance pursuant to a new award under the 2017 Performance Plan. Shares issued under our stock compensation plans are usually issued from shares of our common stock held in treasury. Stock Options Grants of stock options and SARs (collectively referred to as “options”) under the Plans generally have a graded vesting period of four years whereby one-fourth The following table summarizes the activity related to options during 2020: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (In millions) Outstanding at January 1 4,998,021 $ 20.61 Options granted 4,167,384 10.12 Options exercised (20,218 ) 12.68 $ — Options expired (370,938 ) 12.44 Options cancelled (73,517 ) 18.83 Outstanding at December 31 8,700,732 15.97 5.9 3 Vested and expected to vest at December 31 8,604,644 16.00 5.9 3 Exercisable at December 31 4,462,091 20.98 2.9 — Available for grant at December 31 6,659,546 In addition, the aggregate intrinsic value of options exercised in 2019 and 2018 was $3 million and $9 million, respectively. Significant option groups outstanding at December 31, 2020 Grant Date Options Outstanding Options Exercisable Exercise Price Remaining Contractual Term (Years) 2/25/2020 4,142,384 — $ 10.12 9.16 2/27/2017 556,409 465,203 35.26 6.16 2/22/2016 542,625 542,625 29.90 5.15 2/23/2015 493,730 493,730 27.16 4.15 2/24/2014 381,617 381,617 26.44 3.15 2/28/2013 904,580 904,580 12.98 2.16 2/27/2012 721,878 721,878 12.94 1.16 2/22/2011 523,979 523,979 13.91 0.15 All Other 433,530 428,479 (1 ) (1 ) 8,700,732 4,462,091 (1) Options in the “All other” category had exercise prices ranging from $9.54 to $32.72. The weighted average exercise price for options outstanding and exercisable in that category was $21.45 and $21.32, respectively, while the remaining weighted average contractual term was 3.0 years Weighted average grant date fair values of stock options and the assumptions used in estimating those fair values are as follows: 2020 Weighted average grant date fair value $ 10.12 Black-Scholes model assumptions (1) Expected term (years) 7.50 Interest rate 1.29 % Volatility 41.28 % Dividend yield 6.54 % (1) We review the assumptions used in our Black-Scholes model in conjunction with estimating the grant date fair value of grants of options by our Board of Directors. There were no stock options granted during 2019 or 2018. Performance Share Units Performance share units granted under the Plans are earned over a three-year period beginning January 1 of the year of grant. Total units earned for grants made in 2020 may vary between 0% and 133%, and grants made during 2019 and 2018 may vary between 0% and 200% of the units granted based on the attainment of performance targets during the related three-year The following table summarizes the activity related to performance share units during 2020: Units Weighted Average Grant Date Fair Value Unvested at January 1 588,000 $ 20.98 Units granted 171,871 7.59 Units vested (154,141 ) 29.04 Units forfeited (10,950 ) 20.92 Unvested at December 31 594,780 15.02 We measure the fair value of grants of performance share units based primarily on the closing market price of a share of our common stock on the date of the grant, modified as appropriate to take into account the features of such grants. Restricted Stock Units Restricted stock units granted under the Plans typically vest over a three-year The following table summarizes the activity related to restricted stock units during 2020: Units Weighted Average Grant Date Fair Value Unvested at January 1 2,734,475 $ 23.21 Units granted 600,712 9.86 Units vested and settled (646,444 ) 24.50 Units forfeited (119,870 ) 18.80 Unvested at December 31 2,568,873 19.50 We measure the fair value of grants of restricted stock units based on the closing market price of a share of our common stock on the date of the grant. Other Information Stock-based compensation expense, cash payments made to settle SARs and cash received from the exercise of stock options follows: (In millions) 2020 2019 2018 Stock-based compensation expense recognized $ 31 $ 27 $ 16 Tax benefit (8 ) (7 ) (4 ) After-tax stock-based compensation expense $ 23 $ 20 $ 12 Cash payments to settle SARs $ — $ — $ 1 Cash received from stock option exercises $ — $ 2 $ 9 As of December 31, 2020, unearned compensation cost related to the unvested portion of all stock-based awards was $22 million and is expected to be recognized over the remaining vesting period of the respective grants, through the fourth quarter of 2024.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	Note 19. Commitments and Contingent Liabilities Environmental Matters We have recorded liabilities totaling $64 million and $48 million at December 31, 2020 and 2019, respectively, for anticipated costs related to various environmental matters, primarily the remediation of numerous waste disposal sites and certain properties sold by us. The increase in our recorded reserve was primarily related to a $13 million charge for an environmental remediation liability at a closed facility during 2020. Of these amounts, $16 million and $13 million was included in Other Current Liabilities at December 31, 2020 and 2019, respectively. The costs include legal and consulting fees, site studies, the design and implementation of remediation plans, post-remediation monitoring and related activities, and will be paid over several years. The amount of our ultimate liability in respect of these matters may be affected by several uncertainties, primarily the ultimate cost of required remediation and the extent to which other responsible parties contribute. We have limited potential insurance coverage for future environmental claims. Since many of the remediation activities related to environmental matters vary substantially in duration and cost from site to site and the associated costs for each vary depending on the mix of unique site characteristics, in some cases we cannot reasonably estimate a range of possible losses. Although it is not possible to estimate with certainty the outcome of all of our environmental matters, management believes that potential losses in excess of current reserves for environmental matters, individually and in the aggregate, will not have a material adverse effect on our financial position, cash flows or results of operations. Workers’ Compensation We have recorded liabilities, on a discounted basis, totaling $196 million and $198 million for anticipated costs related to workers’ compensation at December 31, 2020 and 2019, respectively. Of these amounts, $29 million and $39 million were included in Current Liabilities as part of Compensation and Benefits at December 31, 2020 and 2019, respectively. The costs include an estimate of expected settlements on pending claims, defense costs and a provision for claims incurred but not reported. These estimates are based on our assessment of potential liability using an analysis of available information with respect to pending claims, historical experience, and current cost trends. The amount of our ultimate liability in respect of these matters may differ from these estimates. We periodically, and at least annually, update our loss development factors based on actuarial analyses. At December 31, 2020 and 2019, the liability was discounted using a risk-free rate of return. At December 31, 2020, we estimate that it is reasonably possible that the liability could exceed our recorded amounts by approximately $25 General and Product Liability and Other Litigation We have recorded liabilities totaling $285 million and $293 million, including related legal fees expected to be incurred, for potential product liability and other tort claims, including asbestos claims, at December 31, 2020 and 2019, respectively. Of these amounts, $38 million and $43 million were included in Other Current Liabilities at December 31, 2020 and 2019, respectively. The amounts recorded were estimated based on an assessment of potential liability using an analysis of available information with respect to pending claims, historical experience and, where available, recent and current trends. Based upon that assessment, at December 31, 2020, we do not believe that estimated reasonably possible losses associated with general and product liability claims in excess of the amounts recorded will have a material adverse effect on our financial position, cash flows or results of operations. However, the amount of our ultimate liability in respect of these matters may differ from these estimates. We have recorded an indemnification asset within Accounts Receivable of $1 million and within Other Assets of $23 million for Sumitomo Rubber Industries, Ltd.'s ("SRI") obligation to indemnify us for certain product liability claims related to products manufactured by a formerly consolidated joint venture entity, subject to certain caps and restrictions. Asbestos. We are a defendant in numerous lawsuits alleging various asbestos-related personal injuries purported to result from alleged exposure to asbestos in certain products manufactured by us or present in certain of our facilities. Typically, these lawsuits have been brought against multiple defendants in state and federal courts. To date, we have disposed of approximately 154,200 claims by defending, obtaining a dismissal thereof, or entering into a settlement. The sum of our accrued asbestos-related liability and gross payments to date, including legal costs, by us and our insurers totaled $563 million and $554 million through December 31, 2020 and 2019, respectively. A summary of recent approximate asbestos claims activity follows. Because claims are often filed and disposed of by dismissal or settlement in large numbers, the amount and timing of settlements and the number of open claims during a particular period can fluctuate significantly. (Dollars in millions) 2020 2019 2018 Pending claims, beginning of year 39,600 43,100 54,300 New claims filed during the year 1,100 1,500 1,300 Claims settled/dismissed (2,000 ) (5,000 ) (12,500 ) Pending claims, end of year 38,700 39,600 43,100 Payments (1) $ 13 $ 22 $ 18 (1) Represents cash payments made during the period by us and our insurers on asbestos litigation defense and claim resolution. We periodically, and at least annually, review our existing reserves for pending claims, including a reasonable estimate of the liability associated with unasserted asbestos claims, and estimate our receivables from probable insurance recoveries. We recorded gross liabilities for both asserted and unasserted claims, inclusive of defense costs, totaling $149 million and $153 million at December 31, 2020 and 2019, respectively. In determining the estimate of our asbestos liability, we evaluated claims over the next ten-year We maintain certain primary and excess insurance coverage under coverage-in-place agreements, and also have additional excess liability insurance with respect to asbestos liabilities. After consultation with our outside legal counsel and giving consideration to agreements with certain of our insurance carriers, the financial viability and legal obligations of our insurance carriers and other relevant factors, we determine an amount we expect is probable of recovery from such carriers. We record a receivable with respect to such policies when we determine that recovery is probable and we can reasonably estimate the amount of a particular recovery. We recorded an insurance receivable related to asbestos claims of $90 million and $95 million at December 31, 2020 and 2019, respectively. We expect that approximately 60% of asbestos claim related losses would be recoverable through insurance during the ten-year period covered by the estimated liability. Of these amounts, $13 million was included in Current Assets as part of Accounts Receivable at both December 31, 2020 and 2019. The recorded receivable consists of an amount we expect to collect under coverage-in-place agreements with certain primary and excess insurance carriers as well as an amount we believe is probable of recovery from certain of our other excess insurance carriers. We believe that, at December 31, 2020, we had approximately $550 million in excess level policy limits applicable to indemnity and defense costs for asbestos products claims under coverage-in-place agreements. We also had additional unsettled excess level policy limits potentially applicable to such costs. In addition, we had coverage under certain primary policies for indemnity and defense costs for asbestos products claims under remaining aggregate limits pursuant to a coverage-in-place agreement, as well as coverage for indemnity and defense costs for asbestos premises claims pursuant to coverage-in-place agreements. We believe that our reserve for asbestos claims, and the receivable for recoveries from insurance carriers recorded in respect of these claims, reflects reasonable and probable estimates of these amounts. The estimate of the liabilities and assets related to pending and expected future asbestos claims and insurance recoveries is subject to numerous uncertainties, including, but not limited to, changes in: • the litigation environment, • federal and state law governing the compensation of asbestos claimants, • recoverability of receivables due to potential insolvency of insurance carriers, • our approach to defending and resolving claims, and • the level of payments made to claimants from other sources, including other defendants and 524(g) trusts. As a result, with respect to both asserted and unasserted claims, it is reasonably possible that we may incur a material amount of cost in excess of the current reserve; however, such amounts cannot be reasonably estimated. Coverage under insurance policies is subject to varying characteristics of asbestos claims including, but not limited to, the type of claim (premise vs. product exposure), alleged date of first exposure to our products or premises and disease alleged. Recoveries may also be limited by insurer insolvencies or financial difficulties. Depending upon the nature of these characteristics or events, as well as the resolution of certain legal issues, some portion of the insurance may not be accessible by us. Amiens Labor Claims Approximately 850 former employees of the closed Amiens, France manufacturing facility have asserted wrongful termination or other claims totaling approximately €140 million ($172 million) against Goodyear France SAS. On May 28, 2020, Goodyear France SAS received a judgment from the labor court with respect to approximately 790 of these former employees. As a result of this ruling and settlement discussions to resolve these claims and other similar claims, we accrued approximately €27 million ($30 million) during 2020 for estimated additional termination benefits. We have appealed this ruling and will continue to defend ourselves against these claims and any additional claims that may be asserted against us. Other Actions We are currently a party to various claims, indirect tax assessments and legal proceedings in addition to those noted above. If management believes that a loss arising from these matters is probable and can reasonably be estimated, we record the amount of the loss, or the minimum estimated liability when the loss is estimated using a range and no point within the range is more probable than another. As additional information becomes available, any potential liability related to these matters is assessed and the estimates are revised, if necessary. Based on currently available information, management believes that the ultimate outcome of these matters, individually and in the aggregate, will not have a material adverse effect on our financial position or overall trends in results of operations. Our recorded liabilities and estimates of reasonably possible losses for the contingent liabilities described above are based on our assessment of potential liability using the information available to us at the time and, where applicable, any past experience and recent and current trends with respect to similar matters. Our contingent liabilities are subject to inherent uncertainties, and unfavorable judicial or administrative decisions could occur which we did not anticipate. Such an unfavorable decision could include monetary damages, fines or other penalties or an injunction prohibiting us from taking certain actions or selling certain products. If such an unfavorable decision were to occur, it could result in a material adverse impact on our financial position and results of operations in the period in which the decision occurs or in future periods. Income Tax Matters The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for anticipated tax audit issues based on our estimate of whether, and the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary, we reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer necessary. We also recognize income tax benefits to the extent that it is more likely than not that our positions will be sustained when challenged by the taxing authorities. We derecognize income tax benefits when based on new information we determine that it is no longer more likely than not that our position will be sustained. To the extent we prevail in matters for which liabilities have been established, or determine we need to derecognize tax benefits recorded in prior periods, our results of operations and effective tax rate in a given period could be materially affected. An unfavorable tax settlement would require use of our cash, and lead to recognition of expense to the extent the settlement amount exceeds recorded liabilities and, in the case of an income tax settlement, result in an increase in our effective tax rate in the period of resolution. A favorable tax settlement would be recognized as a reduction of expense to the extent the settlement amount is lower than recorded liabilities and, in the case of an income tax settlement, would result in a reduction in our effective tax rate in the period of resolution. While the Company applies consistent transfer pricing policies and practices globally, supports transfer prices through economic studies, seeks advance pricing agreements and joint audits to the extent possible and believes its transfer prices to be appropriate, such transfer prices, and related interpretations of tax laws, are occasionally challenged by various taxing authorities globally. We have received various tax assessments challenging our interpretations of applicable tax laws in various jurisdictions. Although we believe we have complied with applicable tax laws, have strong positions and defenses and have historically been successful in defending such claims, our results of operations could be materially adversely affected in the case we are unsuccessful in the defense of existing or future claims. Binding Commitments and Guarantees At December 31, 2020, we had binding commitments for raw materials, capital expenditures, utilities and various other types of contracts. Total commitments on contracts that extend beyond 2021 are expected to total approximately We have off-balance sheet financial guarantees and other commitments totaling $73 million and $74 million at December 31, 2020 and 2019, respectively. We issue guarantees to financial institutions or other entities on behalf of certain of our affiliates, lessors or customers. We generally do not receive a separate premium as consideration for, and do not require collateral in connection with, the issuance of these guarantees. In 2017, we issued a guarantee of approximately PLN 165 million ($44 million) in connection with an indirect tax assessment in EMEA. As of December 31, 2020, this guarantee amount has been increased to PLN 181 million ($49 million). We have concluded our performance under this guarantee is not probable and, therefore, have not recorded a liability for this guarantee. In 2015, as a result of the dissolution of the global alliance with SRI, we issued a guarantee of $46 million to an insurance company related to SRI's obligation to pay certain outstanding workers' compensation claims of a formerly consolidated joint venture entity. As of December 31, 2020, this guarantee amount has been reduced to $23 million. We have concluded the probability of our performance to be remote and, therefore, have not recorded a liability for this guarantee. While there is no fixed duration of this guarantee, we expect the amount of this guarantee to continue to decrease over time as the formerly consolidated joint venture entity pays its outstanding claims. If our performance under these guarantees is triggered by non-payment or another specified event, we would be obligated to make payment to the financial institution or the other entity, and would typically have recourse to the affiliate, lessor, customer, or SRI. Except for the workers' compensation guarantee described above, the guarantees expire at various times through 2021. We are unable to estimate the extent to which our affiliates’, lessors’, customers’, or SRI's assets would be adequate to recover any payments made by us under the related guarantees. At December 31, 2020, we had an agreement to provide a revolving loan commitment to TireHub of up to $100 million. As of December 31, 2020, $14 million was drawn on this commitment. Indemnifications At December 31, 2020, we were a party to various agreements under which we had assumed obligations to indemnify the counterparties from certain potential claims and losses. These agreements typically involve standard commercial activities undertaken by us in the normal course of business; the sale of assets by us; the formation or dissolution of joint venture businesses to which we had contributed assets in exchange for ownership interests; and other financial transactions. Indemnifications provided by us pursuant to these agreements relate to various matters including, among other things, environmental, tax and shareholder matters; intellectual property rights; government regulations; employment-related matters; and dealer, supplier and other commercial matters. Certain indemnifications expire from time to time, and certain other indemnifications are not subject to an expiration date. In addition, our potential liability under certain indemnifications is subject to maximum caps, while other indemnifications are not subject to caps. Although we have been subject to indemnification claims in the past, we cannot reasonably estimate the number, type and size of indemnification claims that may arise in the future. Due to these and other uncertainties associated with the indemnifications, our maximum exposure to loss under these agreements cannot be estimated. We have determined that there are no indemnifications or guarantees other than liabilities for which amounts are already recorded or reserved in our consolidated financial statements under which it is probable that we have incurred a liability. Warranty We recorded $22 million for potential claims under warranties offered by us at both December 31, 2020 and 2019, the majority of which are recorded in Other Current Liabilities. The following table presents changes in the warranty reserve during 2020 and 2019: (In millions) 2020 2019 Balance at January 1 $ 22 $ 18 Payments made during the period (21 ) (25 ) Expense recorded during the period 21 29 Translation adjustment — — Balance at December 31 $ 22 $ 22

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2020
Capital Stock [Abstract]
Capital Stock	Note 20. Capital Stock Dividends During 2020, 2019 and 2018, we paid cash dividends of $37 million, $148 million and $138 million, respectively, on our common stock. This excludes dividends earned on stock based compensation plans of $1 million, $2 million and $1 million for the years 2020, 2019 and 2018, respectively. On April 16, 2020, we announced that we have suspended the quarterly dividend on our common stock. Common Stock Repurchases From time to time, we repurchase shares of our common stock under programs approved by the Board of Directors. During 2020 and 2019, we did not repurchase any shares of our common stock. During 2018, we repurchased shares totaling approximately $220 million under a program that expired on December 31, 2019. We may repurchase shares delivered to us by employees as payment for the exercise price of stock options and the withholding taxes due upon the exercise of stock options or the vesting or payment of stock awards. During 2020, 2019 and 2018, we did not repurchase any shares from employees.

Reclassifications out of Accumu

Reclassifications out of Accumulated Other Comprehensive Loss	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Reclassifications out of Accumulated Other Comprehensive Loss	Note 21. Reclassifications out of Accumulated Other Comprehensive Loss The following table presents changes in AOCL by component for the years ended December 31, 2020, 2019 and 2018, after tax and minority interest: (In millions) Income (Loss) Foreign Currency Translation Adjustment Unrecognized Net Actuarial Losses and Prior Service Costs Deferred Derivative Gains (Losses) Total Balance at December 31, 2017 $ (915 ) $ (3,052 ) $ (9 ) $ (3,976 ) Other comprehensive income (loss) before reclassifications (245 ) 4 9 (232 ) Amounts reclassified from accumulated other comprehensive loss — 125 7 132 Balance at December 31, 2018 $ (1,160 ) $ (2,923 ) $ 7 $ (4,076 ) Other comprehensive income (loss) before reclassifications (1) 4 (168 ) 10 (154 ) Amounts reclassified from accumulated other comprehensive loss — 108 (14 ) 94 Balance at December 31, 2019 $ (1,156 ) $ (2,983 ) $ 3 $ (4,136 ) Other comprehensive income (loss) before reclassifications (1) (128 ) (4 ) 15 (117 ) Amounts reclassified from accumulated other comprehensive loss — 131 (13 ) 118 Balance at December 31, 2020 $ (1,284 ) $ (2,856 ) $ 5 $ (4,135 ) (1) Includes adjustments to AOCL of $27 million and $(32) million in 2020 and 2019, respectively, to adjust the respective prior year obligation of our frozen U.K. pension plan. The following table presents reclassifications out of AOCL for the years ended December 31, 2020, 2019 and 2018: Year Ended December 31, (In millions) (Income) Expense 2020 2019 2018 Component of AOCL Amount Reclassified from AOCL Affected Line Item in the Consolidated Statements of Operations Amortization of prior service cost and unrecognized gains and losses $ 144 $ 137 $ 139 Other (Income) Expense Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements and divestitures 29 6 25 Other (Income) Expense / Rationalizations Unrecognized Net Actuarial Losses and Prior Service Costs, before tax $ 173 $ 143 $ 164 Tax effect (42 ) (35 ) (39 ) United States and Foreign Taxes Net of tax $ 131 $ 108 $ 125 Goodyear Net Income (Loss) Deferred Derivative (Gains) Losses $ (13 ) $ (14 ) $ 7 Cost of Goods Sold Tax effect — — — United States and Foreign Taxes Net of tax $ (13 ) $ (14 ) $ 7 Goodyear Net Income (Loss) Total reclassifications $ 118 $ 94 $ 132 Goodyear Net Income (Loss)

Schedule II Valuation and Quali

Schedule II Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2020
Valuation And Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS Year Ended December 31, (In millions) Additions Description Balance at beginning of period Charged (credited) to income Charged (credited) to AOCL Deductions from reserves Translation adjustment during period Balance at end of period 2020 Allowance for doubtful accounts $ 126 (a) $ 30 $ - $ (11 ) (b) $ 5 $ 150 Valuation allowance — deferred tax assets 982 488 (1 ) - - 1,469 2019 Allowance for doubtful accounts $ 113 $ 13 $ - $ (14 ) (b) $ (1 ) $ 111 Valuation allowance — deferred tax assets 317 661 4 - - 982 2018 Allowance for doubtful accounts $ 116 $ 21 $ - $ (19 ) (b) $ (5 ) $ 113 Valuation allowance — deferred tax assets 318 18 (1 ) - (18 ) 317 (a) Effective January 1, 2020, we adopted, using the modified retrospective adoption approach, an accounting standards update with new guidance relating to credit losses on financial instruments. Our adoption of this standards update resulted in a cumulative effect adjustment to decrease Retained Earnings by $12 million, with Accounts Receivables decreasing by $15 million and Deferred Income Taxes increasing by $3 million. Periods prior to 2020 have not been restated for the adoption of this standards update. (b) Accounts receivable charged off.

Accounting Policies (Policies)

Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation We maintain a robust business continuity plan to adequately respond to situations such as the COVID-19 pandemic, including a framework for remote work arrangements, in order to effectively maintain operations, including financial reporting systems, internal control over financial reporting and disclosure controls and procedures. Effective January 1, 2020, we early adopted, as permitted, SEC amendments to the financial disclosure requirements for registered debt securities with subsidiary guarantees. The amendments replace the condensed consolidating financial information with summarized financial information of the issuers and guarantors, require expanded qualitative disclosures with respect to information about guarantors, the terms and conditions of guarantees and the factors that may affect payment, and permit these disclosures to be provided outside the footnotes to the parent company’s audited annual and interim consolidated financial statements. We have elected to provide this information in Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Recently Adopted and Recently Issued Accounting Standards	Recently Adopted Accounting Standards Effective January 1, 2020, we adopted an accounting standards update with new guidance on accounting for credit losses on financial instruments. The new guidance includes an impairment model for estimating credit losses that is based on expected losses, rather than incurred losses. As a result of using the modified retrospective adoption approach, $12 million was recorded as a cumulative effect adjustment to decrease Retained Earnings, with Accounts Receivable decreasing by $15 million and Deferred Income Taxes increasing by $3 million. The following table presents the balance of allowances for credit losses, which represents our allowance for doubtful accounts associated with accounts receivable, and the changes during the year ended December 31, 2020: (In millions) Americas Europe, Middle East & Africa Asia Pacific Total Balance at January 1, 2020 $ 38 $ 78 $ 10 $ 126 Current period provision 10 15 5 30 Write-offs charged against the allowance (4 ) (7 ) — (11 ) Translation (2 ) 6 1 5 Balance at December 31, 2020 $ 42 $ 92 $ 16 $ 150 Effective January 1, 2020, we adopted an accounting standards update with new guidance requiring a customer in a cloud computing arrangement that is a service contract to follow existing internal-use software guidance to determine which implementation costs to capitalize as an asset. The adoption of this standards update did not impact our consolidated financial statements. Effective April 1, 2020, we early adopted, as permitted, an accounting standards update with new guidance that changes the accounting for certain income tax transactions. The adoption of this standards update did not have a material impact on our consolidated financial statements. Recently Issued Accounting Standards In January 2020, the Financial Accounting Standards Board issued an accounting standards update which eliminates differences in practice among fair value accounting for investments in equity securities, equity method investments and certain derivative instruments. The new standard is expected to increase comparability of the accounting for these items.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of all legal entities in which we hold a controlling financial interest. A controlling financial interest generally arises from our ownership of a majority of the voting shares of our subsidiaries. We would also hold a controlling financial interest in variable interest entities if we are considered to be the primary beneficiary. Investments in companies in which we do not own a majority interest and we have the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. Investments in other companies are carried at cost. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and related notes to the consolidated financial statements. Actual results could differ from those estimates. On an ongoing basis, management reviews its estimates, including those related to: • general and product liabilities and other litigation, • workers’ compensation, • goodwill, intangibles and other long-lived assets, • deferred tax asset valuation allowances and uncertain income tax positions, • pension and other postretirement benefits, and • various other operating allowances and accruals, based on currently available information. Changes in facts and circumstances may alter such estimates and affect results of operations and financial position in future periods.
Revenue Recognition and Accounts Receivable Valuation	Revenue Recognition and Accounts Receivable Valuation Sales are recognized when obligations under the terms of a contract are satisfied and control is transferred. This generally occurs with shipment or delivery, depending on the terms of the underlying contract, or when services have been rendered. Sales are measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The amount of consideration we receive and sales we recognize can vary due to changes in sales incentives, rebates, rights of return or other items we offer our customers, for which we estimate the expected amounts based on an analysis of historical experience, or as the most likely amount in a range of possible outcomes. Payment terms with customers vary by region and customer, but are generally 30-90 days or at the point of sale for our consumer retail locations. Net sales exclude sales, value added and other taxes. Costs to obtain contracts are generally expensed as incurred due to the short term nature of individual contracts. Incidental items that are immaterial in the context of the contract are recognized as expense as incurred. We have elected to recognize the costs incurred for transportation of products to customers as a component of cost of goods sold ("CGS"). Appropriate provisions are made for uncollectible accounts based on historical loss experience, portfolio duration, economic conditions and credit risk, considering both expected future losses as well as current incurred losses. The adequacy of the allowances are assessed quarterly.
Research and Development Costs	Research and Development Costs Research and development costs include, among other things, materials, equipment, compensation and contract services. These costs are expensed as incurred and included as a component of CGS. Research and development expenditures were $390
Warranty	Warranty Warranties are provided on the sale of certain of our products and services and an accrual for estimated future claims is recorded at the time revenue is recognized. Tire replacement under most of the warranties we offer is on a prorated basis. Warranty reserves are based on past claims experience, sales history and other considerations. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities.
Environmental Cleanup Matters	Environmental Cleanup Matters We expense environmental costs related to existing conditions resulting from past or current operations and from which no current or future benefit is discernible. Expenditures that extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. We determine our liability on a site by site basis and record a liability at the time when it is probable and can be reasonably estimated. Our estimated liability is reduced to reflect the anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are legally responsible and financially capable of paying their respective shares of the relevant costs. Our estimated liability is not discounted or reduced for possible recoveries from insurance carriers. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities.
Legal Costs	Legal Costs We record a liability for estimated legal and defense costs related to pending general and product liability claims, environmental matters and workers’ compensation claims. Refer to Note to the Consolidated Financial Statements No. 19, Commitments and Contingent Liabilities.
Advertising Costs	Advertising Costs Costs incurred for producing and communicating advertising are generally expensed when incurred as a component of selling, administrative and general expense ("SAG"). Costs incurred under our cooperative advertising programs with dealers and franchisees are generally recorded as reductions of sales as related revenues are recognized. Advertising costs, including costs for our cooperative advertising programs with dealers and franchisees, were $304 million, $353 million and $345 million in 2020, 2019 and 2018, respectively.
Rationalizations	Rationalizations We record costs for rationalization actions implemented to reduce excess and high-cost manufacturing capacity and operating and administrative costs. Associate-related costs include severance, supplemental unemployment compensation and benefits, medical benefits, pension curtailments, postretirement benefits, and other termination benefits. For ongoing benefit arrangements, a liability is recognized when it is probable that employees will be entitled to benefits and the amount can be reasonably estimated. For one-time benefit arrangements, a liability is incurred and must be accrued at the date the plan is communicated to employees, unless they will be retained beyond a minimum retention period. In this case, the liability is calculated at the date the plan is communicated to employees and is accrued ratably over the future service period. For voluntary benefit arrangements, a liability is not estimable and is not recognized until eligible associates apply for the benefit and we accept the applications. Other costs generally include non-cancelable lease, contract termination and relocation costs. A liability for these costs is recognized in the period in which the liability is incurred. Rationalization charges related to accelerated depreciation and asset impairments are recorded in CGS or SAG. Refer to Note to the Consolidated Financial Statements No. 3, Costs Associated with Rationalization Programs.
Income Taxes	Income Taxes Income taxes are recognized during the year in which transactions enter into the determination of financial statement income, with deferred taxes being provided for temporary differences between carrying values of assets and liabilities for financial reporting purposes and such carrying values as measured under applicable tax laws. The effect on deferred tax assets or liabilities of a change in the tax law or tax rate is recognized in the period the change is enacted. Valuation allowances are recorded to reduce net deferred tax assets to the amount that is more likely than not to be realized. The calculation of our tax liabilities also involves considering uncertainties in the application of complex tax regulations. We recognize liabilities for uncertain income tax positions based on our estimate of whether it is more likely than not that additional taxes will be required and we report related interest and penalties as income taxes. To the extent that we incur expense under the global intangible low-taxed income provisions we will treat it as a component of income tax expense in the period incurred. Refer to Note to the Consolidated Financial Statements No. 6, Income Taxes.
Cash and Cash Equivalents / Consolidated Statements of Cash Flows	Cash and Cash Equivalents / Consolidated Statements of Cash Flows Cash and cash equivalents consist of cash on hand and marketable securities with original maturities of three months or less. Substantially all of our cash and short-term investment securities are held with investment grade rated counterparties. At December 31, 2020, our cash investments with any single counterparty did not exceed approximately $345 million. Cash flows associated with derivative financial instruments designated as hedges of identifiable transactions or events are classified in the same category as the cash flows from the related hedged items. Cash flows associated with derivative financial instruments not designated as hedges are classified as operating activities. Bank overdrafts, if any, are recorded within Notes Payable and Overdrafts. Cash flows associated with bank overdrafts are classified as financing activities.
Restricted Cash	Restricted Cash The following table provides a reconciliation of Cash, Cash Equivalents and Restricted Cash as reported within the Consolidated Statements of Cash Flows: December 31, (In millions) 2020 2019 2018 Cash and Cash Equivalents $ 1,539 $ 908 $ 801 Restricted Cash 85 66 72 Total Cash, Cash Equivalents and Restricted Cash $ 1,624 $ 974 $ 873 Restricted Cash, which is included in Prepaid Expenses and Other Current Assets in the Consolidated Balance Sheets, primarily represents amounts required to be set aside in connection with accounts receivable factoring programs. The restrictions lapse when cash from factored accounts receivable is remitted to the purchaser of those receivables.
Restricted Net Assets	Restricted Net Assets In certain countries where we operate, transfers of funds into or out of such countries by way of dividends, loans or advances are generally or periodically subject to various governmental regulations. In addition, certain of our credit agreements and other debt instruments limit the ability of foreign subsidiaries to make cash distributions. At December 31, 2020, approximately $680 million of net assets were subject to such regulations or limitations.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or the average cost method. Costs include direct material, direct labor and applicable manufacturing and engineering overhead. We allocate fixed manufacturing overheads based on normal production capacity and recognize abnormal manufacturing costs as period costs. We determine a provision for excess and obsolete inventory based on management’s review of inventories on hand compared to estimated future usage and sales. Refer to Note to the Consolidated Financial Statements No. 10, Inventories.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill is recorded when the cost of acquired businesses exceeds the fair value of the identifiable net assets acquired. Goodwill and intangible assets with indefinite useful lives are not amortized but are assessed for impairment annually with the option to perform a qualitative assessment to determine whether further impairment testing is necessary or to perform a quantitative assessment by comparing the fair value of the reporting unit or indefinite-lived intangible to its carrying amount. Under the qualitative assessment, an entity is not required to calculate the fair value unless the entity determines that it is more likely than not that the fair value is less than the carrying amount. If under the quantitative assessment the fair value is less than the carrying amount, then an impairment loss will be recorded for the difference between the carrying value and the fair value . We perform a quantitative assessment at least once every five years. In addition to annual testing, impairment testing is conducted when events occur or circumstances change that would more likely than not reduce the fair value of the asset below its carrying amount. Goodwill and intangible assets with indefinite useful lives would be written down to fair value if considered impaired. Intangible assets with finite useful lives are amortized to their estimated residual values over such finite lives, and reviewed for impairment whenever events or circumstances warrant such a review. Refer to Note to the Consolidated Financial Statements No. 11, Goodwill and Intangible Assets.
Investments	Investments Investments in marketable securities are stated at fair value. Fair value is determined using quoted market prices at the end of the reporting period and, when appropriate, exchange rates at that date. Unrealized gains and losses on marketable equity securities are recorded in earnings. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recorded in Accumulated Other Comprehensive Income (Loss) (“AOCL”), net of tax. Our investment in TireHub, LLC (“TireHub”), a distribution joint venture in the U.S., is accounted for under the equity method.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are stated at cost. Depreciation is computed using the straight-line method. Additions and improvements that substantially extend the useful life of property, plant and equipment, and interest costs incurred during the construction period of major projects are capitalized. Government grants to us that are predominately related to capital expenditures are recorded as reductions of the cost of the associated assets. Repair and maintenance costs are expensed as incurred. Property, plant and equipment are depreciated to their estimated residual values over their estimated useful lives, and reviewed for impairment whenever events or circumstances warrant such a review. Depreciation expense for property, plant and equipment was $857 million, $793 million and $776 million in 2020, 2019 and 2018, respectively. Refer to Notes to the Consolidated Financial Statements No. 4, Interest Expense, and No. 13, Property, Plant and Equipment.
Leases	Leases Effective January 1, 2019, we adopted, using the modified retrospective adoption approach, an accounting standards update with new guidance relating to leases. Our adoption of this standards update resulted in adjustments that increased Total Assets by $873 million, increased Long Term Debt and Finance Leases by $14 million, and decreased Goodyear Shareholders’ Equity and Total Shareholders’ Equity by $23 million. Periods prior to 2019 have not been restated for the adoption of this standards update. We determine if an arrangement is or contains a lease at inception. We enter into leases primarily for our distribution facilities, manufacturing equipment, administrative offices, retail stores, vehicles and data processing equipment under varying terms and conditions. Our leases have remaining lease terms of less than 1 year to approximately 50 years. Most of our leases include options to extend the lease, with renewal terms ranging from 1 to 50 years or more, and some include options to terminate the lease within 1 year. If it is reasonably certain that an option to extend or terminate a lease will be exercised, that option is considered in the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and we recognize short-term lease expense for these leases on a straight-line basis over the lease term. Certain of our lease agreements include variable lease payments, generally based on consumer price indices. Variable lease payments that are assigned to an index are determined based on the initial index at commencement, and the variability based on changes in the index is accounted for as it changes. The variable portion of payments is not included in the initial measurement of the right-of-use asset or lease liability due to the uncertainty of the payment amount and are recorded as lease expense in the period incurred. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. We have lease agreements with lease and non-lease components, which are accounted for separately. Operating leases are included in Operating Lease Right-of-Use (“ROU”) Assets, Operating Lease Liabilities due Within One Year and Operating Lease Liabilities on our Consolidated Balance Sheets. Finance leases are included in Property, Plant and Equipment, Long Term Debt and Finance Leases due Within One Year, and Long Term Debt and Finance Leases on our Consolidated Balance Sheets. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Generally, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments, unless there is a rate stated in the lease agreement. Operating lease expense is recognized on a straight-line basis over the lease term. Refer to Note to the Consolidated Financial Statements No. 14, Leases.
Foreign Currency Translation	Foreign Currency Translation The functional currency for most subsidiaries outside the United States is the local currency. Financial statements of these subsidiaries are translated into U.S. dollars using the exchange rate at each balance sheet date for assets and liabilities and a weighted average exchange rate for each period for revenues, expenses, gains and losses. The U.S. dollar is used as the functional currency in countries with a history of high inflation and in countries that predominantly sell into the U.S. dollar export market. For all operations, gains or losses from remeasuring foreign currency transactions into the functional currency are included in Other (Income) Expense. Translation adjustments are recorded in AOCL. Income taxes are generally not provided for foreign currency translation adjustments.
Derivative Financial Instruments and Hedging Activities	Derivative Financial Instruments and Hedging Activities To qualify for hedge accounting, hedging instruments must be designated as hedges and meet defined correlation and effectiveness criteria. These criteria require that the anticipated cash flows and/or changes in fair value of the hedging instrument substantially offset those of the position being hedged. Derivative contracts are reported at fair value on the Consolidated Balance Sheets as Accounts Receivable, Other Assets, Other Current Liabilities or Other Long Term Liabilities. Deferred gains and losses on contracts designated as cash flow hedges are recorded net of tax in AOCL. Interest Rate Contracts — Gains and losses on contracts designated as cash flow hedges are initially deferred and recorded in AOCL. Amounts are transferred from AOCL and recognized in income as Interest Expense in the same period that the hedged item is recognized in income. Gains and losses on contracts designated as fair value hedges are recognized in income in the current period as Interest Expense. Gains and losses on contracts with no hedging designation are recorded in the current period in Other (Income) Expense. Foreign Currency Contracts — Gains and losses on contracts designated as cash flow hedges are initially deferred and recorded in AOCL. Amounts are transferred from AOCL and recognized in income in the same period and on the same line that the hedged item is recognized in income. Gains and losses on contracts designated as fair value hedges, excluding premiums and discounts, are recorded in Other (Income) Expense in the current period. Gains and losses on contracts with no hedging designation are also recorded in Other (Income) Expense in the current period. We do not include premiums or discounts on forward currency contracts in our assessment of hedge effectiveness. Premiums and discounts on contracts designated as hedges are recorded in AOCL. The amounts are recognized in the Statement of Operations on a straight-line basis over the life of the contract on the same line that the hedged item is recognized in the Statement of Operations. Net Investment Hedging — Nonderivative instruments denominated in foreign currencies are used from time to time to hedge net investments in foreign subsidiaries. Gains and losses on these instruments are deferred and recorded in AOCL as Foreign Currency Translation Adjustments. These gains and losses are only recognized in income upon the complete or partial sale of the related investment or the complete liquidation of the investment. Termination of Contracts — Gains and losses (including deferred gains and losses in AOCL) are recognized in Other (Income) Expense when contracts are terminated concurrently with the termination of the hedged position. To the extent that such position remains outstanding, gains and losses are amortized to Interest Expense or to Other (Income) Expense over the remaining life of that position. Gains and losses on contracts that we temporarily continue to hold after the early termination of a hedged position, or that otherwise no longer qualify for hedge accounting, are recognized in Other (Income) Expense. Refer to Note to the Consolidated Financial Statements No. 15, Financing Arrangements and Derivative Financial Instruments.
Stock-Based Compensation	Stock-Based Compensation We measure compensation cost arising from the grant of stock-based awards to employees at fair value and recognize such cost in income over the period during which the service is provided, usually the vesting period. We recognize compensation expense using the straight-line approach. Stock-based awards to employees include grants of performance share units, restricted stock units and stock options. We measure the fair value of grants of performance share units and restricted stock units based primarily on the closing market price of a share of our common stock on the date of the grant, modified as appropriate to take into account the features of such grants. We estimate the fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate compensation expense are determined as follows: • Expected term represents the period of time that options granted are expected to be outstanding based on our historical experience of option exercises; • Expected volatility is measured using the weighted average of historical daily changes in the market price of our common stock over the expected term of the award and implied volatility calculated for our exchange traded options with an expiration date greater than one year; • Risk-free interest rate is equivalent to the implied yield on zero-coupon U.S. Treasury bonds with a remaining maturity equal to the expected term of the awards; and • Forfeitures are based substantially on the history of cancellations of similar awards granted in prior years. Refer to Note to the Consolidated Financial Statements No. 18, Stock Compensation Plans.
Earnings Per Share of Common Stock	Earnings Per Share of Common Stock Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share primarily reflects the dilutive impact of outstanding stock options and other stock based awards. All earnings per share amounts in these notes to the consolidated financial statements are diluted, unless otherwise noted. Refer to Note to the Consolidated Financial Statements No. 7, Earnings Per Share.
Fair Value Measurements	Fair Value Measurements Valuation Hierarchy Assets and liabilities measured at fair value are classified using the following hierarchy, which is based upon the transparency of inputs to the valuation as of the measurement date. • Level 1 — Valuation is based upon quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 — Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3 — Valuation is based upon other unobservable inputs that are significant to the fair value measurement. The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement. Valuation methodologies used for assets and liabilities measured at fair value are as follows: Investments Where quoted prices are available in an active market, investments are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid government bonds, certain mortgage products and exchange-traded equities. If quoted market prices are not available, fair values are estimated using quoted prices of securities with similar characteristics or inputs other than quoted prices that are observable for the security, and would be classified within Level 2 of the valuation hierarchy. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities would be classified within Level 3 of the valuation hierarchy. Derivative Financial Instruments Exchange-traded derivative financial instruments that are valued using quoted prices would be classified within Level 1 of the valuation hierarchy. Derivative financial instruments valued using internally-developed models that use as their basis readily observable market parameters are classified within Level 2 of the valuation hierarchy. Derivative financial instruments that are valued based upon models with significant unobservable market parameters, and that are normally traded less actively, would be classified within Level 3 of the valuation hierarchy. Refer to Notes to the Consolidated Financial Statements No. 15, Financing Arrangements and Derivative Financial Instruments, and No. 16, Fair Value Measurements.
Reclassifications and Adjustments	Reclassifications and Adjustments Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation.

Accounting Policies (Tables)

Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Balance of Allowances for Credit Losses, Doubtful Accounts with Accounts Receivable and Changes	The following table presents the balance of allowances for credit losses, which represents our allowance for doubtful accounts associated with accounts receivable, and the changes during the year ended December 31, 2020: (In millions) Americas Europe, Middle East & Africa Asia Pacific Total Balance at January 1, 2020 $ 38 $ 78 $ 10 $ 126 Current period provision 10 15 5 30 Write-offs charged against the allowance (4 ) (7 ) — (11 ) Translation (2 ) 6 1 5 Balance at December 31, 2020 $ 42 $ 92 $ 16 $ 150
Reconciliation of Cash, Cash Equivalents and Restricted Cash	The following table provides a reconciliation of Cash, Cash Equivalents and Restricted Cash as reported within the Consolidated Statements of Cash Flows: December 31, (In millions) 2020 2019 2018 Cash and Cash Equivalents $ 1,539 $ 908 $ 801 Restricted Cash 85 66 72 Total Cash, Cash Equivalents and Restricted Cash $ 1,624 $ 974 $ 873

Net Sales (Tables)

Net Sales (Tables)	12 Months Ended
	Dec. 31, 2020
Revenue From Contract With Customer [Abstract]
Disaggregated Net Sales From Contracts with Customers	The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2020: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales (1) $ 5,138 $ 3,611 $ 1,590 $ 10,339 Other tire and related sales 549 309 98 956 Retail services and service related sales 538 95 55 688 Chemical sales 317 — — 317 Other 14 5 2 21 Net Sales by reportable segment $ 6,556 $ 4,020 $ 1,745 $ 12,321 (1) Americas tire unit sales for 2020 include a gain of $34 million for a one-time legal settlement. The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2019: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales $ 6,300 $ 4,300 $ 1,924 $ 12,524 Other tire and related sales 659 363 117 1,139 Retail services and service related sales 535 39 70 644 Chemical sales 403 — — 403 Other 25 6 4 35 Net Sales by reportable segment $ 7,922 $ 4,708 $ 2,115 $ 14,745 The following table shows disaggregated net sales from contracts with customers by major source for the year ended December 31, 2018: (In millions) Americas Europe, Middle East and Africa Asia Pacific Total Tire unit sales $ 6,381 $ 4,670 $ 2,009 $ 13,060 Other tire and related sales 656 379 127 1,162 Retail services and service related sales 564 34 77 675 Chemical sales 554 — — 554 Other 13 7 4 24 Net Sales by reportable segment $ 8,168 $ 5,090 $ 2,217 $ 15,475
Balance and Changes in Deferred Revenue Related to Contracts with Customers	The following table presents the balances of deferred revenue related to contracts with customers, and changes during the years ended December 31: (In millions) 2020 2019 Balance at January 1 $ 54 $ 78 Revenue deferred during period 169 155 Revenue recognized during period (173 ) (179 ) Impact of foreign currency translation — — Balance at December 31 $ 50 $ 54

Costs Associated with Rationa_2

Costs Associated with Rationalization Programs (Tables)	12 Months Ended
	Dec. 31, 2020
Restructuring And Related Activities [Abstract]
Roll-Forward of Liability Balance	The following table presents the roll-forward of the liability balance between periods: (In millions) Associate- Related Costs Other Costs Total Balance at December 31, 2017 $ 210 $ 3 $ 213 2018 charges (1) 47 17 64 Incurred, net of foreign currency translation of $(3) million and $0 million, respectively (158 ) (19 ) (177 ) Reversed to the Statement of Operations (19 ) — (19 ) Balance at December 31, 2018 $ 80 $ 1 $ 81 2019 charges (1) 185 19 204 Incurred, net of foreign currency translation of $(2) million and $0 million, respectively (41 ) (20 ) (61 ) Reversed to the Statement of Operations (4 ) — (4 ) Balance at December 31, 2019 $ 220 $ — $ 220 2020 charges (1) 129 27 156 Incurred, net of foreign currency translation of $12 million and $0 million, respectively (147 ) (27 ) (174 ) Reversed to the Statement of Operations (2 ) — (2 ) Balance at December 31, 2020 $ 200 $ — $ 200 (1) Charges of $156 million, $204 million and $64 million in 2020, 2019 and 2018, respectively, exclude $5 million, $5 million and $(1) million, respectively, of benefit plan curtailments and settlements recorded in Rationalizations in the Statements of Operations.
Net Rationalization Charges Included in Income (Loss) Before Income Taxes	The following table shows net rationalization charges included in Income (Loss) before Income Taxes: (In millions) 2020 2019 2018 Current Year Plans Associate severance and other related costs $ 77 $ 183 $ 40 Benefit plan curtailment and special termination benefits 9 5 — Other exit and non-cancelable lease costs 16 11 — Current Year Plans - Net Charges $ 102 $ 199 $ 40 Prior Year Plans Associate severance and other related costs $ 50 $ (2 ) $ (11 ) Benefit plan curtailment and special termination benefits (4 ) — (1 ) Other exit and non-cancelable lease costs 11 8 16 Prior Year Plans - Net Charges $ 57 $ 6 $ 4 Total Net Charges $ 159 $ 205 $ 44 Asset write-off and accelerated depreciation charges $ 105 $ 15 $ 4

Interest Expense (Tables)

Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Interest Expense	Interest expense includes interest and the amortization of deferred financing fees and debt discounts, less amounts capitalized, as follows: (In millions) 2020 2019 2018 Interest expense before capitalization $ 339 $ 351 $ 335 Capitalized interest (15 ) (11 ) (14 ) $ 324 $ 340 $ 321

Other (Income) Expense (Tables)

Other (Income) Expense (Tables)	12 Months Ended
	Dec. 31, 2020
Other Income And Expenses [Abstract]
Schedule of Other Income and Expense	(In millions) 2020 2019 2018 Gain on TireHub transaction, net of transaction costs $ — $ — $ (272 ) Non-service related pension and other postretirement benefits costs 110 118 121 Interest income on indirect tax settlements in Brazil — (8 ) (38 ) Financing fees and financial instruments expense 26 34 36 Net foreign currency exchange (gains) losses (9 ) (22 ) (16 ) General and product liability expense - discontinued products 10 11 9 Royalty income (19 ) (19 ) (20 ) Net (gains) losses on asset sales 2 (16 ) (1 ) Interest income (14 ) (18 ) (16 ) Miscellaneous (income) expense 13 18 23 $ 119 $ 98 $ (174 )

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Components of Income before Income Taxes	The components of Income (Loss) before Income Taxes follow: (In millions) 2020 2019 2018 U.S. $ (993 ) $ (39 ) $ 439 Foreign (147 ) 216 572 $ (1,140 ) $ 177 $ 1,011
Reconciliation of Income Taxes at the U.S. Statutory Rate to United States and Foreign Tax (Benefit) Expense	A reconciliation of income taxes at the U.S. statutory rate to United States and Foreign Tax Expense follows: (In millions) 2020 2019 2018 U.S. federal income tax expense (benefit) at the statutory rate of 21% $ (239 ) $ 37 $ 212 Net establishment (release) of U.S. valuation allowances 310 (98 ) 25 Net foreign losses (income) with no tax due to valuation allowances 37 48 7 Goodwill impairment 34 — — Deferred tax impact of enacted tax rate and law changes (18 ) 3 — State income taxes, net of U.S. federal benefit (17 ) (1 ) (1 ) U.S. charges (benefits) related to foreign tax credits, R&D and foreign derived intangible deduction (9 ) (17 ) 20 Adjustment for foreign income taxed at different rates 7 16 30 Net establishment of uncertain tax positions 6 7 18 Federal and state tax on accelerated royalty income transaction — 334 — Net establishment (release) of foreign valuation allowances — 140 (5 ) Other (1 ) 5 (3 ) United States and Foreign Tax Expense $ 110 $ 474 $ 303
Components of United States and Foreign Tax (Benefit) Expense	The components of United States and Foreign Tax Expense by taxing jurisdiction, follow: (In millions) 2020 2019 2018 Current: Federal $ (5 ) $ — $ (15 ) Foreign 95 134 188 State (3 ) 17 (1 ) 87 151 172 Deferred: Federal 63 133 120 Foreign (31 ) 153 6 State (9 ) 37 5 23 323 131 United States and Foreign Tax Expense $ 110 $ 474 $ 303
Deferred Tax Assets and Liabilities	Temporary differences and carryforwards giving rise to deferred tax assets and liabilities at December 31 follow: (In millions) 2020 2019 Tax loss carryforwards and credits $ 1,570 $ 1,159 Prepaid royalty income 629 576 Capitalized research and development expenditures 421 416 Accrued expenses deductible as paid 255 347 Postretirement benefits and pensions 209 221 Lease liabilities 76 75 Rationalizations and other provisions 34 38 Vacation and sick pay 21 23 Other 133 106 3,348 2,961 Valuation allowance (1,469 ) (982 ) Total deferred tax assets 1,879 1,979 Property basis differences (420 ) (467 ) Right-of-use assets (75 ) (74 ) Tax on undistributed earnings of subsidiaries (1 ) (1 ) Total net deferred tax assets $ 1,383 $ 1,437
Reconciliation of Unrecognized Tax Benefits	A summary of our unrecognized tax benefits and changes during the year follows: (In millions) 2020 2019 2018 Balance at January 1 $ 82 $ 71 $ 52 Increases related to prior year tax positions 26 24 9 Decreases related to prior year tax positions (1 ) — (1 ) Settlements (15 ) (11 ) (2 ) Foreign currency impact (7 ) (2 ) (5 ) Increases related to current year tax positions — — 21 Lapse of statute of limitations — — (3 ) Balance at December 31 $ 85 $ 82 $ 71

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Basic and Diluted Earnings per Common Share	Basic and diluted earnings per common share are calculated as follows: (In millions, except per share amounts) 2020 2019 2018 Earnings (loss) per share — basic: Goodyear net income (loss) $ (1,254 ) $ (311 ) $ 693 Weighted average shares outstanding 234 233 237 Earnings (loss) per common share — basic $ (5.35 ) $ (1.33 ) $ 2.92 Earnings (loss) per share — diluted: Goodyear net income (loss) $ (1,254 ) $ (311 ) $ 693 Weighted average shares outstanding 234 233 237 Dilutive effect of stock options and other dilutive securities — — 2 Weighted average shares outstanding — diluted 234 233 239 Earnings (loss) per common share — diluted $ (5.35 ) $ (1.33 ) $ 2.89

Business Segments (Tables)

Business Segments (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Business Segment Reporting Information	The following table presents segment sales and operating income (loss), and the reconciliation of segment operating income (loss) to Income (Loss) before Income Taxes: (In millions) 2020 2019 2018 Sales Americas $ 6,556 $ 7,922 $ 8,168 Europe, Middle East and Africa 4,020 4,708 5,090 Asia Pacific 1,745 2,115 2,217 Net Sales $ 12,321 $ 14,745 $ 15,475 Segment Operating Income (Loss) Americas $ 9 $ 550 $ 654 Europe, Middle East and Africa (72 ) 202 363 Asia Pacific 49 193 257 Total Segment Operating Income (Loss) $ (14 ) $ 945 $ 1,274 Less: Goodwill and Other Asset Impairments (Notes 11 and 12) 330 — — Rationalizations (Note 3) 159 205 44 Interest expense (Note 4) 324 340 321 Other (income) expense (Note 5) 119 98 (174 ) Asset write-offs and accelerated depreciation (Note 3) 105 15 4 Corporate incentive compensation plans 44 50 13 Retained expenses of divested operations 8 10 9 Other (1) 37 50 46 Income (Loss) before Income Taxes $ (1,140 ) $ 177 $ 1,011 ( 1 ) Primarily represents unallocated corporate costs and the elimination of $17 million, $17 million and $18 million for the years ended December 31, 2020, 2019 and 2018, respectively, of royalty income attributable to the strategic business units.
Segment Assets	The following table presents segment assets at December 31: (In millions) 2020 2019 Assets Americas $ 6,666 $ 7,606 Europe, Middle East and Africa 4,825 4,724 Asia Pacific 2,725 2,711 Total Segment Assets 14,216 15,041 Corporate (1) 2,290 2,144 $ 16,506 $ 17,185 (1) Corporate includes substantially all of our U.S. net deferred tax assets.
Geographic Information	The following table presents geographic information. Net sales by country were determined based on the location of the selling subsidiary. Long-lived assets consisted of property, plant and equipment. Besides Germany, management did not consider the net sales of any other individual countries outside the United States to be significant to the consolidated financial statements. For long-lived assets, only China and Germany were considered to be significant. (In millions) 2020 2019 2018 Net Sales United States $ 5,424 $ 6,489 $ 6,692 Germany (1) 705 979 1,691 Other international 6,192 7,277 7,092 $ 12,321 $ 14,745 $ 15,475 Long-Lived Assets United States $ 2,517 $ 2,681 China 742 722 Germany 729 653 Other international 3,085 3,152 $ 7,073 $ 7,208 (1) The decrease in net sales from 2018 primarily related to a business reorganization that centralized our OE sales for EMEA in Luxembourg.
Rationalizations, Asset sales, Other Expense and Asset Write-offs and Accelerated Depreciation Attributable to the SBUs	Goodwill and other asset impairments, as described in Notes to the Consolidated Financial Statements No. 11, Goodwill and Intangible Assets, and No. 12, Other Assets and Investments; rationalizations, as described in Note to the Consolidated Financial Statements No. 3, Costs Associated with Rationalization Programs; net (gains) losses on asset sales, as described in Note to the Consolidated Financial Statements No. 5, Other (Income) Expense, and asset write-offs and accelerated depreciation were not charged (credited) to the SBUs for performance evaluation purposes but were attributable to the SBUs as follows: (In millions) 2020 2019 2018 Goodwill and Other Asset Impairments Americas $ 148 $ — $ — Europe, Middle East and Africa 182 — — Total Segment Goodwill and Other Asset Impairments $ 330 $ — $ — (In millions) 2020 2019 2018 Rationalizations Americas $ 94 $ 90 $ 3 Europe, Middle East and Africa 59 115 36 Asia Pacific 4 — 3 Total Segment Rationalizations $ 157 $ 205 $ 42 Corporate 2 — 2 $ 159 $ 205 $ 44 (In millions) 2020 2019 2018 Net (Gains) Losses on Asset Sales Americas (1) $ — $ — $ (275 ) Europe, Middle East and Africa 2 (16 ) 2 Total Segment Asset Sales $ 2 $ (16 ) $ (273 ) (1) Americas Net (Gains) Losses on Asset Sales for the year ended December 31, 2018 includes the gain of $272 million related to the TireHub transaction, net of transaction costs. (In millions) 2020 2019 2018 Asset Write-Offs and Accelerated Depreciation Americas $ 103 $ 13 $ — Europe, Middle East and Africa 2 2 4 Total Segment Asset Write-Offs and Accelerated Depreciation $ 105 $ 15 $ 4
Segment Capital Expenditures, Depreciation and Amortization	The following tables present segment capital expenditures and depreciation and amortization: (In millions) 2020 2019 2018 Capital Expenditures Americas $ 302 $ 369 $ 406 Europe, Middle East and Africa 235 227 180 Asia Pacific 91 141 188 Total Segment Capital Expenditures $ 628 $ 737 $ 774 Corporate 19 33 37 $ 647 $ 770 $ 811 (In millions) 2020 2019 2018 Depreciation and Amortization Americas $ 490 $ 430 $ 414 Europe, Middle East and Africa 201 197 201 Asia Pacific 133 133 131 Total Segment Depreciation and Amortization $ 824 $ 760 $ 746 Corporate 35 35 32 $ 859 $ 795 $ 778
Segment Equity In Net Income (Loss) of Investees Accounted For By the Equity Method	The following table presents segment equity in the net income (loss) of investees accounted for by the equity method: (In millions) 2020 2019 2018 Equity in (Income) Loss Americas $ 31 $ 32 $ 11 Europe, Middle East and Africa — — (1 ) Total Segment Equity in (Income) Loss $ 31 $ 32 $ 10

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Schedule of Accounts Receivable	(In millions) 2020 2019 Accounts receivable $ 1,841 $ 2,052 Allowance for doubtful accounts (150 ) (111 ) $ 1,691 $ 1,941

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory	(In millions) 2020 2019 Raw materials $ 517 $ 530 Work in process 143 143 Finished goods 1,493 2,178 $ 2,153 $ 2,851

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill by Reporting Unit	The following table presents the net carrying amount of goodwill allocated by segment, and changes during 2020 (In millions) Balance at December 31, 2019 Acquisitions Divestitures Impairment Translation Balance at December 31, 2020 Americas $ 91 $ — $ — $ — $ — $ 91 Europe, Middle East and Africa 411 10 — (182 ) 11 250 Asia Pacific 63 — — — 4 67 $ 565 $ 10 $ — $ (182 ) $ 15 $ 408 The following table presents the net carrying amount of goodwill allocated by segment, and changes during 2019: (In millions) Balance at December 31, 2018 Acquisitions Divestitures Impairment Translation Balance at December 31, 2019 Americas $ 91 $ — $ — $ — $ — $ 91 Europe, Middle East and Africa 415 2 — — (6 ) 411 Asia Pacific 63 1 — — (1 ) 63 $ 569 $ 3 $ — $ — $ (7 ) $ 565
Indefinite-Lived Intangible Assets	The following table presents information about intangible assets: 2020 2019 (In millions) Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Intangible assets with indefinite lives $ 125 $ (6 ) $ 119 $ 124 $ (6 ) $ 118 Trademarks and patents 23 (19 ) 4 24 (19 ) 5 Other intangible assets 25 (13 ) 12 25 (11 ) 14 $ 173 $ (38 ) $ 135 $ 173 $ (36 ) $ 137 (1) Includes impact of foreign currency translation.
Finite-Lived Intangible Assets	The following table presents information about intangible assets: 2020 2019 (In millions) Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Gross Carrying Amount (1) Accumulated Amortization (1) Net Carrying Amount Intangible assets with indefinite lives $ 125 $ (6 ) $ 119 $ 124 $ (6 ) $ 118 Trademarks and patents 23 (19 ) 4 24 (19 ) 5 Other intangible assets 25 (13 ) 12 25 (11 ) 14 $ 173 $ (38 ) $ 135 $ 173 $ (36 ) $ 137 (1) Includes impact of foreign currency translation.

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Property, Plant and Equipment	2020 2019 (In millions) Owned Finance Leases Total Owned Finance Leases Total Property, plant and equipment, at cost: Land $ 436 $ 1 $ 437 $ 425 $ 1 $ 426 Buildings 2,467 232 2,699 2,431 227 2,658 Machinery and equipment 13,893 29 13,922 13,624 30 13,654 Construction in progress 737 — 737 681 1 682 17,533 262 17,795 17,161 259 17,420 Accumulated depreciation (10,931 ) (60 ) (10,991 ) (10,438 ) (50 ) (10,488 ) 6,602 202 6,804 6,723 209 6,932 Spare parts 269 — 269 276 — 276 $ 6,871 $ 202 $ 7,073 $ 6,999 $ 209 $ 7,208

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Lease, Cost	The components of lease expense included in Income (Loss) before Income Taxes for the years ended December 31, 2020 and 2019 are as follows: (In millions) 2020 2019 Operating Lease Expense $ 286 $ 292 Finance Lease Expense: Amortization of ROU assets 11 11 Interest on lease liabilities 21 21 Short Term Lease Expense 6 6 Variable Lease Expense 3 7 Sublease Income (11 ) (15 ) Total Lease Expense $ 316 $ 322
Schedule of Rent Expense	Net rental expense for the year ended December 31, 2018 is comprised of the following: (In millions) 2018 Gross rental expense $ 333 Sublease rental income (16 ) $ 317
Direct Financing Lease, Lease Income	Supplemental cash flow information related to leases for the years ended December 31, 2020 and 2019 is as follows: (In millions) 2020 2019 Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating Cash Flows for Operating Leases $ 268 $ 267 Operating Cash Flows for Finance Leases 21 21 Financing Cash Flows for Finance Leases 7 7 ROU Assets Obtained in Exchange for Lease Obligations Operating Leases 202 197 Finance Leases 3 34
Operating Lease, Lease Income	Supplemental cash flow information related to leases for the years ended December 31, 2020 and 2019 is as follows: (In millions) 2020 2019 Cash Paid for Amounts Included in the Measurement of Lease Liabilities Operating Cash Flows for Operating Leases $ 268 $ 267 Operating Cash Flows for Finance Leases 21 21 Financing Cash Flows for Finance Leases 7 7 ROU Assets Obtained in Exchange for Lease Obligations Operating Leases 202 197 Finance Leases 3 34
Lessee, Balance Sheet Information	Supplemental balance sheet information related to leases as of December 31, 2020 and 2019 is as follows: (In millions, except lease term and discount rate) 2020 2019 Operating Leases Operating Lease ROU Assets $ 851 $ 855 Operating Lease Liabilities due Within One Year $ 198 $ 199 Operating Lease Liabilities 684 668 Total Operating Lease Liabilities $ 882 $ 867 Finance Leases Property, Plant and Equipment, at cost $ 262 $ 259 Accumulated Depreciation (60 ) (50 ) Property, Plant and Equipment, net $ 202 $ 209 Long Term Debt and Finance Leases due Within One Year $ 18 $ 6 Long Term Debt and Finance Leases 232 243 Total Finance Lease Liabilities $ 250 $ 249 Weighted Average Remaining Lease Term (years) Operating Leases 7.3 7.2 Finance Leases 30.9 31.6 Weighted Average Discount Rate Operating Leases 6.85% 6.69% Finance Leases 8.48% 8.46%
Lessee, Operating Lease, Liability, Maturity	Future maturities of our lease liabilities, excluding subleases, as of December 31, 2020 are as follows: (In millions) Operating Leases Finance Leases 2021 $ 245 $ 38 2022 186 23 2023 146 21 2024 110 21 2025 88 22 Thereafter 376 671 Total Lease Payments 1,151 796 Less: Imputed Interest 269 546 Total $ 882 $ 250
Finance Lease, Liability, Maturity	Future maturities of our lease liabilities, excluding subleases, as of December 31, 2020 are as follows: (In millions) Operating Leases Finance Leases 2021 $ 245 $ 38 2022 186 23 2023 146 21 2024 110 21 2025 88 22 Thereafter 376 671 Total Lease Payments 1,151 796 Less: Imputed Interest 269 546 Total $ 882 $ 250

Financing Arrangements and De_2

Financing Arrangements and Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2020
Financing Arrangements And Derivative Financial Instruments [Abstract]
Long Term Debt and Capital Leases Due Within One Year	The following table presents amounts due within one year: December 31, December 31, (In millions) 2020 2019 Chinese credit facilities $ 163 $ 118 Other domestic and foreign debt 243 230 Notes Payable and Overdrafts $ 406 $ 348 Weighted average interest rate 4.52 % 4.92 % Chinese credit facilities $ 13 $ 95 8.75% due 2020 — 280 Other domestic and foreign debt (including finance leases) 139 187 Long Term Debt and Finance Leases due Within One Year $ 152 $ 562 Weighted average interest rate 3.87 % 6.58 % Total obligations due within one year $ 558 $ 910
Schedule of Debt	The following table presents long term debt and finance leases, net of unamortized discounts, and interest rates: December 31, 2020 December 31, 2019 (In millions) Amount Interest Rate Amount Interest Rate Notes: 8.75% due 2020 $ — $ 280 5.125% due 2023 1,000 1,000 3.75% Euro Notes due 2023 307 281 9.5% due 2025 803 — 5% due 2026 900 900 4.875% due 2027 700 700 7% due 2028 150 150 Credit Facilities: First lien revolving credit facility due 2025 — — — — Second lien term loan facility due 2025 400 2.15 % 400 3.97 % European revolving credit facility due 2024 — — — — Pan-European accounts receivable facility 291 1.18 % 327 0.98 % Mexican credit facilities 152 1.87 % 200 3.44 % Chinese credit facilities 212 4.49 % 195 4.87 % Other foreign and domestic debt (1) 451 3.22 % 661 4.02 % 5,366 5,094 Unamortized deferred financing fees (32 ) (28 ) 5,334 5,066 Finance lease obligations (2) 250 249 5,584 5,315 Less portion due within one year (152 ) (562 ) $ 5,432 $ 4,753 (1) Interest rates are weighted average interest rates related to various foreign credit facilities with customary terms and conditions. (2) Includes non-cash financing additions of $3 million during the twelve month period ended December 31, 2020.
Maturities of Long-term Debt and Capital Leases	The annual aggregate maturities of our debt (excluding the impact of deferred financing fees and unamortized discounts) and finance leases for the five years subsequent to December 31, 2020 are presented below. Maturities of debt credit agreements have been reported on the basis that the commitments to lend under these agreements will be terminated effective at the end of their current terms. (In millions) 2021 2022 2023 2024 2025 U.S. $ 1 $ 151 $ 999 $ — $ 1,199 Foreign 555 324 699 88 19 $ 556 $ 475 $ 1,698 $ 88 $ 1,218
Fair Values for Foreign Currency Contracts not Designated as Hedging Instruments	The following table presents the fair values for foreign currency hedge contracts that do not meet the criteria to be accounted for as cash flow hedging instruments: December 31, December 31, (In millions) 2020 2019 Fair Values — Current asset (liability): Accounts receivable $ 1 $ 1 Other current liabilities (27 ) (15 )
Fair Values for Foreign Currency Contracts Designated as Cash Flow Hedges	The following table presents fair values for foreign currency hedge contracts that meet the criteria to be accounted for as cash flow hedging instruments: December 31, December 31, (In millions) 2020 2019 Fair Values — Current asset (liability): Accounts receivable $ — $ 9 Other current liabilities (7 ) (3 ) Fair Values — Long term asset (liability): Other assets $ — $ 1 Other long term liabilities — (1 )
Classification of Changes in Fair Values of Foreign Currency Contracts Designated as Cash Flow Hedging Instruments	The following table presents the classification of changes in fair values of foreign currency contracts that meet the criteria to be accounted for as cash flow hedging instruments (before tax and minority): Year Ended December 31, (In millions) 2020 2019 2018 Amount of gains (losses) deferred to AOCL (1) $ 15 $ 10 $ 9 Reclassification adjustment for amounts recognized in CGS (1) (13 ) (14 ) 7 (1) Excluded components deferred to AOCL and excluded components reclassified from AOCL to CGS for the twelve months ended December 31, 2020, 2019 and 2018 were not material.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Assets and Liabilities at Fair Value	The following table presents information about assets and liabilities recorded at fair value on the Consolidated Balance Sheet at December 31: Total Carrying Value in the Consolidated Balance Sheet Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (In millions) 2020 2019 2020 2019 2020 2019 2020 2019 Assets: Investments $ 11 $ 11 $ 11 $ 11 $ — $ — $ — $ — Foreign Exchange Contracts 1 11 — — 1 11 — — Total Assets at Fair Value $ 12 $ 22 $ 11 $ 11 $ 1 $ 11 $ — $ — Liabilities: Foreign Exchange Contracts $ 34 $ 19 $ — $ — $ 34 $ 19 $ — $ — Total Liabilities at Fair Value $ 34 $ 19 $ — $ — $ 34 $ 19 $ — $ —
Supplemental Fair Value Information	The following table presents supplemental fair value information about long term fixed rate and variable rate debt, excluding finance leases, at December 31: December 31, December 31, (In millions) 2020 2019 Fixed Rate Debt (1) Carrying amount — liability $ 4,094 $ 3,434 Fair value — liability 4,283 3,558 Variable Rate Debt (1) Carrying amount — liability $ 1,240 $ 1,632 Fair value — liability 1,197 1,632 (1) Excludes Notes Payable and Overdrafts of $406 million and $348 million at December 31, 2020 and 2019, respectively, of which $227 million and $143 million, respectively, are at fixed rates and $179 million and $205 million, respectively, are at variable rates. The carrying value of Notes Payable and Overdrafts approximates fair value due to the short term nature of the facilities.

Pension, Other Postretirement_2

Pension, Other Postretirement Benefits and Savings Plans (Tables)	12 Months Ended
	Dec. 31, 2020
Compensation And Retirement Disclosure [Abstract]
Benefit Costs and Amounts Recognized in Other Comprehensive (Income) Loss	Total benefits cost and amounts recognized in other comprehensive (income) loss follows: Pension Plans U.S. Non-U.S. Other Postretirement Benefits (In millions) 2020 2019 2018 2020 2019 2018 2020 2019 2018 Benefits cost (credit): Service cost $ 4 $ 3 $ 4 $ 30 $ 26 $ 28 $ 2 $ 2 $ 3 Interest cost 126 173 157 56 69 69 8 11 12 Expected return on plan assets (193 ) (223 ) (219 ) (54 ) (59 ) (70 ) — — — Amortization of prior service cost (credit) — — — 1 2 — (9 ) (9 ) (8 ) Amortization of net losses 109 112 112 38 29 29 4 3 4 Net periodic cost $ 46 $ 65 $ 54 $ 71 $ 67 $ 56 $ 5 $ 7 $ 11 Net curtailments/settlements /termination benefits 31 8 8 (4 ) 3 13 (4 ) — — Total benefits cost $ 77 $ 73 $ 62 $ 67 $ 70 $ 69 $ 1 $ 7 $ 11 Recognized in other comprehensive (income) loss before tax and minority: Prior service cost (credit) from plan amendments $ — $ — $ — $ 3 $ (2 ) $ 31 $ — $ — $ (16 ) Increase (decrease) in net actuarial losses 108 4 14 (100 ) 201 (18 ) 5 6 (14 ) Amortization of prior service (cost) credit in net periodic cost — — — (2 ) (2 ) — 9 9 8 Amortization of net losses in net periodic cost (109 ) (112 ) (112 ) (38 ) (29 ) (30 ) (4 ) (3 ) (5 ) Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures (26 ) (5 ) (11 ) (9 ) (3 ) (14 ) 6 2 — Total recognized in other comprehensive (income) loss before tax and minority (27 ) (113 ) (109 ) (146 ) 165 (31 ) 16 14 (27 ) Total recognized in total benefits cost and other comprehensive (income) loss before tax and minority $ 50 $ (40 ) $ (47 ) $ (79 ) $ 235 $ 38 $ 17 $ 21 $ (16 )
Changes in Benefit Obligation and Plan Assets	The change in benefit obligation and plan assets for 2020 and 2019 and the amounts recognized in our Consolidated Balance Sheets at December 31, 2020 and 2019 are as follows: Pension Plans U.S. Non-U.S. Other Postretirement Benefits (In millions) 2020 2019 2020 2019 2020 2019 Change in benefit obligation: Beginning balance $ (5,009 ) $ (4,734 ) $ (3,195 ) $ (2,774 ) $ (241 ) $ (234 ) Newly adopted plans — — — (19 ) — — Service cost — benefits earned (4 ) (3 ) (30 ) (26 ) (2 ) (2 ) Interest cost (126 ) (173 ) (56 ) (69 ) (8 ) (11 ) Plan amendments — — (3 ) 2 — — Actuarial loss (520 ) (477 ) (123 ) (381 ) (4 ) (6 ) Participant contributions — — (3 ) (2 ) (8 ) (12 ) Curtailments/settlements/termination benefits 51 12 21 5 — (2 ) Foreign currency translation — — (133 ) (62 ) 4 (5 ) Benefit payments 373 366 140 131 23 31 Ending balance $ (5,235 ) $ (5,009 ) $ (3,382 ) $ (3,195 ) $ (236 ) $ (241 ) Change in plan assets: Beginning balance $ 4,780 $ 4,445 $ 2,740 $ 2,464 $ — $ 3 Newly adopted plans — — — 19 — — Actual return on plan assets 605 696 305 252 — — Company contributions to plan assets — — 20 39 — — Cash funding of direct participant payments 14 20 22 20 15 16 Participant contributions — — 3 2 8 12 Settlements (56 ) (15 ) (8 ) (5 ) — — Foreign currency translation — — 99 80 — — Benefit payments (373 ) (366 ) (140 ) (131 ) (23 ) (31 ) Ending balance $ 4,970 $ 4,780 $ 3,041 $ 2,740 $ — $ — Funded status at end of year $ (265 ) $ (229 ) $ (341 ) $ (455 ) $ (236 ) $ (241 )
Funded Status Recognized in the Consolidated Balance Sheets	The funded status recognized in the Consolidated Balance Sheets consists of: Pension Plans Other Postretirement U.S. Non-U.S. Benefits (In millions) 2020 2019 2020 2019 2020 2019 Noncurrent assets $ — $ — $ 408 $ 237 $ — $ — Current liabilities (11 ) (16 ) (22 ) (20 ) (16 ) (16 ) Noncurrent liabilities (254 ) (213 ) (727 ) (672 ) (220 ) (225 ) Net amount recognized $ (265 ) $ (229 ) $ (341 ) $ (455 ) $ (236 ) $ (241 )
Amounts Recognized in Accumulated Other Comprehensive Loss	The amounts recognized in AOCL, net of tax, consist of: Pension Plans Other Postretirement U.S. Non-U.S. Benefits (In millions) 2020 2019 2020 2019 2020 2019 Prior service (credit) cost $ (3 ) $ (3 ) $ 25 $ 25 $ (7 ) $ (23 ) Net actuarial loss 2,353 2,380 636 782 30 30 Gross amount recognized 2,350 2,377 661 807 23 7 Deferred income taxes (43 ) (50 ) (104 ) (135 ) (29 ) (22 ) Minority shareholders’ equity — — (2 ) (1 ) — — Net amount recognized $ 2,307 $ 2,327 $ 555 $ 671 $ (6 ) $ (15 )
Weighted Average Assumptions Used	The following table presents significant weighted average assumptions used to determine benefit obligations at December 31: Pension Plans Other Postretirement Benefits 2020 2019 2020 2019 Discount rate: —U.S. 2.42 % 3.22 % 2.34 % 3.14 % —Non-U.S. 1.49 1.98 4.09 4.39 Rate of compensation increase: —U.S. N/A N/A N/A N/A —Non-U.S. 2.89 2.92 N/A N/A The following table presents significant weighted average assumptions used to determine benefits cost for the years ended December 31: Pension Plans Other Postretirement Benefits 2020 2019 2018 2020 2019 2018 Discount rate for determining interest cost: —U.S. 2.66 % 3.85 % 3.09 % 2.68 % 3.79 % 2.99 % —Non-U.S. 2.26 2.84 2.56 5.68 6.25 6.13 Expected long term return on plan assets: —U.S. 4.22 5.25 4.58 N/A N/A N/A —Non-U.S. 2.52 2.95 3.02 N/A N/A N/A Rate of compensation increase: —U.S. N/A N/A N/A N/A N/A N/A —Non-U.S. 2.92 2.91 2.91 N/A N/A N/A
Estimated Future Benefit Payments	The following table presents estimated future benefit payments from the plans as of December 31, 2020. Benefit payments for other postretirement benefits are presented net of retiree contributions and Medicare Part D Subsidy Receipts: Pension Plans Other Postretirement (In millions) U.S. Non-U.S. Benefits 2021 $ 417 $ 136 $ 16 2022 390 129 16 2023 366 130 15 2024 352 137 15 2025 339 138 14 2026-2030 1,578 743 68
Selected Pension Plan Information	The following table presents selected information on our pension plans: U.S. Non-U.S. (In millions) 2020 2019 2020 2019 All plans: Accumulated benefit obligation $ 5,220 $ 4,994 $ 3,284 $ 3,097 Plans not fully-funded: Projected benefit obligation $ 5,235 $ 5,009 $ 933 $ 1,059 Accumulated benefit obligation 5,220 4,994 856 991 Fair value of plan assets 4,970 4,780 185 370
Assumed Health Care Cost Trend Rates	Assumed health care cost trend rates at December 31 follow: 2020 2019 Health care cost trend rate assumed for the next year 6.0 % 6.3 % Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) 5.0 5.0 Year that the rate reaches the ultimate trend rate 2025 2025
Pension Plan Weighted Average Investment Allocation	Our pension plan weighted average investment allocation at December 31, by asset category, follows: U.S. Non-U.S. 2020 2019 2020 2019 Cash and short term securities 3 % 2 % 2 % 1 % Equity securities 4 6 4 3 Debt securities 93 92 93 96 Alternatives — — 1 — Total 100 % 100 % 100 % 100 %
Fair Values of Pension Plan Assets	The fair values of our pension plan assets at December 31, 2020 by asset category are as follows: U.S. Non-U.S (In millions) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Cash and Short Term Securities $ 122 $ 122 $ — $ — $ 46 $ 42 $ 4 $ — Equity Securities Common and Preferred Stock — — — — 24 24 — — Commingled Funds — — — — 19 19 — — Mutual Funds — — — — 6 6 — — Debt Securities Corporate Bonds 2,843 — 2,842 1 230 24 206 — Government Bonds 1,038 — 1,038 — 2,503 42 2,461 — Repurchase Agreements — — — — (650 ) — (650 ) — Asset Backed Securities 280 — 280 — 76 8 68 — Commingled Funds — — — — 20 20 — — Mutual Funds — — — — 19 9 10 — Alternatives Insurance Contracts 2 — — 2 28 — — 28 Other Investments 7 — 7 — 6 — 5 1 Total Investments in the Fair Value Hierarchy 4,292 $ 122 $ 4,167 $ 3 2,327 $ 194 $ 2,104 $ 29 Investments Measured at Net Asset Value, as Practical Expedient: Equity Securities Commingled Funds 23 62 Mutual Funds — 4 Partnership Interests 166 — Debt Securities Mutual Funds 148 81 Commingled Funds 295 665 Partnership Interests 102 — Short Term Securities Commingled Funds 22 3 Alternatives Commingled Funds — 6 Total Investments 5,048 3,148 Other (78 ) (107 ) Total Plan Assets $ 4,970 $ 3,041 The fair values of our pension plan assets at December 31, 2019 by asset category are as follows: U.S. Non-U.S. (In millions) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Cash and Short Term Securities $ 47 $ 47 $ — $ — $ 33 $ 29 $ 4 $ — Equity Securities Common and Preferred Stock — — — — 24 24 — — Commingled Funds — — — — 36 36 — — Mutual Funds — — — — 5 5 — — Debt Securities Corporate Bonds 2,577 — 2,576 1 190 10 180 — Government Bonds 1,120 — 1,120 — 2,271 60 2,211 — Repurchase Agreements — — — — (511 ) — (511 ) — Asset Backed Securities 283 — 282 1 74 5 69 — Mutual Funds — — — — 19 9 10 — Alternatives Insurance Contracts 2 — — 2 22 — — 22 Other Investments 2 — 2 — (4 ) — (5 ) 1 Total Investments in the Fair Value Hierarchy 4,031 $ 47 $ 3,980 $ 4 2,159 $ 178 $ 1,958 $ 23 Investments Measured at Net Asset Value, as Practical Expedient: Equity Securities Commingled Funds 9 69 Mutual Funds — 11 Partnership Interests 267 — Debt Securities Mutual Funds 141 7 Commingled Funds 310 604 Short Term Securities Commingled Funds 67 4 Alternatives Commingled Funds — 6 Total Investments 4,825 2,860 Other (45 ) (120 ) Total Plan Assets $ 4,780 $ 2,740
Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts Classified as Level 3	The following table sets forth a summary of changes in fair value of the non-U.S. pension plan insurance contracts classified as Level 3: (In millions) 2020 2019 Balance, beginning of year $ 22 $ 19 Unrealized gains relating to instruments still held at the reporting date 3 1 Purchases, sales, issuances and settlements (net) 1 2 Foreign currency translation 2 — Balance, end of year $ 28 $ 22

Stock Compensation Plans (Table

Stock Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Stock Option Activity	The following table summarizes the activity related to options during 2020: Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (In millions) Outstanding at January 1 4,998,021 $ 20.61 Options granted 4,167,384 10.12 Options exercised (20,218 ) 12.68 $ — Options expired (370,938 ) 12.44 Options cancelled (73,517 ) 18.83 Outstanding at December 31 8,700,732 15.97 5.9 3 Vested and expected to vest at December 31 8,604,644 16.00 5.9 3 Exercisable at December 31 4,462,091 20.98 2.9 — Available for grant at December 31 6,659,546
Significant Options Groups Outstanding	Significant option groups outstanding at December 31, 2020 Grant Date Options Outstanding Options Exercisable Exercise Price Remaining Contractual Term (Years) 2/25/2020 4,142,384 — $ 10.12 9.16 2/27/2017 556,409 465,203 35.26 6.16 2/22/2016 542,625 542,625 29.90 5.15 2/23/2015 493,730 493,730 27.16 4.15 2/24/2014 381,617 381,617 26.44 3.15 2/28/2013 904,580 904,580 12.98 2.16 2/27/2012 721,878 721,878 12.94 1.16 2/22/2011 523,979 523,979 13.91 0.15 All Other 433,530 428,479 (1 ) (1 ) 8,700,732 4,462,091 (1) Options in the “All other” category had exercise prices ranging from $9.54 to $32.72. The weighted average exercise price for options outstanding and exercisable in that category was $21.45 and $21.32, respectively, while the remaining weighted average contractual term was 3.0 years
Weighted Average Grant Date Fair Values of Stock Options and the Assumptions Used	Weighted average grant date fair values of stock options and the assumptions used in estimating those fair values are as follows: 2020 Weighted average grant date fair value $ 10.12 Black-Scholes model assumptions (1) Expected term (years) 7.50 Interest rate 1.29 % Volatility 41.28 % Dividend yield 6.54 % (1) We review the assumptions used in our Black-Scholes model in conjunction with estimating the grant date fair value of grants of options by our Board of Directors. There were no stock options granted during 2019 or 2018.
Stock-based Compensation Expense and Cash Activity	Stock-based compensation expense, cash payments made to settle SARs and cash received from the exercise of stock options follows: (In millions) 2020 2019 2018 Stock-based compensation expense recognized $ 31 $ 27 $ 16 Tax benefit (8 ) (7 ) (4 ) After-tax stock-based compensation expense $ 23 $ 20 $ 12 Cash payments to settle SARs $ — $ — $ 1 Cash received from stock option exercises $ — $ 2 $ 9
Performance Share Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Nonvested Share Activity	The following table summarizes the activity related to performance share units during 2020: Units Weighted Average Grant Date Fair Value Unvested at January 1 588,000 $ 20.98 Units granted 171,871 7.59 Units vested (154,141 ) 29.04 Units forfeited (10,950 ) 20.92 Unvested at December 31 594,780 15.02
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Nonvested Share Activity	The following table summarizes the activity related to restricted stock units during 2020: Units Weighted Average Grant Date Fair Value Unvested at January 1 2,734,475 $ 23.21 Units granted 600,712 9.86 Units vested and settled (646,444 ) 24.50 Units forfeited (119,870 ) 18.80 Unvested at December 31 2,568,873 19.50

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Summary of Recent Approximate Asbestos Claims Activity	A summary of recent approximate asbestos claims activity follows. Because claims are often filed and disposed of by dismissal or settlement in large numbers, the amount and timing of settlements and the number of open claims during a particular period can fluctuate significantly. (Dollars in millions) 2020 2019 2018 Pending claims, beginning of year 39,600 43,100 54,300 New claims filed during the year 1,100 1,500 1,300 Claims settled/dismissed (2,000 ) (5,000 ) (12,500 ) Pending claims, end of year 38,700 39,600 43,100 Payments (1) $ 13 $ 22 $ 18 (1) Represents cash payments made during the period by us and our insurers on asbestos litigation defense and claim resolution.
Changes in the Warranty Reserve	The following table presents changes in the warranty reserve during 2020 and 2019: (In millions) 2020 2019 Balance at January 1 $ 22 $ 18 Payments made during the period (21 ) (25 ) Expense recorded during the period 21 29 Translation adjustment — — Balance at December 31 $ 22 $ 22

Reclassifications out of Accu_2

Reclassifications out of Accumulated Other Comprehensive Loss (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss by Component	The following table presents changes in AOCL by component for the years ended December 31, 2020, 2019 and 2018, after tax and minority interest: (In millions) Income (Loss) Foreign Currency Translation Adjustment Unrecognized Net Actuarial Losses and Prior Service Costs Deferred Derivative Gains (Losses) Total Balance at December 31, 2017 $ (915 ) $ (3,052 ) $ (9 ) $ (3,976 ) Other comprehensive income (loss) before reclassifications (245 ) 4 9 (232 ) Amounts reclassified from accumulated other comprehensive loss — 125 7 132 Balance at December 31, 2018 $ (1,160 ) $ (2,923 ) $ 7 $ (4,076 ) Other comprehensive income (loss) before reclassifications (1) 4 (168 ) 10 (154 ) Amounts reclassified from accumulated other comprehensive loss — 108 (14 ) 94 Balance at December 31, 2019 $ (1,156 ) $ (2,983 ) $ 3 $ (4,136 ) Other comprehensive income (loss) before reclassifications (1) (128 ) (4 ) 15 (117 ) Amounts reclassified from accumulated other comprehensive loss — 131 (13 ) 118 Balance at December 31, 2020 $ (1,284 ) $ (2,856 ) $ 5 $ (4,135 ) (1) Includes adjustments to AOCL of $27 million and $(32) million in 2020 and 2019, respectively, to adjust the respective prior year obligation of our frozen U.K. pension plan.
Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents reclassifications out of AOCL for the years ended December 31, 2020, 2019 and 2018: Year Ended December 31, (In millions) (Income) Expense 2020 2019 2018 Component of AOCL Amount Reclassified from AOCL Affected Line Item in the Consolidated Statements of Operations Amortization of prior service cost and unrecognized gains and losses $ 144 $ 137 $ 139 Other (Income) Expense Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements and divestitures 29 6 25 Other (Income) Expense / Rationalizations Unrecognized Net Actuarial Losses and Prior Service Costs, before tax $ 173 $ 143 $ 164 Tax effect (42 ) (35 ) (39 ) United States and Foreign Taxes Net of tax $ 131 $ 108 $ 125 Goodyear Net Income (Loss) Deferred Derivative (Gains) Losses $ (13 ) $ (14 ) $ 7 Cost of Goods Sold Tax effect — — — United States and Foreign Taxes Net of tax $ (13 ) $ (14 ) $ 7 Goodyear Net Income (Loss) Total reclassifications $ 118 $ 94 $ 132 Goodyear Net Income (Loss)

Accounting Policies - Narrative

Accounting Policies - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 01, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 1, 2020
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member	us-gaap:AccountingStandardsUpdate201602Member	us-gaap:AccountingStandardsUpdate201409Member
Retained earnings	$ 4,809	$ 6,113
Accounts receivable	1,691	1,941
Deferred income taxes	1,467	1,527
Research and development expenditures	390	430	$ 424
Advertising costs	304	353	345
Maximum cash investments with single counterparty	345
Capital lease obligations	3	36	6
Accrued capital expenditures financed with extended terms	15
Accrued capital expenditures remaining unpaid	224	243	266
Payments for capital expenditures accrued and unpaid in prior year		243	266	$ 265
Restricted net assets	680
Depreciation expense for property, plant and equipment	857	793	776
Total assets	16,506	17,185
Long Term Debt and Finance Leases	5,432	4,753
Total shareholders’ equity	$ 3,259	4,545	$ 5,070	$ 4,850
Lessee, operating lease, option to terminate, term	1 year
Lessee, operating lease, term of contract	12 months
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Payment term	30 days
Operating lease, weighted average remaining lease term	1 year
Lessee, operating lease, renewal term	1 year
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Payment term	90 days
Operating lease, weighted average remaining lease term	50 years
Lessee, operating lease, renewal term	50 years
Accounting Standards Update 2016-13 | Restatement Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Retained earnings					$ (12)
Accounts receivable					(15)
Deferred income taxes					$ 3
Accounting Standards Update 2016-09 | Restatement Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total assets		873
Long Term Debt and Finance Leases		14
Total shareholders’ equity		$ (23)

Accounting Policies - Summary o

Accounting Policies - Summary of Balance of Allowances for Credit Losses, Doubtful Accounts with Accounts Receivable and Changes (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Financing Receivable Allowance For Credit Losses [Line Items]
Balance	$ 126
Current period provision	30
Write-offs charged against the allowance	(11)
Translation	5
Balance	150
Americas
Financing Receivable Allowance For Credit Losses [Line Items]
Balance	38
Current period provision	10
Write-offs charged against the allowance	(4)
Translation	(2)
Balance	42
Europe, Middle East & Africa
Financing Receivable Allowance For Credit Losses [Line Items]
Balance	78
Current period provision	15
Write-offs charged against the allowance	(7)
Translation	6
Balance	92
Asia Pacific
Financing Receivable Allowance For Credit Losses [Line Items]
Balance	10
Current period provision	5
Write-offs charged against the allowance	0
Translation	1
Balance	$ 16

Accounting Policies - Restricte

Accounting Policies - Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Cash and Cash Equivalents	$ 1,539	$ 908	$ 801
Restricted Cash	85	66	72
Total Cash, Cash Equivalents and Restricted Cash	$ 1,624	$ 974	$ 873	$ 1,110

Net Sales - Schedule of Disaggr

Net Sales - Schedule of Disaggregated Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	$ 12,321	$ 14,745	$ 15,475
Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	6,556	7,922	8,168
Europe, Middle East & Africa
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	4,020	4,708	5,090
Asia Pacific
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	1,745	2,115	2,217
Tire unit sales
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	10,339	12,524	13,060
Tire unit sales | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	5,138	6,300	6,381
Tire unit sales | Europe, Middle East & Africa
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	3,611	4,300	4,670
Tire unit sales | Asia Pacific
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	1,590	1,924	2,009
Other tire and related sales
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	956	1,139	1,162
Other tire and related sales | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	549	659	656
Other tire and related sales | Europe, Middle East & Africa
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	309	363	379
Other tire and related sales | Asia Pacific
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	98	117	127
Retail services and service related sales
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	688	644	675
Retail services and service related sales | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	538	535	564
Retail services and service related sales | Europe, Middle East & Africa
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	95	39	34
Retail services and service related sales | Asia Pacific
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	55	70	77
Chemical sales
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	317	403	554
Chemical sales | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	317	403	554
Other
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	21	35	24
Other | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	14	25	13
Other | Europe, Middle East & Africa
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	5	6	7
Other | Asia Pacific
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Net Sales	$ 2	$ 4	$ 4

Net Sales - Schedule of Disag_2

Net Sales - Schedule of Disaggregated Revenue (Parenthetical) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Tire unit sales | Americas
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Gain on one time cash settlement of take-or-pay agreement	$ 34

Net Sales - Narrative (Details)

Net Sales - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Revenue From Contract With Customer [Abstract]
Deferred revenue, current	$ 23	$ 23
Deferred revenue, noncurrent	$ 27	$ 31

Net Sales - Schedule of Balance

Net Sales - Schedule of Balance of Deferred Revenue Related to Contracts with Customers (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Change in Contract with Customer, Liability [Roll Forward]
Balance at January 1	$ 54	$ 78
Revenue deferred during period	169	155
Revenue recognized during period	(173)	(179)
Balance at December 31	$ 50	$ 54

Costs Associated with Rationa_3

Costs Associated with Rationalization Programs - Roll-Forward of Liability Balance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring Reserve
Beginning Balance	$ 220	$ 81	$ 213
New Charges	156	204	64
Incurred, net of foreign currency translation	(174)	(61)	(177)
Reversed to the Statement of Operations	(2)	(4)	(19)
Ending Balance	200	220	81
Rationalizations
Restructuring Reserve
Curtailments and settlements benefits plan credit	5	5	(1)
Associate-Related Costs
Restructuring Reserve
Beginning Balance	220	80	210
New Charges	129	185	47
Incurred, net of foreign currency translation	(147)	(41)	(158)
Reversed to the Statement of Operations	(2)	(4)	(19)
Ending Balance	200	220	80
Foreign currency translation	12	(2)	(3)
Other Costs
Restructuring Reserve
Beginning Balance	0	1	3
New Charges	27	19	17
Incurred, net of foreign currency translation	(27)	(20)	(19)
Reversed to the Statement of Operations	0	0	0
Ending Balance	0	0	1
Foreign currency translation	$ 0	$ 0	$ 0

Costs Associated with Rationa_4

Costs Associated with Rationalization Programs - Narrative (Details) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2019facility	Dec. 31, 2020USD ($)positionemployee	Dec. 31, 2019USD ($)facility	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Restructuring Cost and Reserve [Line Items]
Expected number of position to be released (in employees) | employee		450
Restructuring reserve		$ 200	$ 220	$ 81	$ 213
Rationalizations		159	205	44
Rationalization reversals		2	4	19
Rationalization charges to date		990
Future rationalization charges expected		80
Rationalizations
Restructuring Cost and Reserve [Line Items]
Curtailments and settlements benefits plan credit		5	5	(1)
Amiens Labor Claims
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		35
Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations		57	6	4
Rationalization reversals		$ 2	4	18
Number of associates released | employee		1,200
Prior Year Plans | Rationalizations
Restructuring Cost and Reserve [Line Items]
Curtailments and settlements benefits plan credit		$ 4
Prior Year Plans | Amiens Labor Claims
Restructuring Cost and Reserve [Line Items]
Rationalizations		30
Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations		$ 102	$ 199	40
Rationalization reversals				1
Facility Closing | Plan to Permanently Close Gadsden, Alabama Manufacturing Facility as Part of Strategy to Strengthen Competitiveness of Manufacturing Footprint
Restructuring Cost and Reserve [Line Items]
Expected number of position to be released (in employees) | position		470
Restructuring reserve		$ 32
Modernizing Tire Manufacturing Facilities in Germany
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		89
Number of facilities affected | facility	2		2
Modernizing Tire Manufacturing Facilities in Germany | Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations		19
Europe, Middle East, and Africa Restructuring Plan - Operating Efficiency
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		9
Reduce SAG Headcount
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		11
Reduce SAG Headcount | Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations				3
Reduce SAG Headcount | Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations				28
Gadsden Restructuring Plan to Offer Voluntary Buy-outs to Certain Associates
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		7
Gadsden Restructuring Plan to Offer Voluntary Buy-outs to Certain Associates | Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations		5
Philippsburg Restructuring | Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations		$ 3	$ 10	15
Gadsden, Alabama Manufacturing Facility | Current Year Plans
Restructuring Cost and Reserve [Line Items]
Expected number of position to be released (in employees) | employee		800
Number of associates released | employee		600
Europe, Middle East, and Africa Restructuring Plan - Manufacturing Employee Severance and Operating Efficiency | Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations				3
Europe, Middle East, and Africa Restructuring Plan - Manufacturing Employee Severance and Operating Efficiency | Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations			105	$ 13
Reduction to Manufacturing Headcount, Gadsden, Alabama | Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations			76
Americas Restructuring Plan, Brazil - Manufacturing Employee Severance and Operating Efficiency | Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations			$ 18

Costs Associated with Rationa_5

Costs Associated with Rationalization Programs - Schedule of Net Rationalization Charges Included in Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Rationalizations	$ 159	$ 205	$ 44
Asset write-off and accelerated depreciation charges	105	15	4
Current Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations	102	199	40
Current Year Plans | Associate severance and other related costs
Restructuring Cost and Reserve [Line Items]
Rationalizations	77	183	40
Current Year Plans | Benefit plan curtailment and special termination benefits
Restructuring Cost and Reserve [Line Items]
Rationalizations	9	5
Current Year Plans | Other exit and non-cancelable lease costs
Restructuring Cost and Reserve [Line Items]
Rationalizations	16	11
Prior Year Plans
Restructuring Cost and Reserve [Line Items]
Rationalizations	57	6	4
Prior Year Plans | Associate severance and other related costs
Restructuring Cost and Reserve [Line Items]
Rationalizations	50	(2)	(11)
Prior Year Plans | Benefit plan curtailment and special termination benefits
Restructuring Cost and Reserve [Line Items]
Rationalizations	(4)		(1)
Prior Year Plans | Other exit and non-cancelable lease costs
Restructuring Cost and Reserve [Line Items]
Rationalizations	$ 11	$ 8	$ 16

Interest Expense (Details)

Interest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Interest Expense [Abstract]
Interest expense before capitalization	$ 339	$ 351	$ 335
Capitalized interest	(15)	(11)	(14)
Interest Expense	324	340	321
Interest paid, net	$ 315	$ 324	$ 331

Other (Income) Expense (Details

Other (Income) Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other Income And Expenses [Abstract]
Gain on TireHub transaction, net of transaction costs	$ 0	$ 0	$ (272)
Non-service related pension and other postretirement benefits costs	110	118	121
Interest income on indirect tax settlements in Brazil		(8)	(38)
Financing fees and financial instruments expense	26	34	36
Net foreign currency exchange (gains) losses	(9)	(22)	(16)
General and product liability expense - discontinued products	10	11	9
Royalty income	(19)	(19)	(20)
Net (gains) losses on asset sales	2	(16)	(1)
Interest income	(14)	(18)	(16)
Miscellaneous (income) expense	13	18	23
Other (income) expense	$ 119	$ 98	$ (174)

Other (Income) Expense - Narrat

Other (Income) Expense - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other Income And Expenses [Line Items]
Deconsolidation, gain (loss), gross			$ 286
Professional fees			14
Gain (loss) related to settlement		$ 11	53
Interest income, tax settlement		8	38
Loss from catastrophes		25	12
Other Postretirement Benefits
Other Income And Expenses [Line Items]
Pension settlement and curtailment charges	$ 4
Other Postretirement Benefits | Non-U.S. | Other (Income) Expense
Other Income And Expenses [Line Items]
Pension settlement and curtailment charges	$ 18	$ 6	$ 21

Income Taxes - Income (Loss) be

Income Taxes - Income (Loss) before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
U.S.	$ (993)	$ (39)	$ 439
Foreign	(147)	216	572
Income (loss) before income taxes	$ (1,140)	$ 177	$ 1,011

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Line Items]
U.S. federal income tax expense (benefit) at the statutory rate of 21%	$ (239)	$ 37	$ 212
Net foreign losses (income) with no tax due to valuation allowances	37	48	7
Goodwill impairment	34	0	0
Deferred tax impact of enacted tax rate and law changes	(18)	3	0
State income taxes, net of U.S. federal benefit	(17)	(1)	(1)
U.S. charges (benefits) related to foreign tax credits, R&D and foreign derived intangible deduction	(9)	(17)	20
Adjustment for foreign income taxed at different rates	7	16	30
Net establishment of uncertain tax positions	6	7	18
Federal and state tax on accelerated royalty income transaction	0	334	0
Other	(1)	5	(3)
United States and Foreign Tax Expense	110	474	303
Foreign Tax Authority
Income Taxes [Line Items]
Net establishment (release) of U.S. valuation allowances	0	140	(5)
Domestic Tax Authority
Income Taxes [Line Items]
Net establishment (release) of U.S. valuation allowances	$ 310	$ (98)	$ 25

Income Taxes - Components of Un

Income Taxes - Components of United States and Foreign Tax (Benefit) Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current:
Federal	$ (5)	$ 0	$ (15)
Foreign	95	134	188
State	(3)	17	(1)
Current income tax expense (benefit)	87	151	172
Deferred:
Federal	63	133	120
Foreign	(31)	153	6
State	(9)	37	5
Deferred income tax expense (benefit)	23	323	131
United States and Foreign Tax Expense	$ 110	$ 474	$ 303

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Millions	3 Months Ended			12 Months Ended
	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2020USD ($)Installment	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2017USD ($)
Income Taxes [Line Items]
Income tax (benefit) expense				$ 110	$ 474	$ 303
Income (loss) before income taxes				(1,140)	177	1,011
Net discrete tax adjustments			$ 135	305	386	65
Discrete adjustments, net charge				10
Valuation allowance	$ 1,469			1,469	982
Deferred tax impact of enacted tax rate and law changes				(18)	3	0
Discrete adjustments, other	8					18
Federal and state tax on accelerated royalty income transaction				0	334	0
Increase in valuation allowance on tax losses in subsidiaries					150
Reduction to valuation allowance for foreign tax credits					98
Net deferred tax assets	1,879			1,879	1,979
Deferred tax asset, tax credit carryforwards, foreign	133			133	403
Deferred tax assets	3,348			3,348	2,961
Deferred tax assets, operating loss, capital loss, and tax credit carryforwards	704			704
Operating loss carryforwards, domestic	767			767
Operating loss carryforwards, state and local	99			99
Unrecognized tax benefits	85		71	85	82	71		$ 52
Unrecognized tax benefits that would impact effective tax rate	58			58
Income tax penalties and interest accrued	2			2
Unsettled unrecognized tax benefits that would require cash	9			9
Undistributed earnings of foreign subsidiaries	2,300			2,300
Amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries	85			$ 85
CARES act of 2020, net operating loss carryback period				5 years
CARES Act Of 2020 refundable alternative minimum tax credit carryforwards		$ 5
Number of equal annual installments to receive refund alternative minimum tax credit carryforwards | Installment				2
Income tax cash payments, net				$ 45	142	178
Foreign Tax Authority
Income Taxes [Line Items]
Tax credit carryforward, valuation allowance	328			328	3		$ 295
Valuation allowance	1,101			1,101	1,000
Net establishment (release) of U.S. valuation allowances				$ 0	140	(5)
Tax credit carryforward expiration period				through 2024 and a portion of those expiring in 2025.
Increase in valuation allowance				$ 30
Deferred tax assets	1,300			1,300	1,200
Deferred tax assets, operating loss, capital loss, and tax credit carryforwards, subject to expiration	69			$ 69
Foreign Tax Authority | Beginning Year
Income Taxes [Line Items]
Tax credit carryforward expiration year				2025
Foreign Tax Authority | Ending Year
Income Taxes [Line Items]
Tax credit carryforward expiration year				2030
Domestic Tax Authority
Income Taxes [Line Items]
Valuation allowance	15			$ 15
Net establishment (release) of U.S. valuation allowances				310	(98)	25
Deferred tax asset, tax credit carryforwards, foreign	461			461
Tax credit carryforwards, research	92			92
Venezuela
Income Taxes [Line Items]
Tax credit carryforward, valuation allowance			98			$ 98
Net establishment (release) of U.S. valuation allowances			$ (88)
Domestic and State and Local Authority
Income Taxes [Line Items]
Valuation allowance	368			368	13
Net deferred tax assets	1,200			1,200	$ 1,200
Net deferred tax assets, unlimited lives	900			900
Net deferred tax assets, limited lives	300			$ 300
Net deferred tax assets, expiration period				between 2025 and 2040.
State and Local Authority
Income Taxes [Line Items]
Operating loss carryforwards, subject to expiration	87			$ 87
England
Income Taxes [Line Items]
Deferred tax impact of enacted tax rate and law changes		$ (13)
Luxembourg | Foreign Tax Authority
Income Taxes [Line Items]
Valuation allowance	$ 978			$ 978

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Tax loss carryforwards and credits	$ 1,570	$ 1,159
Prepaid royalty income	629	576
Capitalized research and development expenditures	421	416
Accrued expenses deductible as paid	255	347
Postretirement benefits and pensions	209	221
Lease liabilities	76	75
Rationalizations and other provisions	34	38
Vacation and sick pay	21	23
Other	133	106
Total gross deferred tax assets	3,348	2,961
Valuation allowance	(1,469)	(982)
Total deferred tax assets	1,879	1,979
Property basis differences	(420)	(467)
Right-of-use assets	(75)	(74)
Tax on undistributed earnings of subsidiaries	(1)	(1)
Total net deferred tax assets	$ 1,383	$ 1,437

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Balance at beginning of period	$ 82	$ 71	$ 52
Increases related to prior year tax positions	26	24	9
Decreases related to prior year tax positions	(1)	0	(1)
Settlements	(15)	(11)	(2)
Foreign currency impact	(7)	(2)	(5)
Increases related to current year tax positions	0	0	21
Lapse of statute of limitations	0	0	(3)
Balance at end of period	$ 85	$ 82	$ 71

Earnings Per Share - Basic and

Earnings Per Share - Basic and Diluted Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Earnings (loss) per share — basic:
Goodyear net income (loss)	$ (1,254)	$ (311)	$ 693
Weighted Average Shares Outstanding (in shares)	234	233	237
Earnings (loss) per common share-basic (in dollars per share)	$ (5.35)	$ (1.33)	$ 2.92
Earnings (loss) per share — diluted:
Goodyear net income (loss)	$ (1,254)	$ (311)	$ 693
Weighted Average Shares Outstanding (in shares)	234	233	237
Dilutive effect of stock options and other dilutive securities (in shares)	0	0	2
Weighted average shares outstanding — diluted (in shares)	234	233	239
Earnings (loss) per common share-diluted (in dollars per share)	$ (5.35)	$ (1.33)	$ 2.89

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Underwater Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Equivalent shares excluded from weighted average shares outstanding (in shares)	9	2	2
In-the-money Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Equivalent shares excluded from weighted average shares outstanding (in shares)	0	3

Business Segments - Narrative (

Business Segments - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)segment	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	3
Cash and cash equivalents	$ 1,539	$ 908	$ 801
Asia Pacific
Segment Reporting Information [Line Items]
Cash and cash equivalents	$ 387	$ 337
Concentrations of cash and cash equivalents	25.00%	37.00%
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Cash and cash equivalents	$ 387	$ 214
Concentrations of cash and cash equivalents	25.00%	24.00%
Americas
Segment Reporting Information [Line Items]
Cash and cash equivalents	$ 384	$ 190
Concentrations of cash and cash equivalents	25.00%	21.00%

Business Segments - Reporting I

Business Segments - Reporting Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Operating Income (Loss)
Net Sales	$ 12,321	$ 14,745	$ 15,475
Less:
Income (loss) before income taxes	(1,140)	177	1,011
Goodwill and Other Asset Impairments	330	0	0
Rationalizations	159	205	44
Interest Expense	324	340	321
Other (Income) Expense	119	98	(174)
Asset write-offs and accelerated depreciation (Note 3)	105	15	4
Corporate incentive compensation plans	44	50	13
Operating Segments
Less:
Income (loss) before income taxes	(14)	945	1,274
Rationalizations	157	205	42
Segment Reconciling Items
Less:
Rationalizations	159	205	44
Interest Expense	324	340	321
Other (Income) Expense	119	98	(174)
Asset write-offs and accelerated depreciation (Note 3)	105	15	4
Retained expenses of divested operations	8	10	9
Corporate and Eliminations
Less:
Other	37	50	46
Americas
Segment Operating Income (Loss)
Net Sales	6,556	7,922	8,168
Less:
Asset write-offs and accelerated depreciation (Note 3)	103	13
Americas | Operating Segments
Less:
Income (loss) before income taxes	9	550	654
Rationalizations	94	90	3
Europe, Middle East and Africa
Segment Operating Income (Loss)
Net Sales	4,020	4,708	5,090
Less:
Asset write-offs and accelerated depreciation (Note 3)	2	2	4
Europe, Middle East and Africa | Operating Segments
Less:
Income (loss) before income taxes	(72)	202	363
Rationalizations	59	115	36
Asia Pacific
Segment Operating Income (Loss)
Net Sales	1,745	2,115	2,217
Asia Pacific | Operating Segments
Less:
Income (loss) before income taxes	49	$ 193	257
Rationalizations	$ 4		$ 3

Business Segments - Reporting_2

Business Segments - Reporting Information (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenues From External Customers And Long Lived Assets [Line Items]
Royalty income	$ 19	$ 19	$ 20
Intersegment Eliminations
Revenues From External Customers And Long Lived Assets [Line Items]
Royalty income	$ 17	$ 17	$ 18

Business Segments - Segment Ass

Business Segments - Segment Assets (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Assets	$ 16,506	$ 17,185
Operating Segments
Segment Reporting Information [Line Items]
Assets	14,216	15,041
Operating Segments | Americas
Segment Reporting Information [Line Items]
Assets	6,666	7,606
Operating Segments | Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Assets	4,825	4,724
Operating Segments | Asia Pacific
Segment Reporting Information [Line Items]
Assets	2,725	2,711
Corporate
Segment Reporting Information [Line Items]
Assets	$ 2,290	$ 2,144

Business Segments - Geographic

Business Segments - Geographic Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	$ 12,321	$ 14,745	$ 15,475
Long-Lived Assets	7,073	7,208
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	5,424	6,489	6,692
Long-Lived Assets	2,517	2,681
Germany
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	705	979	1,691
Long-Lived Assets	729	653
Other international
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	6,192	7,277	$ 7,092
Long-Lived Assets	3,085	3,152
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 742	$ 722

Business Segments - Rationaliza

Business Segments - Rationalizations, Asset Sales, Other Expense and Asset Write-offs and Accelerated Depreciation Attributable to the SBUs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Goodwill and Other Asset Impairments	$ 330
Rationalizations	159	$ 205	$ 44
Asset write-Offs and accelerated depreciation	105	15	4
Americas
Segment Reporting Information [Line Items]
Asset write-Offs and accelerated depreciation	103	13
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Asset write-Offs and accelerated depreciation	2	2	4
Operating Segments
Segment Reporting Information [Line Items]
Rationalizations	157	205	42
Net (gains) losses on asset sales	2	(16)	(273)
Operating Segments | Americas
Segment Reporting Information [Line Items]
Goodwill and Other Asset Impairments	148
Rationalizations	94	90	3
Net (gains) losses on asset sales			(275)
Operating Segments | Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Goodwill and Other Asset Impairments	182
Rationalizations	59	115	36
Net (gains) losses on asset sales	2	$ (16)	2
Operating Segments | Asia Pacific
Segment Reporting Information [Line Items]
Rationalizations	4		3
Corporate
Segment Reporting Information [Line Items]
Rationalizations	$ 2		$ 2

Business Segments - Rationali_2

Business Segments - Rationalizations, Asset Sales, Other Expense and Asset Write-offs and Accelerated Depreciation Attributable to the SBUs (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting [Abstract]
Deconsolidation, gain (loss), amount	$ 0	$ 0	$ 272

Business Segments - Capital Exp

Business Segments - Capital Expenditures Depreciation and Amortization (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Capital expenditures	$ 647	$ 770	$ 811
Depreciation and amortization	859	795	778
Operating Segments
Segment Reporting Information [Line Items]
Capital expenditures	628	737	774
Depreciation and amortization	824	760	746
Operating Segments | Americas
Segment Reporting Information [Line Items]
Capital expenditures	302	369	406
Depreciation and amortization	490	430	414
Operating Segments | Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Capital expenditures	235	227	180
Depreciation and amortization	201	197	201
Operating Segments | Asia Pacific
Segment Reporting Information [Line Items]
Capital expenditures	91	141	188
Depreciation and amortization	133	133	131
Corporate
Segment Reporting Information [Line Items]
Capital expenditures	19	33	37
Depreciation and amortization	$ 35	$ 35	$ 32

Business Segments - Equity In N

Business Segments - Equity In Net Income (Loss) of Investees Accounted For By Equity Method (Details) - Operating Segments - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Equity in (Income) Loss	$ 31	$ 32	$ 10
Americas
Segment Reporting Information [Line Items]
Equity in (Income) Loss	31	32	11
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Equity in (Income) Loss	$ 0	$ 0	$ (1)

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Accounts receivable	$ 1,841	$ 2,052
Allowance for doubtful accounts	(150)	(111)
Accounts receivable, net	$ 1,691	$ 1,941

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 517	$ 530
Work in process	143	143
Finished goods	1,493	2,178
Total inventory	$ 2,153	$ 2,851

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Goodwill [Roll Forward]
Beginning balance	$ 565	$ 569
Acquisitions	10	3
Divestitures	0	0
Impairment	(182)	0
Translation	15	(7)
Ending balance	408	565
Americas
Goodwill [Roll Forward]
Beginning balance	91	91
Acquisitions	0	0
Divestitures	0	0
Impairment	0	0
Translation	0	0
Ending balance	91	91
Europe, Middle East & Africa
Goodwill [Roll Forward]
Beginning balance	411	415
Acquisitions	10	2
Divestitures	0	0
Impairment	(182)	0
Translation	11	(6)
Ending balance	250	411
Asia Pacific
Goodwill [Roll Forward]
Beginning balance	63	63
Acquisitions	0	1
Divestitures	0	0
Impairment	0	0
Translation	4	(1)
Ending balance	$ 67	$ 63

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives, gross	$ 125	$ 124
Intangible assets with indefinite lives, accumulated amortization	(6)	(6)
Intangible assets with indefinite lives, net	119	118
Intangible assets, gross	173	173
Intangible assets, accumulated amortization	(38)	(36)
Intangible assets, net	135	137
Trademarks and Patents
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	23	24
Finite-lived intangible assets, accumulated amortization	(19)	(19)
Finite-lived intangible assets, net	4	5
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	25	25
Finite-lived intangible assets, accumulated amortization	(13)	(11)
Finite-lived intangible assets, net	$ 12	$ 14

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Amortization of intangible assets		$ 2	$ 2	$ 2
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2021		2
2022		1
2023		1
2024		1
2025		$ 1
Weighted average remaining amortization period		20 years
Goodwill, impairment charge		$ 182	$ 0
EMEA
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Goodwill, impairment charge	$ 182

Other Assets and Investments (D

Other Assets and Investments (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounts Notes And Loans Receivable [Line Items]
Dividends received from consolidated subsidiaries		$ 155	$ 43	$ 608
Dividends received from affiliates accounted for using the equity method		5	4	5
Net Income (Loss)		(1,250)	(297)	708
Trade receivable from a customer refinanced		$ 30
TireHub
Accounts Notes And Loans Receivable [Line Items]
Equity ownership percentage		50.00%
Net Income (Loss)		$ 36	33	$ 15
Non-cash impairment charge	$ 148
TireHub | Other Assets
Accounts Notes And Loans Receivable [Line Items]
Equity method investments		77	$ 262
Loan receivable, outstanding		$ 14

Property, Plant and Equipment P

Property, Plant and Equipment Property, Plant and Equipment - (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Land	$ 437	$ 426
Buildings	2,699	2,658
Machinery and equipment	13,922	13,654
Construction in progress	737	682
Property, plant, and equipment and finance lease right-of-use asset, gross	17,795	17,420
Accumulated depreciation	(10,991)	(10,488)
Property plant and equipment, net before spare parts	6,804	6,932
Spare parts	269	276
Property, plant and equipment, net	7,073	7,208
Owned
Property, Plant and Equipment [Line Items]
Land	436	425
Buildings	2,467	2,431
Machinery and equipment	13,893	13,624
Construction in progress	737	681
Property, plant, and equipment and finance lease right-of-use asset, gross	17,533	17,161
Accumulated depreciation	(10,931)	(10,438)
Property plant and equipment, net before spare parts	6,602	6,723
Spare parts	269	276
Property, plant and equipment, net	6,871	6,999
Finance Leases
Property, Plant and Equipment [Line Items]
Land	1	1
Buildings	232	227
Machinery and equipment	29	30
Construction in progress		1
Property, plant, and equipment and finance lease right-of-use asset, gross	262	259
Accumulated depreciation	(60)	(50)
Property plant and equipment, net before spare parts	202	209
Property, plant and equipment, net	$ 202	$ 209
Building and Building Improvements | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Building and Building Improvements | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	45 years
Machinery and Equipment | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Machinery and Equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	40 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Operating Lease Expense	$ 286	$ 292	$ 0
Finance Lease Expense:
Amortization of ROU assets	11	11
Interest on lease liabilities	21	21
Short Term Lease Expense	6	6
Variable Lease Expense	3	7
Sublease Income	(11)	(15)
Total Lease Expense	$ 316	$ 322

Leases - Net Rental Expense (De

Leases - Net Rental Expense (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)
Leases [Abstract]
Gross rental expense	$ 333
Sublease rental income	(16)
Rent expense, net	$ 317

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating Cash Flows for Operating Leases	$ 268	$ 267	$ 0
Operating Cash Flows for Finance Leases	21	21
Financing Cash Flows for Finance Leases	7	7
ROU Assets Obtained in Exchange for Lease Obligations
Operating Leases	202	197
Finance Leases	$ 3	$ 34

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Operating Leases
Operating Lease ROU Assets	$ 851	$ 855
Operating Lease Liabilities due Within One Year	198	199
Operating Lease Liabilities	684	668
Total Operating Lease Liabilities	882	867
Finance Leases
Property, Plant and Equipment, at cost	262	259
Accumulated Depreciation	(60)	(50)
Property, Plant and Equipment, net	202	209
Long Term Debt and Finance Leases due Within One Year	18	6
Long Term Debt and Finance Leases	232	243
Total Finance Lease Liabilities	$ 250	$ 249
Weighted Average Remaining Lease Term
Operating Leases	7 years 3 months 18 days	7 years 2 months 12 days
Finance Leases	30 years 10 months 24 days	31 years 7 months 6 days
Weighted Average Discount Rate
Operating Leases	6.85%	6.69%
Finance Leases	8.48%	8.46%

Leases - Future Maturities of L

Leases - Future Maturities of Lease Liabilities - ASC 842 (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Operating Leases
2021	$ 245
2022	186
2023	146
2024	110
2025	88
Thereafter	376
Total Lease Payments	1,151
Less: Imputed Interest	269
Total Operating Lease Liabilities	882	$ 867
Finance Leases
2021	38
2022	23
2023	21
2024	21
2025	22
Thereafter	671
Total Lease Payments	796
Less: Imputed Interest	546
Total Finance Lease Liabilities	$ 250	$ 249

Leases - Additional Information

Leases - Additional Information (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Operating Leased Assets [Line Items]
Lease not yet commenced, amount	$ 23
Operating and finance lease commencement year	2021
Operating and finance lease commencement year	2022
Minimum
Operating Leased Assets [Line Items]
Operating and finance lease, term of contract	7 years
Maximum
Operating Leased Assets [Line Items]
Operating and finance lease, term of contract	15 years

Financing Arrangements and De_3

Financing Arrangements and Derivative Financial Instruments - Other Narrative (Details) $ in Millions	Dec. 31, 2020USD ($)
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 9,707
Credit arrangements, unused amount	$ 3,881
Debt, percentage bearing variable interest	24.00%
Long-term Debt
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 8,632
Credit arrangements, unused amount	3,242
Short-term Debt
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	1,075
Credit arrangements, unused amount	$ 639
Variable Rate Credit Arrangements
Debt Instrument [Line Items]
Interest rate	2.79%

Financing Arrangements and De_4

Financing Arrangements and Derivative Financial Instruments - Long Term Debt and Finance Leases Due Within One Year (Details) - USD ($) $ in Millions	Dec. 31, 2020	Aug. 16, 2020	Dec. 31, 2019
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Notes payable and overdrafts	$ 406		$ 348
Long term debt and finance leases due within one year	152		562
Total obligations due within one year	558		910
Other Foreign and Domestic Debt
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Long term debt and finance leases due within one year	$ 139		$ 187
Weighted average interest rate	3.22%		4.02%
Long Term Debt And Capital Leases, Current
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Weighted average interest rate	3.87%		6.58%
Chinese credit facilities | Foreign Line of Credit | Line of Credit
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Notes payable and overdrafts	$ 163		$ 118
Long term debt and finance leases due within one year	$ 13		$ 95
Weighted average interest rate	4.49%		4.87%
8.75% Due 2020 | Senior Notes
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Long term debt and finance leases due within one year			$ 280
Interest rate, stated percentage	8.75%	8.75%	8.75%
Line of Credit | Chinese credit facilities | Foreign Line of Credit
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Notes payable and overdrafts	$ 163		$ 118
Other Foreign and Domestic Debt
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Notes payable and overdrafts	$ 243		$ 230
Notes Payable and Overdrafts
Notes Payable, Overdrafts, Long-term Debt and Capital Leases Due Within One Year
Weighted average interest rate	4.52%		4.92%

Financing Arrangements and De_5

Financing Arrangements and Derivative Financial Instruments - Long Term Debt and Finance Leases, Net of Unamortized Discounts, and Interest Rates (Details) - USD ($) $ in Millions	Dec. 31, 2020	Aug. 16, 2020	May 18, 2020	Dec. 31, 2019
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 5,366			$ 5,094
Unamortized deferred financing fees	(32)			(28)
Total long term debt excluding capital leases	5,334			5,066
Finance lease obligations	250			249
Long-term debt and capital leases	5,584			5,315
Less portion due within one year	(152)			(562)
Long-term debt and capital leases, excluding current maturities	5,432			4,753
Other Foreign and Domestic Debt
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	451			661
Less portion due within one year	$ (139)			$ (187)
Interest rate	3.22%			4.02%
8.75% Due 2020 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 0	$ 282		$ 280
Less portion due within one year				$ (280)
Interest rate, stated percentage	8.75%	8.75%		8.75%
5.125% due 2023 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 1,000			$ 1,000
Interest rate, stated percentage	5.125%			5.125%
3.75% Euro Notes due 2023 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	3.75%
3.75% Euro Notes due 2023 | Euro Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 307			$ 281
Interest rate, stated percentage	3.75%			3.75%
9.5% due 2025 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 803			$ 0
Interest rate, stated percentage	9.50%		9.50%	9.50%
5% due 2026 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 900			$ 900
Interest rate, stated percentage	5.00%			5.00%
4.875% due 2027 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 700			$ 700
Interest rate, stated percentage	4.875%			4.875%
7% due 2028 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 150			$ 150
Interest rate, stated percentage	7.00%			7.00%
First lien revolving credit facility due 2025 | Revolving Credit Facility | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 0			$ 0
Interest rate	0.00%			0.00%
Second lien term loan facility due 2025 | Senior Notes | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 400			$ 400
Interest rate	2.15%			3.97%
European revolving credit facility due 2024 | Revolving Credit Facility | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 0			$ 0
Interest rate	0.00%			0.00%
Pan-European accounts receivable facility | Senior Notes | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 291			$ 327
Interest rate	1.18%			0.98%
Mexican credit facilities | Foreign Line of Credit | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 152			$ 200
Interest rate	1.87%			3.44%
Chinese credit facilities | Foreign Line of Credit | Line of Credit
Long-term Debt and Lease Obligation [Abstract]
Long-term debt, before deferred financing fees	$ 212			$ 195
Less portion due within one year	$ (13)			$ (95)
Interest rate	4.49%			4.87%

Financing Arrangements and De_6

Financing Arrangements and Derivative Financial Instruments - Long Term Debt and Finance Leases, Net of Unamortized Discounts, and Interest Rates (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Aug. 16, 2020	May 18, 2020	Dec. 31, 2019
Long-term Debt and Lease Obligation [Abstract]
Non-cash financing additions	$ 3
8.75% Due 2020 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	8.75%	8.75%		8.75%
5.125% due 2023 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	5.125%			5.125%
3.75% Euro Notes due 2023 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	3.75%
3.75% Euro Notes due 2023 | Euro Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	3.75%			3.75%
9.5% due 2025 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	9.50%		9.50%	9.50%
5% due 2026 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	5.00%			5.00%
4.875% due 2027 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	4.875%			4.875%
7% due 2028 | Senior Notes
Long-term Debt and Lease Obligation [Abstract]
Interest rate, stated percentage	7.00%			7.00%

Financing Arrangements and De_7

Financing Arrangements and Derivative Financial Instruments - Notes Narrative (Details)	Aug. 17, 2020USD ($)	May 18, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2020EUR (€)	Aug. 16, 2020USD ($)	May 22, 2020USD ($)
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 5,366,000,000	$ 5,094,000,000
Repayments of long-term debt			6,059,000,000	6,008,000,000	$ 6,469,000,000
8.75% Due 2020 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 0	$ 280,000,000			$ 282,000,000
Interest rate, stated percentage			8.75%	8.75%		8.75%	8.75%
Repayments of long-term debt	$ 282,000,000
5.125% due 2023 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 1,000,000,000	$ 1,000,000,000
Interest rate, stated percentage			5.125%	5.125%		5.125%
Debt instrument, principal amount			$ 1,000,000,000
Notes sold, percentage of principle amount			100.00%			100.00%
Debt instrument, maturity date			Nov. 15, 2023
Debt instrument, redemption price			100.00%
3.75% Euro Notes due 2023 | Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage			3.75%			3.75%
Debt instrument, principal amount | €						€ 250,000,000
Notes sold, percentage of principle amount			100.00%			100.00%
Debt instrument, maturity date			Dec. 15, 2023
Debt instrument, redemption price			100.00%
9.5% due 2025 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 803,000,000	$ 0
Interest rate, stated percentage		9.50%	9.50%	9.50%		9.50%
Debt instrument, principal amount		$ 600,000,000	$ 800,000,000					$ 200,000,000
Notes sold, percentage of principle amount		100.00%						101.75%
Debt instrument, maturity date		May 31, 2025
Effective yield								9.056%
Debt redemption, potential percentage of principal amount from equity offerings			35.00%
Debt redemption, redemption price from equity offerings			109.50%
9.5% due 2025 | Senior Notes | Period Commencing May 31, 2022
Debt Instrument [Line Items]
Debt instrument, redemption price			104.75%
9.5% due 2025 | Senior Notes | Period Commencing May 31, 2023
Debt Instrument [Line Items]
Debt instrument, redemption price			102.375%
9.5% due 2025 | Senior Notes | Period Commencing May 31, 2024
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
9.5% due 2025 | Senior Notes | Period Prior to May 31, 2022
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
5% due 2026 | Period Commencing May 31, 2022
Debt Instrument [Line Items]
Debt instrument, redemption price			101.667%
5% due 2026 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 900,000,000	$ 900,000,000
Interest rate, stated percentage			5.00%	5.00%		5.00%
Debt instrument, principal amount			$ 900,000,000
Notes sold, percentage of principle amount			100.00%			100.00%
Debt instrument, maturity date			May 31, 2026
5% due 2026 | Senior Notes | Period Commencing May 31, 2023
Debt Instrument [Line Items]
Debt instrument, redemption price			100.833%
5% due 2026 | Senior Notes | Period Commencing May 31, 2024
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
5% due 2026 | Senior Notes | Period Commencing May 31, 2021
Debt Instrument [Line Items]
Debt instrument, redemption price			102.50%
5% due 2026 | Senior Notes | Period Prior to May 31, 2021
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
4.875% due 2027 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 700,000,000	$ 700,000,000
Interest rate, stated percentage			4.875%	4.875%		4.875%
Debt instrument, principal amount			$ 700,000,000
Notes sold, percentage of principle amount			100.00%			100.00%
Debt instrument, maturity date			Mar. 15, 2027
Basis spread			0.50%
4.875% due 2027 | Senior Notes | Debt Instrument, Redemption, Prior to December 15, 2026
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
4.875% due 2027 | Senior Notes | Debt Instrument, Redemption, After December 15, 2026
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%
7% due 2028 | Senior Notes
Debt Instrument [Line Items]
Long-term debt, before deferred financing fees			$ 150,000,000	$ 150,000,000
Interest rate, stated percentage			7.00%	7.00%		7.00%
Debt instrument, principal amount			$ 150,000,000
Debt instrument, maturity date			Mar. 15, 2028
Basis spread			0.15%
7% due 2028 | Senior Notes | Debt Instrument, Redemption, Prior to December 15, 2026
Debt Instrument [Line Items]
Debt instrument, redemption price			100.00%

Financing Arrangements and De_8

Financing Arrangements and Derivative Financial Instruments - Credit Facilities Narrative (Details)	Apr. 09, 2020USD ($)	Mar. 27, 2019EUR (€)	Dec. 31, 2020USD ($)	Oct. 18, 2021EUR (€)	Dec. 31, 2020EUR (€)	Oct. 15, 2020EUR (€)	Dec. 31, 2019USD ($)	Dec. 31, 2019EUR (€)
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 9,707,000,000
Notes payable and overdrafts			406,000,000				$ 348,000,000
Long term debt and finance leases due within one year			152,000,000				562,000,000
Credit arrangements, unused amount			3,881,000,000
Accounts Receivable Factoring Facilities | Secured Debt
Line Of Credit Facility [Line Items]
Off-balance sheet accounts receivable securitization			451,000,000				548,000,000
Chinese credit facilities | Secured Debt
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			981,000,000				735,000,000
Line of credit facility, amount outstanding			375,000,000				313,000,000
Credit arrangements, unused amount			99,000,000				106,000,000
Line of Credit | First lien revolving credit facility due 2025
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity	$ 2,000,000,000
Increase in value of principal trademarks			400,000,000
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			2,000,000,000
Increase in value of principal trademarks	$ 100,000,000
Commitment fee percentage	0.25%
Basis spread	0.50%
Line of credit facility, additional borrowing capacity which may be requested from lenders			250,000,000
Line of credit facility, maximum borrowing capacity inputs, increase based on value of cash			200,000,000
Line of credit facility, borrowing base amount below stated amount			454,000,000
Amount of availability under the facility plus available cash, less than			$ 200,000,000
Minimum EBITDA ratio permitted in four consecutive quarters if below available cash threshold			2
Available cash plus availability under facility			$ 750,000,000
Line of credit facility, amount outstanding			0				0
Letters of credit, amount outstanding			$ 11,000,000				37,000,000
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Basis spread	1.75%		1.75%
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum
Line Of Credit Facility [Line Items]
Basis spread on reference rate			1.00%
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum
Line Of Credit Facility [Line Items]
Basis spread			2.00%
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | Base Rate | Minimum
Line Of Credit Facility [Line Items]
Basis spread			0.75%
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | Base Rate | Maximum
Line Of Credit Facility [Line Items]
Basis spread			1.00%
Line of Credit | First lien revolving credit facility due 2025 | Revolving Credit Facility | Overnight Bank Funding Rate
Line Of Credit Facility [Line Items]
Basis spread on reference rate			0.50%
Line of Credit | First lien revolving credit facility due 2025 | Letter of Credit
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 800,000,000
Line of Credit | First lien revolving credit facility due 2025 | Bridge Loan
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 50,000,000
Line of Credit | First lien revolving credit facility due 2021
Line Of Credit Facility [Line Items]
Maximum percentage of voting equity interest In foreign subsidiaries to guarantee debt obligation			65.00%		65.00%
Line of Credit | Second lien term loan facility due 2025 | Secured Debt
Line Of Credit Facility [Line Items]
Required total leverage ratio			1.25		1.25
Optional reduction of basis spreads			0.25%
Long-term debt, before deferred financing fees			$ 400,000,000				400,000,000
Line of Credit | Second lien term loan facility due 2025 | Secured Debt | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Basis spread			2.00%
Basis spread on reference rate			1.00%
Line of Credit | Second lien term loan facility due 2025 | Secured Debt | Base Rate
Line Of Credit Facility [Line Items]
Basis spread			1.00%
Line of Credit | Second lien term loan facility due 2025 | Secured Debt | Federal Funds Rate
Line Of Credit Facility [Line Items]
Basis spread on reference rate			0.50%
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | Revolving Credit Facility
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €		€ 800,000,000
Line of credit facility, amount outstanding			$ 0				0
Annual commitment fee percentage on undrawn amounts		0.25%
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Basis spread		1.50%
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | Revolving Credit Facility | European Interbank Offer Rate (Euribor)
Line Of Credit Facility [Line Items]
Basis spread		1.50%
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | Letter of Credit
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €		€ 75,000,000
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | Bridge Loan
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €		175,000,000
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | German Tranche
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €		180,000,000
Line of Credit | Amended and Restated Senior Secured European Revolving Credit Facility | All-Borrower Tranche
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €		€ 620,000,000
Line of Credit | Pan-European Accounts Receivable Facility | Secured Debt
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €						€ 320,000,000
Line of credit facility, current borrowing capacity			291,000,000		€ 237,000,000		327,000,000	€ 291,000,000
Line of Credit | Pan-European Accounts Receivable Facility | Secured Debt | Scenario Forecast
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €				€ 280,000,000
Line of Credit | Pan-European Accounts Receivable Facility | Secured Debt | Minimum
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €					30,000,000
Line of Credit | Pan-European Accounts Receivable Facility | Secured Debt | Maximum
Line Of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity | €					€ 450,000,000
Line of Credit | Mexican Credit Facilities | Foreign Line of Credit
Line Of Credit Facility [Line Items]
Line of credit facility, current borrowing capacity			200,000,000				200,000,000
Amount utilized under facility			152,000,000
Line of Credit | Chinese credit facilities | Foreign Line of Credit
Line Of Credit Facility [Line Items]
Long-term debt, before deferred financing fees			212,000,000				195,000,000
Notes payable and overdrafts			163,000,000				118,000,000
Long term debt and finance leases due within one year			$ 13,000,000				$ 95,000,000

Financing Arrangements and De_9

Financing Arrangements and Derivative Financial Instruments - Maturities of Long-term Debt and Finance Leases (Details) $ in Millions	Dec. 31, 2020USD ($)
Debt and Capital Lease Annual Maturities
2021	$ 556
2022	475
2023	1,698
2024	88
2025	1,218
United States
Debt and Capital Lease Annual Maturities
2021	1
2022	151
2023	999
2024	0
2025	1,199
Foreign
Debt and Capital Lease Annual Maturities
2021	555
2022	324
2023	699
2024	88
2025	$ 19

Financing Arrangements and D_10

Financing Arrangements and Derivative Financial Instruments - Fair Values for Foreign Currency Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Not Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 1,664	$ 1,707
Foreign currency derivatives, net transaction gains (losses)	(87)	22
Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	50	365
Accounts receivable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - asset, not designated as hedging instrument	1	1
Fair value - asset, designated as hedging instrument	0	9
Other Current Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - liability, not designated as hedging instrument	(27)	(15)
Fair value - liability, designated as hedging instrument	(7)	(3)
Other Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - asset, designated as hedging instrument	0	1
Other Long Term Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value - liability, designated as hedging instrument	$ 0	$ (1)

Financing Arrangements and D_11

Financing Arrangements and Derivative Financial Instruments - Classification of Changes in Fair Values of Foreign Currency Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Cash flow hedge gain (loss) to be reclassified within twelve months	$ 2
Foreign Exchange Contract
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Amount of gains (losses) deferred to AOCL	15	$ 10	$ 9
Foreign Exchange Contract | Cost of Goods Sold
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Reclassification adjustment for amounts recognized in CGS	$ (13)	$ (14)	$ 7

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Assets:
Investments	$ 11	$ 11
Foreign Exchange Contracts	1	11
Total Assets at Fair Value	12	22
Liabilities:
Foreign Exchange Contracts	34	19
Total Liabilities at Fair Value	34	19
Supplemental Fair Value Information
Carrying amount — liability	5,334	5,066
Notes Payable and Overdrafts	406	348
Fixed Rate Debt, Excluding Capital Leases
Supplemental Fair Value Information
Carrying amount — liability	4,094	3,434
Fair value — liability	4,283	3,558
Notes Payable and Overdrafts	227	143
Variable Rate Debt, Excluding Capital Leases
Supplemental Fair Value Information
Carrying amount — liability	1,240	1,632
Fair value — liability	1,197	1,632
Notes Payable and Overdrafts	179	205
Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)
Assets:
Investments	11	11
Foreign Exchange Contracts	0	0
Total Assets at Fair Value	11	11
Liabilities:
Foreign Exchange Contracts	0	0
Total Liabilities at Fair Value	0	0
Supplemental Fair Value Information
Fair value — liability	4,391	3,808
Significant Other Observable Inputs (Level 2)
Assets:
Investments	0	0
Foreign Exchange Contracts	1	11
Total Assets at Fair Value	1	11
Liabilities:
Foreign Exchange Contracts	34	19
Total Liabilities at Fair Value	34	19
Significant Unobservable Inputs (Level 3)
Assets:
Investments	0	0
Foreign Exchange Contracts	0	0
Total Assets at Fair Value	0	0
Liabilities:
Foreign Exchange Contracts	0	0
Total Liabilities at Fair Value	$ 0	$ 0

Pension, Other Postretirement_3

Pension, Other Postretirement Benefits and Savings Plans - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]
Weighted average discount rate	1.70%	2.30%
Defined contribution plans, contribution expenses	$ 100	$ 110	$ 111
Maximum
Defined Benefit Plan Disclosure [Line Items]
Expected contribution to funded non-U.S. pension plans in next year	50
Minimum
Defined Benefit Plan Disclosure [Line Items]
Expected contribution to funded non-U.S. pension plans in next year	25
United States
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 5,220	4,994
United States | Private Equity and Private Credit Securities
Defined Benefit Plan Disclosure [Line Items]
Target asset allocation	6.00%
United States | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target asset allocation	94.00%
Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 3,284	3,097
Non-U.S. | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Target asset allocation	95.00%
Non-U.S. | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Target asset allocation	5.00%
Non-U.S. | Unfunded Plan
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 264	247
Pension benefit obligation	299	277
AOCL adjustment	90	82
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Settlement charges	28
Curtailment credit (charge) and special termination benefits		5
Settlement payments	56	15
Service cost	4	3	4
Benefits cost	77	73	$ 62
Postretirement benefits funded status	$ 265	$ 229
Weighted average discount rate	2.66%	3.85%	3.09%
Assumed weighted average long term rate of return	4.22%	5.25%	4.58%
Pension benefit obligation	$ 5,235	$ 5,009	$ 4,734
AOCL adjustment	2,350	2,377
Pension Plan | United States | Other (Income) Expense
Defined Benefit Plan Disclosure [Line Items]
Settlement charges	24	6	8
Pension Plan | United States | Rationalizations
Defined Benefit Plan Disclosure [Line Items]
Settlement charges	4
Pension Plan | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Settlement payments	8	5
Service cost	30	26	28
Increase (decrease) for plan amendment	3	(2)
Benefits cost	67	70	$ 69
Postretirement benefits funded status	$ 341	$ 455
Weighted average discount rate	2.26%	2.84%	2.56%
Assumed weighted average long term rate of return	2.52%	2.95%	3.02%
Pension benefit obligation	$ 3,382	$ 3,195	$ 2,774
AOCL adjustment	661	807
Pension Plan | Non-U.S. | Other (Income) Expense
Defined Benefit Plan Disclosure [Line Items]
Curtailment credit (charge)	6
Pension Plan | United Kingdom
Defined Benefit Plan Disclosure [Line Items]
Settlement charges			13
Service cost			16
Pension Plan | United Kingdom | Other (Income) Expense
Defined Benefit Plan Disclosure [Line Items]
Settlement payments			103
Pension Plan | BRAZIL
Defined Benefit Plan Disclosure [Line Items]
Increase (decrease) for plan amendment			16
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	2	2	3
Benefits cost	1	7	11
Prescription drug subsidy (less than)	1
Postretirement benefits funded status	236	241
Pension benefit obligation	236	241	234
AOCL adjustment	23	7
Other Postretirement Benefits | United States
Defined Benefit Plan Disclosure [Line Items]
Curtailment credit (charge)	4
Termination benefit charge	5
Benefits cost	1	3	$ 4
Postretirement benefits funded status	$ 106	$ 106
Weighted average discount rate	2.68%	3.79%	2.99%
Other Postretirement Benefits | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Benefits cost	$ 0	$ 4	$ 7
Postretirement benefits funded status	$ 130	$ 135
Weighted average discount rate	5.68%	6.25%	6.13%
Other Postretirement Benefits | BRAZIL
Defined Benefit Plan Disclosure [Line Items]
Increase (decrease) for plan amendment			$ (14)

Pension, Other Postretirement_4

Pension, Other Postretirement Benefits and Savings Plans - Benefit Costs and Amounts Recognized in Other Comprehensive (Income) Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other Postretirement Benefits
Benefits cost (credit):
Service cost	$ 2	$ 2	$ 3
Interest cost	8	11	12
Amortization of prior service cost (credit)	(9)	(9)	(8)
Amortization of net losses	4	3	4
Net periodic cost	5	7	11
Net curtailments/settlements /termination benefits	(4)
Total benefits cost	1	7	11
Recognized in other comprehensive (income) loss before tax and minority:
Prior service cost (credit) from plan amendments			(16)
Increase (decrease) in net actuarial losses	5	6	(14)
Amortization of prior service (cost) credit in net periodic cost	9	9	8
Amortization of net losses in net periodic cost	(4)	(3)	(5)
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures	6	2
Total recognized in other comprehensive (income) loss before tax and minority	16	14	(27)
Total recognized in total benefits cost and other comprehensive (income) loss before tax and minority	17	21	(16)
United States | Pension Plan
Benefits cost (credit):
Service cost	4	3	4
Interest cost	126	173	157
Expected return on plan assets	(193)	(223)	(219)
Amortization of net losses	109	112	112
Net periodic cost	46	65	54
Net curtailments/settlements /termination benefits	31	8	8
Total benefits cost	77	73	62
Recognized in other comprehensive (income) loss before tax and minority:
Increase (decrease) in net actuarial losses	108	4	14
Amortization of net losses in net periodic cost	(109)	(112)	(112)
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures	(26)	(5)	(11)
Total recognized in other comprehensive (income) loss before tax and minority	(27)	(113)	(109)
Total recognized in total benefits cost and other comprehensive (income) loss before tax and minority	50	(40)	(47)
United States | Other Postretirement Benefits
Benefits cost (credit):
Total benefits cost	1	3	4
Non-U.S. | Pension Plan
Benefits cost (credit):
Service cost	30	26	28
Interest cost	56	69	69
Expected return on plan assets	(54)	(59)	(70)
Amortization of prior service cost (credit)	1	2
Amortization of net losses	38	29	29
Net periodic cost	71	67	56
Net curtailments/settlements /termination benefits	(4)	3	13
Total benefits cost	67	70	69
Recognized in other comprehensive (income) loss before tax and minority:
Prior service cost (credit) from plan amendments	3	(2)	31
Increase (decrease) in net actuarial losses	(100)	201	(18)
Amortization of prior service (cost) credit in net periodic cost	(2)	(2)
Amortization of net losses in net periodic cost	(38)	(29)	(30)
Immediate recognition of prior service cost and unrecognized gains and losses due to curtailments, settlements, and divestitures	(9)	(3)	(14)
Total recognized in other comprehensive (income) loss before tax and minority	(146)	165	(31)
Total recognized in total benefits cost and other comprehensive (income) loss before tax and minority	(79)	235	38
Non-U.S. | Other Postretirement Benefits
Benefits cost (credit):
Total benefits cost	$ 0	$ 4	$ 7

Pension, Other Postretirement_5

Pension, Other Postretirement Benefits and Savings Plans - Changes in Benefit Obligation and Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Change in benefit obligation:
Curtailments/settlements/termination benefits	$ 18	$ 6	$ 22
United States
Change in plan assets:
Beginning balance	4,780
Ending balance	4,970	4,780
Non-U.S.
Change in plan assets:
Beginning balance	370
Ending balance	185	370
Pension Plan | United States
Change in benefit obligation:
Beginning balance	(5,009)	(4,734)
Service cost — benefits earned	(4)	(3)	(4)
Interest cost	(126)	(173)	(157)
Actuarial loss	(520)	(477)
Curtailments/settlements/termination benefits	51	12
Benefit payments	373	366
Ending balance	(5,235)	(5,009)	(4,734)
Change in plan assets:
Beginning balance	4,780	4,445
Actual return on plan assets	605	696
Cash funding of direct participant payments	14	20
Settlements	(56)	(15)
Benefit payments	(373)	(366)
Ending balance	4,970	4,780	4,445
Funded status at end of year	(265)	(229)
Pension Plan | Non-U.S.
Change in benefit obligation:
Beginning balance	(3,195)	(2,774)
Newly adopted plans		(19)
Service cost — benefits earned	(30)	(26)	(28)
Interest cost	(56)	(69)	(69)
Plan amendments	(3)	2
Actuarial loss	(123)	(381)
Participant contributions	(3)	(2)
Curtailments/settlements/termination benefits	21	5
Foreign currency translation	(133)	(62)
Benefit payments	140	131
Ending balance	(3,382)	(3,195)	(2,774)
Change in plan assets:
Beginning balance	2,740	2,464
Newly adopted plans		19
Actual return on plan assets	305	252
Company contributions to plan assets	20	39
Cash funding of direct participant payments	22	20
Participant contributions	3	2
Settlements	(8)	(5)
Foreign currency translation	99	80
Benefit payments	(140)	(131)
Ending balance	3,041	2,740	2,464
Funded status at end of year	(341)	(455)
Other Postretirement Benefits
Change in benefit obligation:
Beginning balance	(241)	(234)
Service cost — benefits earned	(2)	(2)	(3)
Interest cost	(8)	(11)	(12)
Actuarial loss	(4)	(6)
Participant contributions	(8)	(12)
Curtailments/settlements/termination benefits		(2)
Foreign currency translation	4	(5)
Benefit payments	23	31
Ending balance	(236)	(241)	(234)
Change in plan assets:
Beginning balance		3
Cash funding of direct participant payments	15	16
Participant contributions	8	12
Benefit payments	(23)	(31)
Ending balance			$ 3
Funded status at end of year	(236)	(241)
Other Postretirement Benefits | United States
Change in plan assets:
Funded status at end of year	(106)	(106)
Other Postretirement Benefits | Non-U.S.
Change in plan assets:
Funded status at end of year	$ (130)	$ (135)

Pension, Other Postretirement_6

Pension, Other Postretirement Benefits and Savings Plans - Funded Status Recognized in the Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Noncurrent liabilities	$ (1,470)	$ (1,334)
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Current liabilities	(11)	(16)
Noncurrent liabilities	(254)	(213)
Net amount recognized	(265)	(229)
Pension Plan | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Noncurrent assets	408	237
Current liabilities	(22)	(20)
Noncurrent liabilities	(727)	(672)
Net amount recognized	(341)	(455)
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Current liabilities	(16)	(16)
Noncurrent liabilities	(220)	(225)
Net amount recognized	$ (236)	$ (241)

Pension, Other Postretirement_7

Pension, Other Postretirement Benefits and Savings Plans - Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	$ (3)	$ (3)
Net actuarial loss	2,353	2,380
Gross amount recognized	2,350	2,377
Deferred income taxes	(43)	(50)
Net amount recognized	2,307	2,327
Pension Plan | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	25	25
Net actuarial loss	636	782
Gross amount recognized	661	807
Deferred income taxes	(104)	(135)
Minority shareholders’ equity	(2)	(1)
Net amount recognized	555	671
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Prior service (credit) cost	(7)	(23)
Net actuarial loss	30	30
Gross amount recognized	23	7
Deferred income taxes	(29)	(22)
Net amount recognized	$ (6)	$ (15)

Pension, Other Postretirement_8

Pension, Other Postretirement Benefits and Savings Plans - Weighted Average Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Pension Plan | United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate, benefit obligations	2.42%	3.22%
Discount rate for determining interest costs, benefit costs	2.66%	3.85%	3.09%
Expected long term return on plan assets, benefit costs	4.22%	5.25%	4.58%
Pension Plan | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate, benefit obligations	1.49%	1.98%
Rate of compensation increase, benefit obligations	2.89%	2.92%
Discount rate for determining interest costs, benefit costs	2.26%	2.84%	2.56%
Expected long term return on plan assets, benefit costs	2.52%	2.95%	3.02%
Rate of compensation increase, benefit cost	2.92%	2.91%	2.91%
Other Postretirement Benefits | United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate, benefit obligations	2.34%	3.14%
Discount rate for determining interest costs, benefit costs	2.68%	3.79%	2.99%
Other Postretirement Benefits | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate, benefit obligations	4.09%	4.39%
Discount rate for determining interest costs, benefit costs	5.68%	6.25%	6.13%

Pension, Other Postretirement_9

Pension, Other Postretirement Benefits and Savings Plans - Estimated Future Benefit Payments (Details) $ in Millions	Dec. 31, 2020USD ($)
Pension Plan | United States
Without Medicare Part D Subsidy, Fiscal Year Maturity
2021	$ 417
2022	390
2023	366
2024	352
2025	339
2026-2030	1,578
Pension Plan | Non-U.S.
Without Medicare Part D Subsidy, Fiscal Year Maturity
2021	136
2022	129
2023	130
2024	137
2025	138
2026-2030	743
Other Postretirement Benefits
Without Medicare Part D Subsidy, Fiscal Year Maturity
2021	16
2022	16
2023	15
2024	15
2025	14
2026-2030	$ 68

Pension, Other Postretiremen_10

Pension, Other Postretirement Benefits and Savings Plans - Selected Pension Plan Information (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
United States
All plans:
Accumulated benefit obligation	$ 5,220	$ 4,994
Plans not fully-funded:
Projected benefit obligation	5,235	5,009
Accumulated benefit obligation	5,220	4,994
Fair value of plan assets	4,970	4,780
Non-U.S.
All plans:
Accumulated benefit obligation	3,284	3,097
Plans not fully-funded:
Projected benefit obligation	933	1,059
Accumulated benefit obligation	856	991
Fair value of plan assets	$ 185	$ 370

Pension, Other Postretiremen_11

Pension, Other Postretirement Benefits and Savings Plans - Health Care Cost Trends (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Compensation And Retirement Disclosure [Abstract]
Health care cost trend rate assumed for the next year	6.00%	6.30%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5.00%	5.00%
Year that the rate reaches the ultimate trend rate	2025	2025

Pension, Other Postretiremen_12

Pension, Other Postretirement Benefits and Savings Plans - Pension Plan Weighted Average Investment Allocation (Details)	Dec. 31, 2020	Dec. 31, 2019
United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	100.00%	100.00%
Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	100.00%	100.00%
Cash and short term securities | United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	3.00%	2.00%
Cash and short term securities | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	2.00%	1.00%
Equity securities | United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	4.00%	6.00%
Equity securities | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	4.00%	3.00%
Debt securities | United States
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	93.00%	92.00%
Debt securities | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	93.00%	96.00%
Alternatives | Non-U.S.
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension plan weighted average investment allocation	1.00%

Pension, Other Postretiremen_13

Pension, Other Postretirement Benefits and Savings Plans - Fair Values of Pension Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	$ 4,970	$ 4,780
Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	185	370
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	4,970	4,780	$ 4,445
Pension Plan | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	3,041	2,740	2,464
Pension Plan | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	4,292	4,031
Pension Plan | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,327	2,159
Pension Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	122	47
Pension Plan | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	194	178
Pension Plan | Significant Unobservable Inputs (Level 3) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	3	4
Pension Plan | Significant Unobservable Inputs (Level 3) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	29	23
Pension Plan | Significant Other Observable Inputs (Level 2) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	4,167	3,980
Pension Plan | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,104	1,958
Pension Plan | Cash and short term securities | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	122	47
Pension Plan | Cash and short term securities | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	46	33
Pension Plan | Cash and short term securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	122	47
Pension Plan | Cash and short term securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	42	29
Pension Plan | Cash and short term securities | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	4	4
Pension Plan | Equity Securities, Common and Preferred Stock | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	24	24
Pension Plan | Equity Securities, Common and Preferred Stock | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	24	24
Pension Plan | Equity Securities, Commingled Funds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	19	36
Pension Plan | Equity Securities, Commingled Funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	19	36
Pension Plan | Equity Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	23	9
Pension Plan | Equity Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	62	69
Pension Plan | Equity Securities, Mutual Funds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	6	5
Pension Plan | Equity Securities, Mutual Funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	6	5
Pension Plan | Equity Securities, Mutual Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	4	11
Pension Plan | Debt Securities, Corporate Bonds | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,843	2,577
Pension Plan | Debt Securities, Corporate Bonds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	230	190
Pension Plan | Debt Securities, Corporate Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	24	10
Pension Plan | Debt Securities, Corporate Bonds | Significant Unobservable Inputs (Level 3) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	1	1
Pension Plan | Debt Securities, Corporate Bonds | Significant Other Observable Inputs (Level 2) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,842	2,576
Pension Plan | Debt Securities, Corporate Bonds | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	206	180
Pension Plan | Debt Securities, Government Bonds | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	1,038	1,120
Pension Plan | Debt Securities, Government Bonds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,503	2,271
Pension Plan | Debt Securities, Government Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	42	60
Pension Plan | Debt Securities, Government Bonds | Significant Other Observable Inputs (Level 2) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	1,038	1,120
Pension Plan | Debt Securities, Government Bonds | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2,461	2,211
Pension Plan | Debt Securities, Repurchase Agreements | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	(650)	(511)
Pension Plan | Debt Securities, Repurchase Agreements | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	(650)	(511)
Pension Plan | Debt Securities, Asset-backed Securities | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	280	283
Pension Plan | Debt Securities, Asset-backed Securities | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	76	74
Pension Plan | Debt Securities, Asset-backed Securities | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	8	5
Pension Plan | Debt Securities, Asset-backed Securities | Significant Unobservable Inputs (Level 3) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value		1
Pension Plan | Debt Securities, Asset-backed Securities | Significant Other Observable Inputs (Level 2) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	280	282
Pension Plan | Debt Securities, Asset-backed Securities | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	68	69
Pension Plan | Debt Securities, Commingled Funds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	20
Pension Plan | Debt Securities, Commingled Funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	20
Pension Plan | Debt Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	295	310
Pension Plan | Debt Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	665	604
Pension Plan | Debt Securities, Mutual Funds | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	19	19
Pension Plan | Debt Securities, Mutual Funds | Quoted Prices in Active Markets for Identical Assets (Level 1) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	9	9
Pension Plan | Debt Securities, Mutual Funds | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	10	10
Pension Plan | Debt Securities, Mutual Funds | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	148	141
Pension Plan | Debt Securities, Mutual Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	81	7
Pension Plan | Alternatives, Insurance Contracts | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2	2
Pension Plan | Alternatives, Insurance Contracts | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	28	22
Pension Plan | Alternatives, Insurance Contracts | Significant Unobservable Inputs (Level 3) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	2	2
Pension Plan | Alternatives, Insurance Contracts | Significant Unobservable Inputs (Level 3) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	28	22	$ 19
Pension Plan | Alternatives, Other Investments | Fair Value, Inputs, Level 1, 2 and 3 | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	7	2
Pension Plan | Alternatives, Other Investments | Fair Value, Inputs, Level 1, 2 and 3 | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	6	(4)
Pension Plan | Alternatives, Other Investments | Significant Unobservable Inputs (Level 3) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	1	1
Pension Plan | Alternatives, Other Investments | Significant Other Observable Inputs (Level 2) | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	7	2
Pension Plan | Alternatives, Other Investments | Significant Other Observable Inputs (Level 2) | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	5	(5)
Pension Plan | Equity Securities, Partnership Interests | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	166	267
Pension Plan | Debt Securities, Partnership Interests | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	102
Pension Plan | Short Term Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	22	67
Pension Plan | Short Term Securities, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	3	4
Pension Plan | Alternatives, Commingled Funds | Fair Value Measured at Net Asset Value Per Share | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	6	6
Pension Plan | Investments Before Other Plan Assets | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	5,048	4,825
Pension Plan | Investments Before Other Plan Assets | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	3,148	2,860
Pension Plan | Other Assets | United States
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	(78)	(45)
Pension Plan | Other Assets | Non-U.S.
Defined Benefit Plan Disclosure [Line Items]
Total plan assets, fair value	$ (107)	$ (120)

Pension, Other Postretiremen_14

Pension, Other Postretirement Benefits and Savings Plans - Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts (Details) - Non-U.S. - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan, Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts Classified as Level 3
Beginning balance	$ 370
Ending balance	185	$ 370
Pension Plan
Defined Benefit Plan, Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts Classified as Level 3
Beginning balance	2,740	2,464
Foreign currency translation	99	80
Ending balance	3,041	2,740
Pension Plan | Significant Other Unobservable Inputs (Level 3)
Defined Benefit Plan, Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts Classified as Level 3
Beginning balance	23
Ending balance	29	23
Pension Plan | Significant Other Unobservable Inputs (Level 3) | Insurance Contracts
Defined Benefit Plan, Changes in Fair Value of Non-U.S. Pension Plan Insurance Contracts Classified as Level 3
Beginning balance	22	19
Unrealized gains relating to instruments still held at the reporting date	3	1
Purchases, sales, issuances and settlements (net)	1	2
Foreign currency translation	2	0
Ending balance	$ 28	$ 22

Stock Compensation Plans - Narr

Stock Compensation Plans - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Potential shares of common stock issued under current stock compensation plan (in shares)	18,000,000
Stock compensation plan, expiration date	Apr. 9, 2027
Contractual term	7 years 6 months
Aggregate intrinsic value of options exercised	$ 0	$ 3	$ 9
Unearned compensation cost related to unvested portion	$ 22
Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares that count towards shares authorized limit per share granted (in shares)	1
Vesting period	4 years
Stock options conversion basis (in shares)	1
Contractual term	10 years
Cancellation, days after termination of employment	90 days
Options | Year 1
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	25.00%
Options | Year 2
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	25.00%
Options | Year 3
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	25.00%
Options | Year 4
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage	25.00%
Awards, Excluding Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares that count towards shares authorized limit per share granted (in shares)	2
Performance Share Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award performance period	3 years
Performance Share Units | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of units earned to units granted	0.00%	0.00%	0.00%
Performance Share Units | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of units earned to units granted	133.00%	200.00%	200.00%
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award performance period	3 years

Stock Compensation Plans - Opti

Stock Compensation Plans - Options (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Options Outstanding Activity
Options outstanding, beginning of period (in shares)	4,998,021
Options granted (in shares)	4,167,384
Options exercised (in shares)	(20,218)
Options expired (in shares)	(370,938)
Options cancelled (in shares)	(73,517)
Options outstanding, end of period (in shares)	8,700,732	4,998,021
Weighted Average Exercise Price
Options outstanding, beginning of period (in dollars per share)	$ 20.61
Options granted (in dollars per share)	10.12
Options exercised (in dollars per share)	12.68
Options expired (in dollars per share)	12.44
Options cancelled (in dollars per share)	18.83
Options outstanding, end of period (in dollars per share)	$ 15.97	$ 20.61
Other Options Information
Options vested and expected to vest (in shares)	8,604,644
Options exercisable (in shares)	4,462,091
Options available for grant (in shares)	6,659,546
Options vested and expected to vest, weighted average exercise price (in dollars per share)	$ 16
Options exercisable, weighted average exercise price (in dollars per share)	$ 20.98
Options outstanding, weighted average remaining contractual term	5 years 10 months 24 days
Options vested and expected to vest, weighted average remaining contractual term	5 years 10 months 24 days
Options exercisable, weighted average remaining contractual term	2 years 10 months 24 days
Options exercised, aggregate intrinsic value	$ 0	$ 3	$ 9
Options outstanding, aggregate intrinsic value	3
Options vested and expected to vest, aggregate intrinsic value	3
Options exercisable, aggregate intrinsic value	$ 0

Stock Compensation Plans - Op_2

Stock Compensation Plans - Option Groups Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	8,700,732	4,998,021
Options exercisable (in shares)	4,462,091
Options remaining contractual term	5 years 10 months 24 days
Grant Date February 25 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	4,142,384
Options exercisable (in shares)	0
Options exercise price (in dollars per share)	$ 10.12
Options remaining contractual term	9 years 1 month 28 days
Grant Date February 27 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	556,409
Options exercisable (in shares)	465,203
Options exercise price (in dollars per share)	$ 35.26
Options remaining contractual term	6 years 1 month 28 days
Grant Date February 22 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	542,625
Options exercisable (in shares)	542,625
Options exercise price (in dollars per share)	$ 29.90
Options remaining contractual term	5 years 1 month 24 days
Grant Date February 23 2015
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	493,730
Options exercisable (in shares)	493,730
Options exercise price (in dollars per share)	$ 27.16
Options remaining contractual term	4 years 1 month 24 days
Grant Date February 24 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	381,617
Options exercisable (in shares)	381,617
Options exercise price (in dollars per share)	$ 26.44
Options remaining contractual term	3 years 1 month 24 days
Grant Date February 28 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	904,580
Options exercisable (in shares)	904,580
Options exercise price (in dollars per share)	$ 12.98
Options remaining contractual term	2 years 1 month 28 days
Grant Date February 27 2012
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	721,878
Options exercisable (in shares)	721,878
Options exercise price (in dollars per share)	$ 12.94
Options remaining contractual term	1 year 1 month 28 days
Grant Date February 22 2011
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	523,979
Options exercisable (in shares)	523,979
Options exercise price (in dollars per share)	$ 13.91
Options remaining contractual term	1 month 24 days
All Other Grant Dates
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding (in shares)	433,530
Options exercisable (in shares)	428,479
Options remaining contractual term	3 years

Stock Compensation Plans - Op_3

Stock Compensation Plans - Option Groups Outstanding (Parenthetical) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price for options outstanding (in dollars per share)	$ 15.97	$ 20.61
Weighted average exercise price for options exercisable (in dollars per share)	$ 20.98
Options outstanding, weighted average remaining contractual term	5 years 10 months 24 days
Options exercisable, weighted average remaining contractual term	2 years 10 months 24 days
All Other Grant Dates
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Other options exercise price range, lower range limit (in dollars per share)	$ 9.54
Other options exercise price range, upper range limit (in dollars per share)	32.72
Weighted average exercise price for options outstanding (in dollars per share)	21.45
Weighted average exercise price for options exercisable (in dollars per share)	$ 21.32
Options outstanding, weighted average remaining contractual term	3 years
Options exercisable, weighted average remaining contractual term	3 years

Stock Compensation Plans - Weig

Stock Compensation Plans - Weighted Average Grant Date Fair Values of Stock Options and the Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2020$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Weighted average grant date fair value	$ 10.12
Black-Scholes model assumptions:
Expected term (years)	7 years 6 months
Interest rate	1.29%
Volatility	41.28%
Dividend yield	6.54%

Stock Compensation Plans - We_2

Stock Compensation Plans - Weighted Average Grant Date Fair Values of Stock Options and the Assumptions Used (Parenthetical) (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Black-Scholes model assumptions:
Options granted in period (in shares)	0	0

Stock Compensation Plans - Nonv

Stock Compensation Plans - Nonvested Share Activity (Details)	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Performance Share Units
Summary of Activity Related to Share-based Compensation
Unvested units, beginning of period (in shares) | shares	588,000
Units granted (in shares) | shares	171,871
Units vested (in shares) | shares	(154,141)
Units forfeited (in shares) | shares	(10,950)
Unvested units, end of period (in shares) | shares	594,780
Weighted Average Grant Date Fair Value Related to Share-based Compensation
Unvested units, beginning of period (in dollars per share) | $ / shares	$ 20.98
Units granted (in dollars per share) | $ / shares	7.59
Units vested (in dollars per share) | $ / shares	29.04
Units forfeited (in dollars per share) | $ / shares	20.92
Unvested units, end of period (in dollars per share) | $ / shares	$ 15.02
Restricted Stock Units
Summary of Activity Related to Share-based Compensation
Unvested units, beginning of period (in shares) | shares	2,734,475
Units granted (in shares) | shares	600,712
Units vested (in shares) | shares	(646,444)
Units forfeited (in shares) | shares	(119,870)
Unvested units, end of period (in shares) | shares	2,568,873
Weighted Average Grant Date Fair Value Related to Share-based Compensation
Unvested units, beginning of period (in dollars per share) | $ / shares	$ 23.21
Units granted (in dollars per share) | $ / shares	9.86
Units vested (in dollars per share) | $ / shares	24.50
Units forfeited (in dollars per share) | $ / shares	18.80
Unvested units, end of period (in dollars per share) | $ / shares	$ 19.50

Stock Compensation Plans - Stoc

Stock Compensation Plans - Stock-based Compensation Expense and Cash Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-based compensation expense recognized	$ 31	$ 27	$ 16
Tax benefit	(8)	(7)	(4)
After-tax stock-based compensation expense	23	20	12
Cash payments to settle SARs	0	0	1
Cash received from stock option exercises	$ 0	$ 2	$ 9

Commitments and Contingent Li_3

Commitments and Contingent Liabilities - Narrative (Details) € in Millions, zł in Millions, claim in Millions	May 28, 2020employee	Dec. 31, 2020USD ($)employeeclaim	Dec. 31, 2020EUR (€)employee	Dec. 31, 2020EUR (€)claim	Dec. 31, 2020PLN (zł)claim	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2017PLN (zł)	Dec. 31, 2015USD ($)
Loss Contingencies [Line Items]
Liability for anticipated environmental matters		$ 64,000,000				$ 48,000,000
Charge for environmental remediation liability at a closed facility		13,000,000
Liability for anticipated environment matters, current		16,000,000				13,000,000
Workers' compensation liability		196,000,000				198,000,000
Workers' compensation liability, current		29,000,000				39,000,000
Commitments on contracts that extend beyond one year		1,000,000,000
Off-balance sheet financial guarantees and other commitments		73,000,000				74,000,000
Warranty reserve		22,000,000				22,000,000	$ 18,000,000
Corporate Joint Venture
Loss Contingencies [Line Items]
Financing receivable, joint venture, face amount		100,000,000
Loans receivable, related parties		14,000,000
Accounts receivable
Loss Contingencies [Line Items]
Indemnification asset		1,000,000
Other Assets
Loss Contingencies [Line Items]
Indemnification asset		23,000,000
Workers' Compensation
Loss Contingencies [Line Items]
Potential workers' compensation liability in excess of recorded amount		25,000,000
General Product Liability
Loss Contingencies [Line Items]
Product liability and other tort claims liability		285,000,000				293,000,000
General Product Liability | Other Current Liabilities
Loss Contingencies [Line Items]
Product liability and other tort claims liability		38,000,000				43,000,000
Asbestos Related Product Liability
Loss Contingencies [Line Items]
Product liability and other tort claims liability		$ 149,000,000				153,000,000
Asbestos claims dismissed to date (in claims) | claim		154,200		154,200	154,200
Accrued asbestos-related liability and gross payments to date		$ 563,000,000				554,000,000
Product liability contingency, evaluation period		10 years	10 years
Asbestos claims receivable		$ 90,000,000				95,000,000
Expected percentage of asbestos claim related losses recoverable through insurance		60.00%		60.00%	60.00%
Asbestos claims receivable, current		$ 13,000,000				13,000,000
Limits of excess insurance policies						$ 550,000,000
Amiens Labor Claims
Loss Contingencies [Line Items]
Loss contingency, number of plaintiffs | employee	790	850	850
Contingent loss		$ 172,000,000		€ 140
Loss contingency, accrual		30,000,000	€ 27
Unfavorable Regulatory Action
Loss Contingencies [Line Items]
Guarantee issued		49,000,000			zł 181			$ 44,000,000	zł 165
Workers' Compensation Claims
Loss Contingencies [Line Items]
Guarantee issued		$ 23,000,000								$ 46,000,000

Commitments and Contingent Li_4

Commitments and Contingent Liabilities - Asbestos Claims Activity (Details) - Asbestos Related Product Liability $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)claim	Dec. 31, 2019USD ($)claim	Dec. 31, 2018USD ($)claim
Number of claims filed
Pending claims, beginning of year	39,600	43,100	54,300
New claims filed during the year	1,100	1,500	1,300
Claims settled/dismissed	(2,000)	(5,000)	(12,500)
Pending claims, end of year	38,700	39,600	43,100
Payments | $	$ 13	$ 22	$ 18

Commitments and Contingent Li_5

Commitments and Contingent Liabilities - Changes in Warranty Reserve (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Movement in Standard and Extended Product Warranty
Warranty reserve, beginning of period	$ 22	$ 18
Payments made during the period	(21)	(25)
Expense recorded during the period	21	29
Translation adjustment	0	0
Warranty reserve, end of period	$ 22	$ 22

Capital Stock - Narrative (Deta

Capital Stock - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class Of Stock [Line Items]
Common stock cash dividends paid	$ 37	$ 148	$ 138
Dividends, share-based compensation	1	2	1
Common stock repurchased	0	0	220
Common Stock
Class Of Stock [Line Items]
Common stock cash dividends paid	$ 37	$ 148	138
Common stock repurchased			$ 220
Common stock repurchased (in shares)	0	0	8,936,302
Common Stock | Payments for Share Repurchases Related to Employee Stock Based Compensation
Class Of Stock [Line Items]
Common stock repurchased (in shares)	0	0	0

Reclassifications out of Accu_3

Reclassifications out of Accumulated Other Comprehensive Loss - Changes in AOCL (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 4,545	$ 5,070	$ 4,850
Ending balance	3,259	4,545	5,070
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(1,156)	(1,160)	(915)
Other comprehensive income (loss) before reclassifications	(128)	4	(245)
Amounts reclassified from accumulated other comprehensive loss	0	0	0
Ending balance	(1,284)	(1,156)	(1,160)
Unrecognized Net Actuarial Losses and Prior Service Costs
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(2,983)	(2,923)	(3,052)
Other comprehensive income (loss) before reclassifications	(4)	(168)	4
Amounts reclassified from accumulated other comprehensive loss	131	108	125
Ending balance	(2,856)	(2,983)	(2,923)
Deferred Derivative Gains (Losses)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	3	7	(9)
Other comprehensive income (loss) before reclassifications	15	10	9
Amounts reclassified from accumulated other comprehensive loss	(13)	(14)	7
Ending balance	5	3	7
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(4,136)	(4,076)	(3,976)
Other comprehensive income (loss) before reclassifications	(117)	(154)	(232)
Amounts reclassified from accumulated other comprehensive loss	118	94	132
Ending balance	$ (4,135)	$ (4,136)	$ (4,076)

Reclassifications out of Accu_4

Reclassifications out of Accumulated Other Comprehensive Loss - Changes in AOCL (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
United Kingdom
Accumulated Other Comprehensive Income Loss [Line Items]
Adjustment for frozen plan	$ 27	$ (32)

Reclassifications out of Accu_5

Reclassifications out of Accumulated Other Comprehensive Loss - Schedule of Reclassifications (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other (Income) Expense	$ 119	$ 98	$ (174)
United States and Foreign Taxes	(110)	(474)	(303)
Goodyear Net Income (Loss)	(1,254)	(311)	693
Cost of Goods Sold	(10,337)	(11,602)	(11,961)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Goodyear Net Income (Loss)	118	94	132
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment Attributable to Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other (Income) Expense	144	137	139
Income (Loss) Attributable to Parent	173	143	164
United States and Foreign Taxes	(42)	(35)	(39)
Goodyear Net Income (Loss)	131	108	125
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment, Immediate Recognition of Prior Service and Gain (Loss) Attributable to Parent, Due to Divestitures
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other (Income) Expense	29	6	25
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
United States and Foreign Taxes	0	0	0
Goodyear Net Income (Loss)	(13)	(14)	7
Cost of Goods Sold	$ (13)	$ (14)	$ 7

Schedule II Valuation and Qua_2

Schedule II Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 111	$ 113	$ 116
Additions, charged (credited) to income	30	13	21
Additions, charged (credited) to AOCL	0	0	0
Deductions from reserves	(11)	(14)	(19)
Translation adjustment during period	5	(1)	(5)
Balance at end of period	150	111	113
Allowance for doubtful accounts | Accounting Standards Update 2016-13 | Revision of Prior Period, Accounting Standards Update, Adjustment
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	126
Balance at end of period		126
Valuation allowance — deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	982	317	318
Additions, charged (credited) to income	488	661	18
Additions, charged (credited) to AOCL	(1)	4	(1)
Deductions from reserves	0	0	0
Translation adjustment during period	0	0	(18)
Balance at end of period	$ 1,469	$ 982	$ 317

Schedule II Valuation and Qua_3

Schedule II Valuation and Qualifying Accounts (Parenthetical) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jan. 01, 2020
Valuation And Qualifying Accounts Disclosure [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 1, 2020
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member	us-gaap:AccountingStandardsUpdate201602Member	us-gaap:AccountingStandardsUpdate201409Member
Retained earnings	$ 4,809	$ 6,113
Accounts receivable	1,691	1,941
Deferred income taxes	$ 1,467	$ 1,527
Accounting Standards Update 2016-13 | Restatement Adjustment
Valuation And Qualifying Accounts Disclosure [Line Items]
Retained earnings				$ (12)
Accounts receivable				(15)
Deferred income taxes				$ 3